Profile image of Michael Berk

Prof Michael Berk

STAFF PROFILE

Position

Alfred Deakin Professor

Faculty

Faculty of Health

Department

School of Medicine

Campus

HERB

Publications

Filter by

2020

Differences in the immune-inflammatory profiles of unipolar and bipolar depression

A Brunoni, T Supasitthumrong, A Teixeira, E Vieira, W Gattaz, I Benseor, P Lotufo, B Lafer, M Berk, A Carvalho, M Maes

(2020), Vol. 262, pp. 8-15, Journal of Affective Disorders, C1

journal
2019

The role of depression pharmacogenetic decision support tools in shared decision making

K Arandjelovic, H Eyre, E Lenze, A Singh, M Berk, C Bousman

(2019), Vol. 126, pp. 87-94, Journal of neural transmission, Vienna, Austria, C1

journal

Could alzheimer's disease originate in the periphery and if so how so?

Gerwyn Morris, Michael Berk, Michael Maes, Basant Puri

(2019), Vol. 56, pp. 406-434, Molecular neurobiology, Berlin, Germany, C1

journal

Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder

Seetal Dodd, Adam Walker, Alan Brnabic, Nancy Hong, Amber Burns, Michael Berk

(2019), Vol. 21, pp. 142-150, Bipolar disorders, Chichester, Eng., C1

journal

Staged treatment and acceptability guidelines in early psychosis study (STAGES): a randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants

Brian O'Donoghue, Shona Francey, Barnaby Nelson, Aswin Ratheesh, Kelly Allott, Jessica Graham, Lara Baldwin, Mario Alvarez-Jimenez, Andrew Thompson, Alex Fornito, Andrea Polari, Michael Berk, Craig Macneil, Kingsley Crisp, Christos Pantelis, Hok Yuen, Susy Harrigan, Patrick McGorry

(2019), Vol. 13, pp. 953-960, Early intervention in psychiatry, Chichester, Eng., C1

journal

Association of depression with mortality in an elderly treated hypertensive population

Enayet Chowdhury, Michael Berk, Mark Nelson, Lindon Wing, Christopher Reid

(2019), Vol. 31, pp. 371-381, International psychogeriatrics, Cambridge, Eng., C1

journal

New drug candidates for depression - a nationwide population-based study

L Kessing, H Rytgaard, T Gerds, M Berk, C Ekstrm, P Andersen

(2019), Vol. 139, pp. 68-77, Acta psychiatrica Scandinavica, Chichester, Eng., C1

journal

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean

(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

journal

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: an integrative review of evidence, mechanisms, and clinical implications

Michele Fornaro, Annalisa Anastasia, Stefano Novello, Andrea Fusco, Riccardo Pariano, Domenico De Berardis, Marco Solmi, Nicola Veronese, Brendon Stubbs, Eduard Vieta, Michael Berk, Andrea de Bartolomeis, Andr Carvalho

(2019), Vol. 139, pp. 494-502, Pharmacological research, Amsterdam, The Netherlands, C1

journal

Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial

Jerome Sarris, Gerard Byrne, Con Stough, Chad Bousman, David Mischoulon, Jenifer Murphy, Patricia Macdonald, Laura Adams, Sonia Nazareth, Georgina Oliver, Lachlan Cribb, Karen Savage, Ranjit Menon, Suneel Chamoli, Michael Berk, Chee Ng

(2019), Vol. 245, pp. 1007-1015, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition

Diego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, Anthony Cleare, Arianna Florio, Daniel Dietch, John Geddes, Guy Goodwin, Heinz Grunze, Joseph Hayes, Ian Jones, Siegfried Kasper, Karine Macritchie, R McAllister-Williams, Richard Morriss, Sam Nayrouz, Sofia Pappa, Jair Soares, Daniel Smith, Trisha Suppes, Peter Talbot, Eduard Vieta, Stuart Watson, Lakshmi Yatham, Allan Young, Paul Stokes

(2019), Vol. 214, pp. 27-35, British journal of psychiatry, Cambridge, Eng., C1

journal

WFSBP guidelines on how to grade treatment evidence for clinical guideline development

Alkomiet Hasan, Borwin Bandelow, Lakshmi Yatham, Michael Berk, Peter Falkai, Hans-Jrgen Mller, Siegfried Kasper, WFSBP Guideline Task Force Chairs

(2019), Vol. 20, pp. 2-16, World journal of biological psychiatry, Abingdon, Eng., C1

journal

The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study

Pernille Ellegaard, Rasmus Licht, Ren Nielsen, Olivia Dean, Michael Berk, Henrik Poulsen, Mohammadreza Mohebbi, Connie Nielsen

(2019), Vol. 245, pp. 1043-1051, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Michael Berk, Alyna Turner, Gin Malhi, Chee Ng, Susan Cotton, Seetal Dodd, Yuval Samuni, Michelle Tanious, Claire McAulay, Nathan Dowling, Jerome Sarris, Lauren Owen, Astrid Waterdrinker, Deidre Smith, Olivia Dean

(2019), Vol. 17, pp. 1-11, BMC medicine, London, Eng., C1

journal

The impact of urbanization on mood disorders: an update of recent evidence

Erin Hoare, Felice Jacka, Michael Berk

(2019), Vol. 32, pp. 198-203, Current opinion in psychiatry, Philadelphia, Pa., C1

journal

Socioeconomic deprivation, adverse childhood experiences and medical disorders in adulthood: mechanisms and associations

Gerwyn Morris, Michael Berk, Michael Maes, Andr Carvalho, Basant Puri

(2019), Vol. 56, pp. 5866-5890, Molecular neurobiology, New York, N.Y., C1

journal

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

Oliver Robertson, Nieves Coronado, Rickinder Sethi, Michael Berk, Seetal Dodd

(2019), Vol. 13, pp. 1032-1049, Early intervention in psychiatry, Chichester, Eng., C1

journal

Improving functional outcomes in early-stage bipolar disorder: the protocol for the REsearch into COgnitive and behavioural VERsatility trial

Sue Cotton, Michael Berk, Henry Jackson, Greg Murray, Kate Filia, Melissa Hasty, Andrew Chanen, Christopher Davey, Barnaby Nelson, Aswin Ratheesh, Craig MacNeil

(2019), pp. 1-10, Early intervention in psychiatry, Chichester, Eng., C1

journal

Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?

Gerwyn Morris, Michael Maes, Michael Berk, Basant Puri

(2019), Vol. 34, pp. 385-415, Metabolic brain disease, New York, N.Y., C1

journal

Bipolar disorder and bone health: a systematic review

Vinoomika Chandrasekaran, Sharon Brennan-Olsen, Amanda Stuart, Julie Pasco, Michael Berk, Jason Hodge, Lana Williams

(2019), Vol. 249, pp. 262-269, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Development of a miniature device for emerging deep brain stimulation paradigms

Scott Adams, Kevin Bennet, Susannah Tye, Michael Berk, Abbas Kouzani

(2019), Vol. 14, pp. 1-17, PLoS one, San Francisco, Calif., C1

journal

Buffering against maladaptive perfectionism in bipolar disorder: the role of self-compassion

Kathryn Fletcher, Yan Yang, Sheri Johnson, Michael Berk, Tania Perich, Sue Cotton, Steven Jones, Sara Lapsley, Erin Michalak, Greg Murray

(2019), Vol. 250, pp. 132-139, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Association between solar insolation and a history of suicide attempts in bipolar I disorder

Michael Bauer, Tasha Glenn, Martin Alda, Ole Andreassen, Elias Angelopoulos, Raffaella Ardau, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard Baune, Claudia Becerra-Palars, Frank Bellivier, Robert Belmaker, Michael Berk, Yuly Bersudsky, ?ule Bicakci, Harriet Birabwa-Oketcho, Thomas Bjella, Jorge Cabrera, Eric Wo Cheung, Maria Del Zompo, Seetal Dodd, Markus Donix, Bruno Etain, Andrea Fagiolini, Kostas Fountoulakis, Mark Frye, Ana Gonzalez-Pinto, John Gottlieb, Paul Grof, Hirohiko Harima, Chantal Henry, Erkki Isomets, Sven Janno, Flvio Kapczinski, Mathias Kardell, Slim Khaldi, Sebastian Kliwicki, Barbara Knig, Timur Kot, Rikke Krogh, Mauricio Kunz, Beny Lafer, Mikael Landn, Erik Larsen, Ute Lewitzka, Rasmus Licht, Carlos Lopez-Jaramillo, Glenda MacQueen, Mirko Manchia, Wendy Marsh, Mnica Martinez-Cengotitabengoa, Ingrid Melle, Ftima Meza-Urza, Mok Ming, Scott Monteith, Gunnar Morken, Enrica Mosca, Anton Mozzhegorov, Rodrigo Munoz, Starlin Mythri, Fethi Nacef, Ravi Nadella, Fabiano Nery, Ren Nielsen, Claire O'Donovan, Adel Omrani, Yamima Osher, Helle Srensen, Uta Ouali, Yolanda Ruiz, Maximilian Pilhatsch, Marco Pinna, Francisco da Ponte, Danilo Quiroz, Raj Ramesar, Natalie Rasgon, M Reddy, Andreas Reif, Philipp Ritter, Janusz Rybakowski, Kemal Sagduyu, Bharathram Raghuraman, ngela Scippa, Emanuel Severus, Christian Simhandl, Paul Stackhouse, Dan Stein, Sergio Strejilevich, Mythily Subramaniam, Ahmad Sulaiman, Kirsi Suominen, Hiromi Tagata, Yoshitaka Tatebayashi, Leonardo Tondo, Carla Torrent, Arne Vaaler, Edgar Vares, Julia Veeh, Eduard Vieta, Biju Viswanath, Maria Yoldi-Negrete, Mark Zetin, Yosra Zgueb, Peter Whybrow

(2019), Vol. 113, pp. 1-9, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal

Statins and inflammation: new therapeutic opportunities in psychiatry

Sung-Wan Kim, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam Walker, Bruno Agustini, Jae-Min Kim, Michael Berk

(2019), Vol. 10, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal

New drug candidates for bipolar disorder- a nation-wide population-based study

Lars Kessing, Helene Rytgaard, Thomas Gerds, Michael Berk, Claus Ekstrm, Per Andersen

(2019), Vol. 21, pp. 410-418, Bipolar disorders, Chichester, Eng., C1

journal

The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia

Melanie Ashton, Olivia Dean, Adam Walker, Chiara Bortolasci, Chee Ng, Malcolm Hopwood, Brian Harvey, Marisa Mller, John McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James Scott, Jon-Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk

(2019), Vol. 10, pp. 1-17, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal

Protocol and rationale: a 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostanaLinn. (mangosteen) pericarp for schizophrenia

Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk

(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1

journal

Variation in the prevalence of depression and patterns of association, sociodemographic and lifestyle factors in community-dwelling older adults in six low- and middle-income countries

Mojtaba Lotfaliany, Erin Hoare, Felice Jacka, Paul Kowal, Michael Berk, Mohammadreza Mohebbi

(2019), Vol. 251, pp. 218-226, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review

Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Bianca Kavanagh, Lana Williams, Jerome Sarris, Olivia Dean

(2019), Vol. 9, BMJ Open, London, Eng., C1

journal

Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis

Carmen Lim, Andrea Baker, Sukanta Saha, Sharon Foley, Anne Gordon, David Ward, Bjorn Burgher, Frances Dark, Martin Beckmann, Stephen Stathis, George Bruxner, Alex Ryan, Drew Richardson, Sean Hatherill, Michael Berk, Olivia Dean, John McGrath, Cadence Working Group, James Scott

(2019), Vol. 20, Trials, London, Eng., C1

journal

Childbirth and prevention of bipolar disorder: an opportunity for change

Verinder Sharma, Veerle Bergink, Michael Berk, Prabha Chandra, Trine Munk-Olsen, Adele Viguera, Lakshmi Yatham

(2019), Vol. 6, pp. 786-792, Lancet psychiatry, Amsterdam, The Netherlands, C1

journal

Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States

Mohammadreza Mohebbi, Bruno Agustini, Robyn Woods, John McNeil, Mark Nelson, Raj Shah, Van Nguyen, Elsdon Storey, Anne Murray, Christopher Reid, Brenda Kirpach, Rory Wolfe, Jessica Lockery, Michael Berk, ASPREE Investigator Group

(2019), Vol. 34, pp. 1208-1216, International journal of geriatric psychiatry, Chichester, Eng., C1

journal

Supporting engagement, adherence, and behavior change in online dietary interventions

Claire Young, Sara Campolonghi, Stephanie Ponsonby, Samantha Dawson, Adrienne O'Neil, Frances Kay-Lambkin, Sarah McNaughton, Michael Berk, Felice Jacka

(2019), Vol. 51, pp. 719-739, Journal of nutrition education and behavior, Amsterdam, The Netherlands, C1

journal

Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis

Bianca Kavanagh, Sharon Brennan-Olsen, Alyna Turner, Olivia Dean, Michael Berk, Melanie Ashton, Heli Koivumaa-Honkanen, Lana Williams

(2019), Vol. 9, BMJ open, London, Eng., C1

journal

Co-occurrence of depression with chronic diseases among the older population living in low- and middle-income countries: a compound health challenge

Mojtaba Lotfaliany, Bruno Agustini, Paul Kowal, Michael Berk, Mohammadreza Mohebbi

(2019), Vol. 31, pp. 95-105, Annals of clinical psychiatry, Montvale, N.J., C1

journal

Association between statin use and depressive symptoms in a large community-dwelling older population living in Australia and the USA: a cross-sectional study

Bruno Agustini, Mohammadreza Mohebbi, Robyn Woods, John McNeil, Mark Nelson, Raj Shah, Anne Murray, Michael Ernst, Christopher Reid, Andrew Tonkin, Jessica Lockery, Michael Berk, ASPREE Investigator Group

(2019), Vol. 33, pp. 685-694, CNS drugs, Cham, Switzerland, C1

journal

Supporting self-management in Bipolar Disorder: mixed-methods knowledge translation study

Erin Michalak, Emma Morton, Steven Barnes, Rachelle Hole, Greg Murray, CREST.BD, Michael Berk

(2019), Vol. 6, JMIR mental health, Toronto, Ont., C1

journal

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial

Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean

(2019), Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

journal

Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis

Wolfgang Marx, Melissa Lane, Tetyana Rocks, Anu Ruusunen, Amy Loughman, Adrian Lopresti, Skye Marshall, Michael Berk, Felice Jacka, Olivia Dean

(2019), Vol. 77, pp. 557-571, Nutrition reviews, Oxford, Eng., C1

journal

The potential of carnosine in brain-related disorders: a comprehensive review of current evidence

M Schn, A Mousa, M Berk, W Chia, J Ukropec, A Majid, B Ukropcov, B De Courten

(2019), Vol. 11, pp. 1-26, Nutrients, Basel, Switzerland, C1

journal

Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity

Hajara Aslam, Anu Ruusunen, Michael Berk, Amy Loughman, Leni Rivera, Julie Pasco, Felice Jacka

(2019), pp. 1-14, International journal of food sciences and nutrition, Abingdon, Eng., C1

journal

Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol

Hailey Tremain, Kathryn Fletcher, Jan Scott, Carla McEnery, Michael Berk, Greg Murray

(2019), Vol. 8, pp. 1-10, Systematic reviews, London, Eng., C1

journal

A study protocol for the N-ICE trial: a randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence

Rebecca McKetin, Olivia Dean, Alyna Turner, Peter Kelly, Brendan Quinn, Dan Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Amanda Baker, Barbara Sinclair, David Reid, Victoria Manning, Nina Te Pas, Wenbin Liang, Tamsin Thomas, Ramez Bathish, Margaret Kent, Dayle Raftery, Shalini Arunogiri, Frank Cordaro, Harry Hill, Michael Berk

(2019), Vol. 20, pp. 1-11, Trials, London, Eng., C1

journal

Lessons from Iceland: developing scalable and sustainable community approaches for the prevention of mental disorders in young Australians

E Hoare, I Thorisdttir, A Kristjansson, I Sigfusdttir, J Hayward, S Allender, C Strugnell, N Reavley, G Patton, M Berk, F Jacka

(2019), Vol. 15, pp. 1-4, Mental health and prevention, Amsterdam, The Netherlands, C1

journal

A neuroethics framework for the Australian brain initiative

J Kennett, A Carter, J Bourne, W Hall, N Levy, J Mattingley, A Lawrence, C Forlini, L Malcolm, N Vincent, L Richards, G Egan, M Breakspear, K Cornish, G Halliday, L Poole-Warren, S Sriram, T Soulis, B Fitzgibbon, I Kiral-Kornek, D Badcock, B Balleine, J Bekkers, M Berk, A Bradley, M Breakspear, A Brichta, A Carter, O Carter, A Castles, J Clements, J Cornish, G de Zubicaray, G Egan, P Enticott, A Fornito, L Griffiths, J Gullifer, A Hannan, S Harrer, A Harvey, I Hickie, L Jazwinska, M Kiernan, T Kilpatrick, R Leventer, J Licinio, N Lovell, G Mackellar, S Medland, P Michie, J Nithianantharajah, J Parker, J Payne, S Rossell, P Sah, Z Sarnyai, P Schofield, D Shum, T Silk, M Slee, S Sriram, G Stuart, J Tapson, A van Schaik, B Vissel, A Waters, D Apthorp, A Carter, S Cohen-Woods, S Conn, M Korgaonkar, A Mason, M Azghadi, O Shimoni, A Smith, M Thompson

(2019), Vol. 101, pp. 365-369, Neuron, Cambridge, Eng., C1

journal

The case for improved care and provision of treatment for people with first-episode mania

S Jauhar, A Ratheesh, C Davey, L Yatham, P McGorry, P McGuire, M Berk, A Young

(2019), Vol. 6, pp. 869-876, The lancet psychiatry, Amsterdam, The Netherlands, C1

journal

Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects

B Agustini, M Bocharova, A Walker, M Berk, A Young, M Juruena

(2019), Vol. 256, pp. 584-593, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Beyond evidence-based treatment of bipolar disorder: rational pragmatic approaches to management

R Post, L Yatham, E Vieta, M Berk, A Nierenberg

(2019), Vol. 21, pp. 650-659, Bipolar disorders, Chichester, Eng., C1

journal

The compensatory antioxidant response system with a focus on neuroprogressive disorders

G Morris, B Puri, A Walker, M Berk, K Walder, C Bortolasci, W Marx, A Carvalho, M Maes

(2019), Vol. 95, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial

C Davey, A Chanen, S Hetrick, S Cotton, A Ratheesh, G Amminger, J Koutsogiannis, M Phelan, E Mullen, B Harrison, S Rice, A Parker, O Dean, A Weller, M Kerr, A Quinn, L Catania, N Kazantzis, P McGorry, M Berk

(2019), Vol. 6, pp. 735-744, The Lancet Psychiatry, Amsterdam, The Netherlands, C1

journal

Early intervention for bipolar disorder - do current treatment guidelines provide recommendations for the early stages of the disorder?

M Chia, S Cotton, K Filia, M Phelan, P Conus, S Jauhar, S Marwaha, P McGorry, C Davey, M Berk, A Ratheesh

(2019), Vol. 257, pp. 669-677, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A case of antibiotic-associated mania in a 67-year-old woman

P Navaln, Y Caada, M Merizalde, P Sierra, A Garca-Blanco, A Domnguez-Carabantes, M Berk

(2019), Vol. 21, pp. 670-672, Bipolar Disorders, London, Eng., C1

journal

Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: Association with inflammation, oxidative and nitrosative stress and autoimmune responses

G Morris, B Puri, L Olive, A Carvalho, M Berk, M Maes

(2019), Vol. 148, pp. 1-14, Pharmacological Research, Amsterdam, The Netherlands, C1

journal

International society for nutritional psychiatry research practice guidelines for Omega-3 fatty acids in the treatment of major depressive disorder

T Guu, D Mischoulon, J Sarris, J Hibbeln, R McNamara, K Hamazaki, M Freeman, M Maes, Y Matsuoka, R Belmaker, F Jacka, C Pariante, M Berk, W Marx, K Su

(2019), Vol. 88, pp. 263-273, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal

Mapping cancer incidence across Western Victoria: The association with age, accessibility, and socioeconomic status among men and women

S Cowdery, M Sajjad, K Holloway-Kew, M Mohebbi, L Williams, M Kotowicz, P Livingston, M Khasraw, S Hakkennes, T Dunning, S Brumby, R Page, A Sutherland, S Brennan-Olsen, M Berk, D Campbell, J Pasco

(2019), Vol. 19, pp. 1-10, BMC cancer, London, Eng., C1

journal

Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? - A monozygotic twin study

N Ottesen, I Meluken, R Frikke-Schmidt, P Plomgaard, T Scheike, B Fernandes, M Berk, H Poulsen, L Kessing, K Miskowiak, M Vinberg

(2019), pp. 1-10, Psychological Medicine, Cambridge, Eng., C1

journal

An international society of bipolar disorders task force report: precursors and prodromes of bipolar disorder

Gianni Faedda, Ross Baldessarini, Ciro Marangoni, Andreas Bechdolf, Michael Berk, Boris Birmaher, Philippe Conus, Melissa DelBello, Anne Duffy, Manon Hillegers, Andrea Pfennig, Robert Post, Martin Preisig, Aswin Ratheesh, Paola Salvatore, Mauricio Tohen, Gustavo Vazquez, Eduard Vieta, Lakshmi Yatham, Eric Youngstrom, Anna Van Meter, Christoph Correll

(2019), Bipolar disorders, Chichester, Eng., C1

journal

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

L Arancini, C Bortolasci, S Dodd, O Dean, M Berk

(2019), Vol. 20, pp. 1-7, Trials, London, Eng., C1

journal

Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders

Rickinder Sethi, Nieves Gomez-Coronado, Adam Walker, Oliver Robertson, Bruno Agustini, Michael Berk, Seetal Dodd

(2019), Vol. 10, pp. 1-21, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal

Myalgic encephalomyelitis/chronic fatigue syndrome: from pathophysiological insights to novel therapeutic opportunities

G Morris, B Puri, A Walker, M Maes, A Carvalho, K Walder, C Mazza, M Berk

(2019), Vol. 148, pp. 1-20, Pharmacological research, Amsterdam, The Netherlands, C1

journal

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials

J Firth, S Teasdale, K Allott, D Siskind, W Marx, J Cotter, N Veronese, F Schuch, L Smith, M Solmi, A Carvalho, D Vancampfort, M Berk, B Stubbs, J Sarris

(2019), Vol. 18, pp. 308-324, World psychiatry, Chichester, Eng., C1

journal

Drugs used in the treatment of bipolar disorder and their effects on cholesterol biosynthesis - A possible therapeutic mechanism

S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2019), pp. 1-12, World Journal of Biological Psychiatry, London, Eng., C1

journal

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

G Morris, B Puri, A Walker, M Maes, A Carvalho, C Bortolasci, K Walder, M Berk

(2019), Vol. 107, pp. 862-882, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

EPA and DHA as markers of nutraceutical treatment response in major depressive disorder

K van der Burg, L Cribb, J Firth, D Karmacoska, D Mischoulon, G Byrne, C Bousman, C Stough, J Murphy, G Oliver, M Berk, C Ng, J Sarris

(2019), European journal of nutrition, New York, N.Y., C1

journal

Promotion of wellbeing for children of parents with mental illness: a model protocol for research and intervention

Charlotte Reedtz, Karin van Doesum, Giulia Signorini, Camilla Lauritzen, Therese van Amelsvoort, Floor van Santvoort, Allan Young, Philippe Conus, Richard Musil, Thomas Schulze, Michael Berk, Argyris Stringaris, Genevieve Piche, Giovanni de Girolamo

(2019), Vol. 10, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal

Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients

M Subbanna, V Shivakumar, D Venugopal, J Narayanaswamy, M Berk, S Varambally, G Venkatasubramanian, M Debnath

(2019), Psychiatry and clinical neurosciences, Chichester, Eng., C1

journal

Opportunities in the Australian national education initiative for promoting mental health in schools

Erin Hoare, Andrew Thorp, Nadine Bartholomeusz-Raymond, Alicia McCoy, Michael Berk

(2019), The Lancet Child & Adolescent Health, C1

journal

An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorder

M Kowalczyk, J Szemraj, K Bli?niewska, M Maes, M Berk, K Su, P Ga?ecki

(2019), Vol. 71, pp. 1299-1307, Pharmacological Reports, C1

journal
2018

Falls and depression in men: a population-based study

A Stuart, J Pasco, F Jacka, M Berk, L Williams

(2018), Vol. 12, pp. 14-18, American journal of men's health, New York, N. Y., C1

journal

Youth depression alleviation-augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schfer, E Mullen, S Hetrick, P McGorry, M Berk

(2018), Vol. 12, pp. 45-54, Early intervention in psychiatry, London, Eng., C1

journal

Functional implications of the IL-23/IL-17 immune axis in schizophrenia

M Debnath, M Berk

(2018), Vol. 54, pp. 8170-8178, Molecular neurobiology, Berlin, Germany, C1

journal

A comparison of neuroimaging abnormalities in multiple sclerosis, major depression and chronic fatigue syndrome (myalgic encephalomyelitis): is there a common cause?

G Morris, M Berk, B Puri

(2018), Vol. 55, pp. 3592-3609, Molecular neurobiology, Cham, Switzerland, C1

journal

The limitations of using randomised controlled trials as a basis for developing treatment guidelines

R Mulder, A Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, B Baune, M Berk, P Boyce, B Lyndon, G Parker, G Malhi

(2018), Vol. 21, pp. 4-6, Evidence-based mental health, London, Eng., C1

journal

Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome

S Kim, H Kang, K Bae, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon, J Kim

(2018), Vol. 80, pp. 250-254, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal

Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials

D Brownstein, E Salagre, C Khler, B Stubbs, J Vian, C Pereira, V Chavarria, C Karmakar, A Turner, J Quevedo, A Carvalho, M Berk, B Fernandes

(2018), Vol. 52, pp. 24-38, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis

A Ratheesh, S Cotton, C Davey, A Lin, S Wood, H Yuen, A Bechdolf, P McGorry, A Yung, M Berk, B Nelson

(2018), Vol. 192, pp. 345-350, Schizophrenia research, Amsterdam, The Netherlands, C1-1

journal

The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases

G Morris, K Walder, A Carvalho, S Tye, K Lucas, M Berk, M Maes

(2018), Vol. 84, pp. 453-469, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Cognition in depression: can we THINC-it better?

B Baune, G Malhi, G Morris, T Outhred, A Hamilton, P Das, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2018), Vol. 225, pp. 559-562, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults.

M Mohebbi, V Nguyen, J McNeil, R Woods, M Nelson, R Shah, E Storey, A Murray, C Reid, B Kirpach, R Wolfe, J Lockery, M Berk, ASPREE Investigator Group

(2018), Vol. 51, pp. 118-125, General hospital psychiatry, Amsterdam, The Netherlands, C1

journal

A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression

C Roomruangwong, G Anderson, M Berk, D Stoyanov, A Carvalho, M Maes

(2018), Vol. 81, pp. 262-274, Progress in neuropsychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: an international consensus statement

S Dodd, P Mitchell, M Bauer, L Yatham, A Young, S Kennedy, L Williams, T Suppes, C Lopez Jaramillo, M Trivedi, M Fava, A Rush, R McIntyre, M Thase, R Lam, E Severus, S Kasper, M Berk

(2018), Vol. 19, pp. 330-348, World journal of biological psychiatry, London, Eng., C1

journal

Cell death pathways: a novel therapeutic approach for neuroscientists

G Morris, A Walker, M Berk, M Maes, B Puri

(2018), Vol. 55, pp. 5767-5786, Molecular neurobiology, New York, N.Y., C1

journal

Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat

I Oberholzer, M Mller, B Holland, O Dean, M Berk, B Harvey

(2018), Vol. 33, pp. 467-480, Metabolic brain disease, New York, N.Y., C1

journal

Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies

D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray

(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis

J Firth, R Carney, B Stubbs, S Teasdale, D Vancampfort, P Ward, M Berk, J Sarris

(2018), Vol. 44, pp. 1275-1292, Schizophrenia bulletin, Oxford, Eng., C1

journal

Current and emerging pharmacotherapies for cessation of tobacco smoking

N Gmez-Coronado, A Walker, M Berk, S Dodd

(2018), Vol. 38, pp. 235-258, Pharmacotherapy, Chichester, Eng., C1

journal

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

G Morris, M Berk, A Carvalho, M Maes, A Walker, B Puri

(2018), Vol. 341, pp. 154-175, Behavioural brain research, Amsterdam, The Netherlands, C1

journal

Multiple immune-inflammatory and oxidative and nitrosative stress pathways explain the frequent presence of depression in Multiple Sclerosis

Gerwyn Morris, Edna Reiche, Andrea Murru, Andr Carvalho, Michael Maes, Michael Berk, Basant Puri

(2018), Vol. 55, pp. 6282-6306, Molecular neurobiology, New York, N.Y., C1

journal

Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis

Min Jhon, Taeyoung Yoo, Ju-Yeon Lee, Seon-Young Kim, Jae-Min Kim, Il-Seon Shin, Lana Williams, Michael Berk, Jin-Sang Yoon, Sung-Wan Kim

(2018), Vol. 33, pp. 1-8, Human Psychopharmacology, Chichester, Eng., C1

journal

Early intervention in Bipolar Disorder

Eduard Vieta, Estela Salagre, Iria Grande, Andr Carvalho, Brisa Fernandes, Michael Berk, Boris Birmaher, Mauricio Tohen, Trisha Suppes

(2018), Vol. 175, pp. 411-426, American journal of psychiatry, Arlington, Va., C1

journal

An update on adjunctive treatment options for bipolar disorder

O Dean, E Gliddon, T Van Rheenen, F Giorlando, S Davidson, M Kaur, T Ngo, L Williams

(2018), Vol. 20, pp. 87-96, Bipolar disorders, Chichester, Eng., C1

journal

An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction

S Adams, A Kouzani, S Tye, K Bennet, M Berk

(2018), Vol. 15, pp. 1-18, Journal of neuroengineering and rehabilitation, London, Eng., C1

journal

Selective serotonin reuptake inhibitors (SSRIs) and markers of bone turnover in men

Lana Williams, Michael Berk, Jason Hodge, Mark Kotowicz, Amanda Stuart, Vinoomika Chandrasekaran, Jasmine Cleminson, Julie Pasco

(2018), Vol. 103, pp. 125-130, Calcified tissue international, New York, N.Y., C1

journal

Mechanisms underpinning the polypharmacy effects of medications in psychiatry

Chiara Bortolasci, Briana Spolding, Edward Callaly, Sheree Martin, Bruna Panizzutti, Srisaiyini Kidnapillai, Timothy Connor, Kyoko Hasebe, Mohammadreza Mohebbi, Olivia Dean, Sean McGee, Seetal Dodd, Laura Gray, Michael Berk, Ken Walder

(2018), Vol. 21, pp. 582-591, The international journal of neuropsychopharmacology, Oxford, Eng., C1

journal

N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials

W Zheng, Q-E Zhang, D-B Cai, X-H Yang, Y Qiu, G Ungvari, C Ng, M Berk, Y-P Ning, Y-T Xiang

(2018), Vol. 137, pp. 391-400, Acta psychiatrica Scandinavica, Chichester, Eng., C1

journal

The subjective wellbeing profile of the 'pretiree' demographic: a cross-sectional study

Julie Pasco, Kara Holloway, Amanda Stuart, Lana Williams, Sharon Brennan-Olsen, Michael Berk

(2018), Vol. 110, pp. 111-117, Maturitas, Amsterdam, The Netherlands, C1

journal

Bipolar disorders

E Vieta, M Berk, T Schulze, A Carvalho, T Suppes, J Calabrese, K Gao, K Miskowiak, I Grande

(2018), Vol. 4, pp. 1-16, Nature reviews disease primers, London, Eng., C1

journal

Association between vitamin D insufficiency and metabolic syndrome in patients with psychotic disorders

T Yoo, W Choi, J-H Hong, J-Y Lee, J-M Kim, I-S Shin, S Yang, P Amminger, M Berk, J-S Yoon, S-W Kim

(2018), Vol. 15, pp. 396-401, Psychiatry Investigation, Soeul, South Korea, C1

journal

Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania

O Dandash, M Ycel, R Daglas, C Pantelis, P McGorry, M Berk, A Fornito

(2018), Vol. 8, pp. 1-9, Translational psychiatry, London, Eng., C1

journal

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

L Yatham, S Kennedy, S Parikh, A Schaffer, D Bond, B Frey, V Sharma, B Goldstein, S Rej, S Beaulieu, M Alda, G MacQueen, R Milev, A Ravindran, C O'Donovan, D McIntosh, R Lam, G Vazquez, F Kapczinski, R McIntyre, J Kozicky, S Kanba, B Lafer, T Suppes, J Calabrese, E Vieta, G Malhi, R Post, M Berk

(2018), Vol. 20, pp. 97-170, Bipolar disorders, London, Eng., C1

journal

Mitochondrial agents for bipolar disorder

Cria Pereira, Victor Chavarria, Joo Vian, Melanie Ashton, Michael Berk, Wolfgang Marx, Olivia Dean

(2018), Vol. 21, pp. 550-569, International journal of neuropsychopharmacology, London, Eng., C1

journal

The endoplasmic reticulum stress response in neuroprogressive diseases: emerging pathophysiological role and translational implications

Gerwyn Morris, Basant Puri, Ken Walder, Michael Berk, Brendon Stubbs, Michael Maes, Andr Carvalho

(2018), Vol. 55, pp. 8765-8787, Molecular neurobiology, New York, N.Y., C1

journal

Lithium and nephrotoxicity: unravelling the complex pathophysiological threads of the lightest metal

J Davis, M Desmond, M Berk

(2018), Vol. 23, pp. 897-903, Nephrology, Chichester, Eng., C1

journal

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

P Ellegaard, R Licht, H Poulsen, R Nielsen, M Berk, O Dean, M Mohebbi, C Nielsen

(2018), Vol. 6, pp. 1-9, International journal of bipolar disorders, Berlin, Germany, C1

journal

Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression

J Price, Carrie Bronars, Sophie Erhardt, Kathyrn Cullen, Lilly Schwieler, Michael Berk, Ken Walder, Sean McGee, Mark Frye, Susannah Tye

(2018), Vol. 90, pp. 212-220, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis

Gerwyn Morris, Brendon Stubbs, Cristiano Khler, Ken Walder, Anastasiya Slyepchenko, Michael Berk, Andr Carvalho

(2018), Vol. 41, pp. 255-265, Sleep medicine reviews, Amsterdam, The Netherlands, C1

journal

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the effects of N-acetylcysteine

O Dean, K Gray, Seetal Dodd, K Villagonzalo, E Browne, B Tonge, M Berk, L Byrne

(2018), pp. 1-7, Journal of intellectual and developmental disability, London, Eng., C1

journal

Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial)

Mary Chatterton, Cathrine Mihalopoulos, Adrienne O'Neil, Catherine Itsiopoulos, Rachelle Opie, David Castle, Sarah Dash, Laima Brazionis, Michael Berk, Felice Jacka

(2018), Vol. 18, BMC public health, London, Eng., C1

journal

Patient centric measures for a patient centric era: agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder

M Mohebbi, S Dodd, O Dean, M Berk

(2018), Vol. 53, pp. 17-22, European psychiatry, Amsterdam, The Netherlands, C1

journal

Ketamine and rapidly acting antidepressants: breaking the speed of sound or light?

Michael Berk, Collen Loo, Christopher Davey, Brian Harvey

(2018), Vol. 52, pp. 1026-1029, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder

Srisaiyini Kidnapillai, Chiara Bortolasci, Madhara Udawela, Bruna Panizzutti, Briana Spolding, Timothy Connor, Andrew Sanigorski, Olivia Dean, Tamsyn Crowley, Stphane Jamain, Laura Gray, Elizabeth Scarr, Marion Leboyer, Brian Dean, Michael Berk, Ken Walder

(2018), pp. 1-9, World journal of biological psychiatry, London, Eng., C1

journal

Psychopathological features of bipolar depression: Italian validation of the Bipolar Depression Rating Scale (I-BDRS).

Angelo Bruschi, Marianna Mazza, Giovanni Camardese, Salvatore Cal, Claudia Palumbo, Laura Mandelli, Antonino Callea, Alessio Gori, Marco Di Nicola, Giuseppe Marano, Michael Berk, Guido di Sciascio, Luigi Janiri

(2018), Vol. 9, Frontiers in psychology, Lausanne, Switzerland, C1

journal

Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

Bruna Panizzutti, Chiara Bortolasci, Kyoko Hasebe, Srisaiyini Kidnapillai, Laura Gray, Ken Walder, Michael Berk, Mohammadreza Mohebbi, Seetal Dodd, Clarissa Gama, Pedro Magalhes, Susan Cotton, Flvio Kapczinski, Ashley Bush, Gin Malhi, Olivia Dean

(2018), Vol. 30, pp. 334-341, Acta neuropsychiatrica, Cambridge, Eng., C1

journal

Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol

Kathryn Fletcher, Fiona Foley, Neil Thomas, Erin Michalak, Lesley Berk, Michael Berk, Steve Bowe, Sue Cotton, Lidia Engel, Sheri Johnson, Steven Jones, Michael Kyrios, Sara Lapsley, Cathrine Mihalopoulos, Tania Perich, Greg Murray

(2018), Vol. 18, pp. 1-13, BMC psychiatry, London, Eng., C1

journal

Efficacy of online lifestyle interventions targeting lifestyle behaviour change in depressed populations: a systematic review

Claire Young, Karen Trapani, Samantha Dawson, Adrienne O'Neil, Frances Kay-Lambkin, Michael Berk, Felice Jacka

(2018), Vol. 52, pp. 834-846, Australia and New Zealand journal of psychiatry, London, England, C1

journal

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial

Jerome Sarris, Gerard Byrne, Chad Bousman, Con Stough, Jenifer Murphy, Patricia MacDonald, Laura Adams, Sonia Nazareth, Georgina Oliver, Lachlan Cribb, Karen Savage, Ranjit Menon, Suneel Chamoli, Michael Berk, Chee Ng, David Mischoulon

(2018), Vol. 28, pp. 1126-1136, European neuropsychopharmacol, Amsterdam, The Netherlands, C1

journal

Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia

Manjula Subbanna, Venkataram Shivakumar, Pinku Talukdar, Janardhanan Narayanaswamy, Deepthi Venugopal, Michael Berk, Shivarama Varambally, Ganesan Venkatasubramanian, Monojit Debnath

(2018), Vol. 111, pp. 112-118, Cytokine, Amsterdam, The Netherlands, C1

journal

A review of the neurobiological underpinning of comorbid substance use and mood disorders

Nieves Gmez-Coronado, Rickinder Sethi, Chiara Bortolasci, Lauren Arancini, Michael Berk, Seetal Dodd

(2018), Vol. 241, pp. 388-401, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Depression and chronic diseases: co-occurrence and communality of risk factors

Mojtaba Lotfaliany, Steven Bowe, Paul Kowal, Liliana Orellana, Michael Berk, Mohammadreza Mohebbi

(2018), Vol. 241, pp. 461-468, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Internet use by older adults with bipolar disorder: international survey results

Rita Bauer, Tasha Glenn, Sergio Strejilevich, Jrn Conell, Martin Alda, Raffaella Ardau, Bernhard Baune, Michael Berk, Yuly Bersudsky, Amy Bilderbeck, Alberto Bocchetta, Angela Castro, Eric Cheung, Caterina Chillotti, Sabine Choppin, Alessandro Cuomo, Maria Del Zompo, Rodrigo Dias, Seetal Dodd, Anne Duffy, Bruno Etain, Andrea Fagiolini, Miryam Fernndez Hernandez, Julie Garnham, John Geddes, Jonas Gildebro, Michael Gitlin, Ana Gonzalez-Pinto, Guy Goodwin, Paul Grof, Hirohiko Harima, Stefanie Hassel, Chantal Henry, Diego Hidalgo-Mazzei, Anne Lund, Vaisnvy Kapur, Girish Kunigiri, Beny Lafer, Erik Larsen, Ute Lewitzka, Rasmus Licht, Blazej Misiak, Patryk Piotrowski, ngela Miranda-Scippa, Scott Monteith, Rodrigo Munoz, Takako Nakanotani, Ren Nielsen, Claire O'Donovan, Yasushi Okamura, Yamima Osher, Andreas Reif, Philipp Ritter, Janusz Rybakowski, Kemal Sagduyu, Brett Sawchuk, Elon Schwartz, Claire Slaney, Ahmad Sulaiman, Kirsi Suominen, Aleksandra Suwalska, Peter Tam, Yoshitaka Tatebayashi, Leonardo Tondo, Julia Veeh, Eduard Vieta, Maj Vinberg, Biju Viswanath, Mark Zetin, Peter Whybrow, Michael Bauer

(2018), Vol. 6, pp. 1-7, International journal of bipolar disorders, London, Eng., C1

journal

The impact of substance use disorders on recovery from bipolar depression: results from the systematic treatment enhancement program for Bipolar Disorder psychosocial treatment trial

A Gold, A Peters, M Otto, L Sylvia, P Magalhaes, M Berk, D Dougherty, D Miklowitz, E Frank, A Nierenberg, T Deckersbach

(2018), Vol. 52, pp. 847-855, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Leaky brain in neurological and psychiatric disorders: drivers and consequences

Gerwyn Morris, Brisa Fernandes, Basant Puri, Adam Walker, Andre Carvalho, Michael Berk

(2018), Vol. 52, pp. 924-948, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Effect of aspirin on all-cause mortality in the healthy elderly

John McNeil, Mark Nelson, Robyn Woods, Jessica Lockery, Rory Wolfe, Christopher Reid, Brenda Kirpach, Raj Shah, Diane Ives, Elsdon Storey, Joanne Ryan, Andrew Tonkin, Anne Newman, Jeff Williamson, Karen Margolis, Michael Ernst, Walter Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne Orchard, Ruth Trevaks, Lawrence Beilin, Geoffrey Donnan, Peter Gibbs, Colin Johnston, Barbara Radziszewska, Richard Grimm, Anne Murray, ASPREE Investigator Group, Michael Berk

(2018), Vol. 379, pp. 1519-1528, New England journal of medicine, Waltham, Mass., C1

journal

Effect of aspirin on disability-free survival in the healthy elderly

John McNeil, Robyn Woods, Mark Nelson, Christopher Reid, Brenda Kirpach, Rory Wolfe, Elsdon Storey, Raj Shah, Jessica Lockery, Andrew Tonkin, Anne Newman, Jeff Williamson, Karen Margolis, Michael Ernst, Walter Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne Orchard, Ruth Trevaks, Lawrence Beilin, Geoffrey Donnan, Peter Gibbs, Colin Johnston, Joanne Ryan, Barbara Radziszewska, Richard Grimm, Anne Murray, Michael Berk

(2018), Vol. 379, pp. 1499-1508, New England journal of medicine, Waltham, Mass., C1

journal

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

John McNeil, Rory Wolfe, Robyn Woods, Andrew Tonkin, Geoffrey Donnan, Mark Nelson, Christopher Reid, Jessica Lockery, Brenda Kirpach, Elsdon Storey, Raj Shah, Jeff Williamson, Karen Margolis, Michael Ernst, Walter Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne Orchard, Ruth Trevaks, Lawrence Beilin, Colin Johnston, Joanne Ryan, Barbara Radziszewska, Michael Jelinek, Mobin Malik, Charles Eaton, Donna Brauer, Geoff Cloud, Erica Wood, Suzanne Mahady, Suzanne Satterfield, Richard Grimm, Anne Murray, Michael Berk

(2018), Vol. 379, pp. 1509-1518, New England journal of medicine, Waltham, Mass., C1

journal

Revising Diagnostic and statistical manual of mental disorders, fifth edition, criteria for the bipolar disorders: phase I of the AREDOC project

Gordon Parker, Gabriela Tavella, Glenda Macqueen, Michael Berk, Heinz Grunze, Thilo Deckersbach, David Dunner, Martha Sajatovic, Jay Amsterdam, Terence Ketter, Lakshmi Yatham, Lars Kessing, Darryl Bassett, Mark Zimmerman, Kostas Fountoulakis, Anne Duffy, Martin Alda, Cynthia Calkin, Verinder Sharma, Amit Anand, Manpreet Singh, Tomas Hajek, Philip Boyce, Benicio Frey, David Castle, Allan Young, Eduard Vieta, Janusz Rybakowski, Holly Swartz, Ayal Schaffer, Greg Murray, Adam Bayes, Raymond Lam, Emre Bora, Robert Post, Michael Ostacher, Beny Lafer, Anthony Cleare, Katherine Burdick, Claire O'Donovan, Abigail Ortiz, Chantal Henry, Shigenobu Kanba, Joshua Rosenblat, Sagar Parikh, David Bond, Michael Grunebaum, Sophia Frangou, Joseph Goldberg, Margo Orum, David Osser, Mark Frye, Roger McIntyre, Andrea Fagiolini, Vijaya Manicavasagar, Gabrielle Carlson, Gin Malhi

(2018), Vol. 52, pp. 1173-1182, Australian & New Zealand journal of psychiartry, London, Eng., C1

journal

Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification

J Davis, M Desmond, M Berk

(2018), Vol. 19, pp. 1-7, BMC nephrology, London, Eng., C1

journal

Fermented foods, the gut and mental health: a mechanistic overview with implications for depression and anxiety

Hajara Aslam, Jessica Green, Felice Jacka, Fiona Collier, Michael Berk, Julie Pasco, Samantha Dawson

(2018), pp. 1-13, Nutritional neuroscience, Abingdon, Eng., C1

journal

Toward precision psychiatry in bipolar disorder: staging 2.0

Estela Salagre, Seetal Dodd, Alberto Aedo, Adriane Rosa, Silvia Amoretti, Justo Pinzon, Maria Reinares, Michael Berk, Flavio Kapczinski, Eduard Vieta, Iria Grande

(2018), Vol. 9, pp. 1-15, Frontiers in psychiatry, Lausanne, Switzerland, C1

journal

Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder

Yann Quid, Chiara Bortolasci, Briana Spolding, Srisaiyini Kidnapillai, Oliver Watkeys, Sarah Cohen-Woods, Michael Berk, Vaughan Carr, Ken Walder, Melissa Green

(2018), pp. 1-9, Psychological medicine, Cambridge, Eng., C1

journal

Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging

Ziqi Zhu, Yoon-Mi Chung, Olga Sergeeva, Vladimir Kepe, Michael Berk, Jianneng Li, Hyun-Kyung Ko, Zhenfei Li, Marianne Petro, Frank DiFilippo, Zhenghong Lee, Nima Sharifi

(2018), Vol. 293, pp. 17829-17837, Journal of biological chemistry, Bethesda, Md., C1

journal
2017

Ethical considerations in preventive interventions for bipolar disorder.

A Ratheesh, S Cotton, C Davey, S Adams, A Bechdolf, C Macneil, M Berk, P McGorry

(2017), Vol. 11, pp. 104-112, Early intervention in psychiatry, Milton, Queensland, C1

journal

A potential role for N-acetylcysteine in the management of methamphetamine dependence

R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk

(2017), Vol. 36, pp. 153-159, Drug and alcohol review, London, Eng., C1

journal

The prevalence, age distribution and comorbidity of personality disorders in Australian women

S Quirk, M Berk, J Pasco, S Brennan-Olsen, A Chanen, H Koivumaa-Honkanen, L Burke, H Jackson, C Hulbert, C Olsson, P Moran, A Stuart, L Williams

(2017), Vol. 51, pp. 141-150, Australia and New Zealand journal of psychiatry, Melbourne, Vic., C1

journal

A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder

O Dean, K Gray, K-A Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk

(2017), Vol. 51, pp. 241-249, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders Including depression and chronic fatigue syndrome.

G Morris, M Berk, H Klein, K Walder, P Galecki, M Maes

(2017), Vol. 54, pp. 4271-4291, Molecular neurobiology, Berlin, Germany, C1

journal

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean

(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1

journal

Do sleep disturbances predict or moderate the response to psychotherapy in bipolar disorder?

L Sylvia, S Salcedo, A Peters, P Magalhes, E Frank, D Miklowitz, M Otto, M Berk, A Nierenberg, T Deckersbach

(2017), Vol. 205, pp. 196-202, Journal of nervous and mental disease, Philadelphia, Pa., C1

journal

Predictors for clinical deterioration of mental state in patients assessed by telephone-based mental health triage

N Sands, S Elsom, R Corbett, S Keppich-Arnold, R Prematunga, M Berk, J Considine

(2017), Vol. 26, pp. 226-237, International journal of mental health nursing, Milton, Qld., C1

journal

Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM)

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 39, pp. 40-50, European psychiatry, Amsterdam, The Netherlands, C1

journal

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study

C Bousman, D Mller, C Ng, K Byron, M Berk, A Singh

(2017), Vol. 27, pp. 1-6, Pharmacogenetics and genomics, London, Eng., C1

journal

Hierarchical estimation of neural activity through explicit identification of temporally synchronous spikes

R Veerabhadrappa, A Bhatti, M Berk, S Tye, S Nahavandi

(2017), Vol. 249, pp. 299-313, Neurocomputing, C1

journal

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean

(2017), Vol. 47, pp. 866-876, Psychological medicine, Cambridge, Eng., C1

journal

Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: evidence for defective immunomodulatory mechanisms

S de Campos-Carli, M Arajo, A de Oliveira Silveira, V de Rezende, N Rocha, R Ferretjans, R Ribeiro-Santos, A Teixeira-Carvalho, O Martins-Filho, M Berk, J Salgado, A Teixeira

(2017), Vol. 87, pp. 44-52, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal

A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder

A Ratheesh, C Davey, S Hetrick, M Alvarez-Jimenez, C Voutier, A Bechdolf, P McGorry, J Scott, M Berk, S Cotton

(2017), Vol. 135, pp. 273-284, Acta psychiatrica Scandinavica, London, Eng., C1

journal

A model of the mitochondrial basis of bipolar disorder

G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk

(2017), Vol. 74, pp. 1-20, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Towards recovery-oriented psychosocial interventions for bipolar disorder: quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms

G Murray, N Leitan, N Thomas, E Michalak, S Johnson, S Jones, T Perich, L Berk, M Berk

(2017), Vol. 52, pp. 148-163, Clinical psychology review, Amsterdam, The Netherlands, C1

journal

Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

M Berk, O Dandash, R Daglas, S Cotton, K Allott, A Fornito, C Suo, P Klauser, B Liberg, L Henry, C Macneil, M Hasty, P McGorry, C Pantelis, M Ycel

(2017), Vol. 7, pp. 1-7, Translational psychiatry, London, Eng., C1

journal

A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)

F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk

(2017), Vol. 15, pp. 1-13, BMC medicine, London, Eng., C1

journal

A review of the theoretical and biological understanding of the nocebo and placebo phenomena

S Dodd, O Dean, J Vian, M Berk

(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1

journal

Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools

C Bousman, M Forbes, M Jayaram, H Eyre, C Reynolds, M Berk, M Hopwood, C Ng

(2017), Vol. 17, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

J Firth, B Stubbs, J Sarris, S Rosenbaum, S Teasdale, M Berk, A Yung

(2017), Vol. 47, pp. 1515-1527, Psychological medicine, Cambridge, Eng., C1

journal

Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis

M Chatterton, E Stockings, M Berk, J Barendregt, R Carter, C Mihalopoulos

(2017), Vol. 210, pp. 333-341, British journal of psychiatry, London, Eng., C1

journal

The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes

V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd

(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1

journal

Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol

V Chandrasekaran, S Brennan-Olsen, A Stuart, J Pasco, M Berk, J Hodge, L Williams

(2017), Vol. 7, pp. 1-4, BMJ open, London, Eng., C1

journal

Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial

M Berk, R Daglas, O Dandash, M Ycel, L Henry, K Hallam, C Macneil, M Hasty, C Pantelis, B Murphy, L Kader, S Damodaran, M Wong, P Conus, A Ratheesh, P McGorry, S Cotton

(2017), Vol. 210, pp. 413-421, British journal of psychiatry, London, United Kingdom, C1

journal

Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: an online intervention for bipolar disorder

S Lauder, V Cosgrove, E Gliddon, D Grimm, S Dodd, L Berk, D Castle, T Suppes, M Berk

(2017), Vol. 56, pp. 18-24, Contemporary clinical trials, Amsterdam, The Netherlands, C1

journal

Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), Vol. 29, pp. 337-346, Acta neuropsychiatrica, Cambridge, Eng., C1

journal

Do statins have antidepressant effects?

O Khler-Forsberg, C Gasse, M Berk, S stergaard

(2017), Vol. 31, pp. 335-343, CNS drugs, Cham, Switzerland, C1

journal

Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis

E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Khler, E Vieta, A Carvalho, M Berk, B Fernandes

(2017), Vol. 43, pp. 81-91, European psychiatry, Amsterdam, The Netherlands, C1

journal

The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - Cadence-BZ: study protocol for a randomized controlled trial

A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, Cadence Working Group, J Scott

(2017), Vol. 18, pp. 1-11, Trials, London, Eng., C1

journal

Youth self-harm in low- and middle-income countries: systematic review of the risk and protective factors

S Aggarwal, G Patton, N Reavley, S Sreenivasan, M Berk

(2017), Vol. 63, pp. 359-375, International journal of social psychiatry, London, Eng., C1

journal

the effect of n-acetylcysteine (nac) on human cognition - a systematic review

D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott

(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder

L Berk, K Hallam, K Venugopal, A Lewis, D Austin, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, M Berk

(2017), Vol. 19, pp. 184-197, Bipolar disorders, Hoboken, N.J., C1

journal

Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses

B Bortolato, C Khler, E Evangelou, J Len-Caballero, M Solmi, B Stubbs, L Belbasis, I Pacchiarotti, L Kessing, M Berk, E Vieta, A Carvalho

(2017), Vol. 19, pp. 84-96, Bipolar disorders, London, Eng., C1

journal

Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients

G Scaini, G Fries, S Valvassori, C Zeni, G Zunta-Soares, M Berk, J Soares, J Quevedo

(2017), Vol. 7, pp. 1-10, Translational psychiatry, [New York, N.Y.], C1

journal

Evaluation of modified patient health questionnaire-9 teen in South African adolescents

S Aggarwal, L Taljard, Z Wilson, M Berk

(2017), Vol. 39, pp. 143-145, Indian Journal of Psychological Medicine, Mumbai, India, C1

journal

Pattern of psychotropic medication use over two decades in Australian women

A Stuart, M Mohebbi, J Pasco, S Quirk, S Brennan-Olsen, M Berk, L Williams

(2017), pp. 1-8, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

journal

Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial

O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk

(2017), Vol. 51, pp. 829-840, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania

A Ratheesh, C Davey, R Daglas, C Macneil, M Hasty, K Filia, P McGorry, M Berk, P Conus, S Cotton

(2017), Vol. 219, pp. 133-140, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Defining melancholia: a core mood disorder

G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, B Baune, M Berk, P Boyce, B Lyndon, R Mulder, A Singh, G Malhi

(2017), Vol. 19, pp. 235-237, Bipolar disorders, London, Eng., C1

journal

Psychotropic pharmacogenetics - distraction or destiny?

A Singh, B Baune, A Hamilton, P Das, T Outhred, G Morris, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, G Malhi

(2017), Vol. 51, pp. 665-667, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

International multi-site survey on the use of online support groups in bipolar disorder

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Zompo, R Dias, S Dodd, A Duffy, B Etain

(2017), Vol. 71, pp. 473-476, Nordic Journal of Psychiatry, Abingdon, Eng, C1

journal

Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers

K Landucci Bonifcio, D Sabbatini Barbosa, E Gastaldello Moreira, C de Farias, L Higachi, A Camargo, J Favaro Soares, H Odebrecht Vargas, S Nunes, M Berk, S Dodd, M Maes

(2017), Vol. 222, pp. 185-194, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Solar insolation in springtime influences age of onset of bipolar I disorder

M Bauer, T Glenn, M Alda, M Aleksandrovich, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, S Bharathram, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, ? Bicakci, H Birabwa-Oketcho, T Bjella, S Dodd

(2017), pp. 1-12, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1

journal

Mixed mood: the not so united states?

G Malhi, M Berk, G Morris, A Hamilton, T Outhred, P Das, D Bassett, B Baune, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2017), Vol. 19, pp. 242-245, Bipolar Disorders, Hoboken, N. J., C1

journal

The renin-angiotensin system: a possible new target for depression

J Vian, C Pereira, V Chavarria, C Khler, B Stubbs, J Quevedo, S-W Kim, A Carvalho, M Berk, B Fernandes

(2017), Vol. 15, pp. 144-156, BMC Medicine, London, Eng., C1

journal

Online ethics: where will the interface of mental health and the internet lead us?

V Cosgrove, E Gliddon, L Berk, D Grimm, S Lauder, S Dodd, M Berk, T Suppes

(2017), Vol. 5, pp. 1-9, International journal of bipolar disorders, London, Eng., C1

journal

Plasma levels of tumor necrosis factor superfamily molecules are increased in bipolar disorder

I Barbosa, G Vaz, N Rocha, R Machado-Vieira, M Ventura, R Huguet, M Bauer, M Berk, A Teixeira

(2017), Vol. 15, pp. 269-275, clinical psychopharmacology and neuroscience, Seoul, South Korea, C1

journal

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

M Berger, S Smesny, S-W Kim, C Davey, S Rice, Z Sarnyai, M Schlgelhofer, M Schfer, M Berk, P McGorry, G Amminger

(2017), Vol. 7, pp. 1-6, Translational psychiatry, London, Eng., C1

journal

Getting RID of the blues: formulating a Risk Index for Depression (RID) using structural equation modeling

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), pp. 1-13, Australian & New Zealand Journal of Psychiatry, London, Eng., C1

journal

Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disorders

S Quirk, A Stuart, M Berk, J Pasco, S Brennan Olsen, H Koivumaa-Honkanen, R Honkanen, P Lukkala, A Chanen, M Kotowicz, L Williams

(2017), Vol. 257, pp. 546-549, Psychiatry Research, Shannon, Clare Ireland, C1

journal

N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis

M Duailibi, Q Cordeiro, E Brietzke, M Ribeiro, S LaRowe, M Berk, A Trevizol

(2017), Vol. 26, pp. 660-666, American journal of addications, London, Eng., C1

journal

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

journal

Validation of a portable low-power deep brain stimulation device through anxiolytic effects in a laboratory rat model

A Kouzani, R Kale, P Zarate-Garza, M Berk, K Walder, S Tye

(2017), Vol. 25, pp. 1365-1374, IEEE transactions on neural systems and rehabilitation engineering, Piscataway, N.J., C1

journal

Nutritional psychiatry: the present state of the evidence

W Marx, G Moseley, M Berk, F Jacka

(2017), Vol. 76, pp. 427-436, Proceedings of the Nutrition Society, Cambridge, Eng., C1

journal

Distinguishing transient versus stable aspects of depression in New Zealand Pacific Island children using generalizability theory

J Paterson, O Medvedev, A Sumich, E Tautolo, C Krgeloh, R Sisk, R McNamara, M Berk, A Narayanan, R Siegert

(2017), Vol. 227, pp. 698-704, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Cognitive functioning following stabilisation from first episode mania

R Daglas, K Allott, M Ycel, L Henry, C Macneil, M Hasty, M Berk, S Cotton

(2017), Vol. 5, pp. 1-11, International journal of bipolar disorders, Berlin, Germany, C1

journal

Mitochondrial modifying nutrients in treating chronic fatigue syndrome: a 16-week open-label pilot study

R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris

(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1

journal

Emergency department youth patients with suicidal ideation or attempts: predicting suicide attempts through 18 months of follow-up

Joan Rosenbaum Asarnow, Michele Berk, Lily Zhang, Peter Wang, Lingqi Tang

(2017), Vol. 47, pp. 551-566, Suicide and life-threatening behavior, Chichester, Eng., C1

journal
2016

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial

S Rice, I Hickie, A Yung, A Mackinnon, M Berk, C Davey, D Hermens, S Hetrick, A Parker, M Schfer, P McGorry, G Amminger

(2016), Vol. 10, pp. 290-299, Early Intervention in Psychiatry, London, Eng., C1

journal

The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases

G Morris, M Berk, P Galecki, K Walder, M Maes

(2016), Vol. 53, pp. 1195-1219, Molecular neurobiology, Berlin, Germany, C1

journal

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonalves, M Berk

(2016), Vol. 21, pp. 554-564, Molecular psychiatry, London, Eng., C1

journal

The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders

G Morris, K Walder, B Puri, M Berk, M Maes

(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1

journal

Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways

M Martin-Subero, G Anderson, B Kanchanatawan, M Berk, M Maes

(2016), Vol. 21, pp. 184-198, CNS Spectrums, Cambridge, Eng., C1

journal

Bipolar disorder

I Grande, M Berk, B Birmaher, E Vieta

(2016), Vol. 387, pp. 1561-1572, The Lancet, C1

journal

Autobiographical memory dysfunctions in depressive disorders

M Talarowska, M Berk, M Maes, P Ga?ecki

(2016), Vol. 70, pp. 100-108, Psychiatry and clinical neurosciences, London, Eng., C1

journal

The prevalence and age of onset of psychiatric disorders in Australian men

L Williams, F Jacka, J Pasco, C Coulson, S Quirk, A Stuart, M Berk

(2016), Vol. 50, pp. 678-684, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Effects of depression and serotonergic antidepressants on bone: Mechanisms and implications for the treatment of depression

B Fernandes, J Hodge, J Pasco, M Berk, L Williams

(2016), Vol. 33, pp. 21-25, Drugs & aging, Berlin, Germany, C1

journal

Theory of mind in major depressive disorder: a meta-analysis

E Bora, M Berk

(2016), Vol. 191, pp. 49-55, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study

R Daglas, S Cotton, K Allott, M Ycel, C Macneil, M Hasty, B Murphy, C Pantelis, K Hallam, L Henry, P Conus, A Ratheesh, L Kader, M Wong, P McGorry, M Berk

(2016), Vol. 31, pp. 20-28, European psychiatry, Amsterdam, The Netherlands, C1

journal

The trajectory of cognitive functioning following first episode mania: a 12-month follow-up study

R Daglas, K Allott, M Ycel, C Pantelis, C Macneil, M Berk, S Cotton

(2016), Vol. 50, pp. 1186-1197, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Depression as a risk factor for fracture in women: a 10 year longitudinal study

L Williams, J Pasco, H Jackson, L Kiropoulos, A Stuart, F Jacka, M Berk

(2016), Vol. 192, pp. 34-40, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

DNA methylation and the social gradient of osteoporotic fracture: A conceptual model

S Brennan-Olsen, R Page, M Berk, J Riancho, W Leslie, S Wilson, K Saban, L Janusek, J Pasco, J Hodge, S Quirk, N Hyde, S Hosking, L Williams

(2016), Vol. 84, pp. 204-212, Bone, C1

journal

Regulators of mitochondrial complex I activity: a review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder

A Duong, Y Che, D Ceylan, A Pinguelo, A Andreazza, L Trevor Young, M Berk

(2016), Vol. 236, pp. 148-157, Psychiatry research, Amsterdam, The Netherlands, C1

journal

Population prevalence of personality disorder and associations with physical health comorbidities and health care service utilization: a review

S Quirk, M Berk, A Chanen, H Koivumaa-Honkanen, S Brennan-Olsen, J Pasco, L Williams

(2016), Vol. 7, pp. 136-146, Personality disorders, Washington, D.C., C1

journal

Specific mood symptoms confer risk for subsequent suicidal ideation in bipolar disorder with and without suicide attempt history: multi-wave data from STEP-BD

J Stange, E Kleiman, L Sylvia, P Magalhes, M Berk, A Nierenberg, T Deckersbach

(2016), Vol. 33, pp. 464-472, Depression and anxiety, London, Eng., C1

journal

Cognitive remission: a novel objective for the treatment of major depression?

B Bortolato, K Miskowiak, C Khler, M Maes, B Fernandes, M Berk, A Carvalho

(2016), Vol. 14, pp. 1-18, BMC medicine, London, Eng., C1

journal

Bias in peripheral depression biomarkers

A Carvalho, C Khler, A Brunoni, K Miskowiak, N Herrmann, K Lanctt, T Hyphantis, J Quevedo, B Fernandes, M Berk

(2016), Vol. 85, pp. 81-90, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal

Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment

J Stange, L Sylvia, P da Silva Magalhes, D Miklowitz, M Otto, E Frank, C Yim, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 208, pp. 352-358, British journal of psychiatry, London, Eng., C1

journal

Statin and aspirin use and the risk of mood disorders among men

L Williams, J Pasco, M Mohebbi, F Jacka, A Stuart, K Venugopal, A O'Neil, M Berk

(2016), Vol. 19, pp. 1-4, International journal of neuropsychopharmacology, Oxford, Eng., C1

journal

Harnessing the potential of community-based participatory research approaches in bipolar disorder

E Michalak, S Jones, F Lobban, G Algorta, S Barnes, L Berk, M Berk, R Hole, S Lapsley, V Maxwell, R Milev, J McManamy, G Murray, M Tohen, S Tse, M Sanchez de Carmona, S Johnson

(2016), Vol. 4, pp. 1-9, International journal of bipolar disorders, Berlin, Germany, C1

journal

Fusing data mining, machine learning and traditional statistics to detect biomarkers associated with depression

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, pp. 1-23, PLoS One, San Francisco, Calif., C1

journal

Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis

G Berger, S Smesny, M Schfer, B Milleit, K Langbein, U-C Hipler, C Milleit, C Klier, M Schlgelhofer, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Amminger

(2016), Vol. 11, pp. 1-17, PLoS one, San Francisco, Calif., C1

journal

Trajectory and predictors of quality of life in first episode psychotic mania

M Oldis, G Murray, C Macneil, M Hasty, R Daglas, M Berk, P Conus, S Cotton

(2016), Vol. 195, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

T helper 17 cells may drive neuroprogression in major depressive disorder: proposal of an integrative model

A Slyepchenko, M Maes, C Khler, G Anderson, J Quevedo, G Alves, M Berk, B Fernandes, A Carvalho

(2016), Vol. 64, pp. 83-100, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

The putative use of lithium in alzheimer's disease

G Morris, M Berk

(2016), Vol. 13, pp. 853-861, Current alzheimer research, Bussum, Netherlands, C1

journal

Depression is a risk factor for incident coronary heart disease in women: an 18-year longitudinal study

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, C Taylor, J Pasco

(2016), Vol. 196, pp. 117-124, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, J Atherton, C Taylor, J Pasco

(2016), Vol. 87, pp. 115-120, Preventive Medicine Reports, Amsterdam, The Netherlands, C1

journal

Physical health comorbidities in women with personality disorder: data from the Geelong osteoporosis study

S Quirk, A Stuart, S Brennan-Olsen, J Pasco, M Berk, A Chanen, H Koivumaa-Honkanen, M Kotowicz, P Lukkala, L Williams

(2016), Vol. 34, pp. 29-35, European psychiatry, Amsterdam, The Netherlands, C1

journal

Fibromyalgia and bipolar disorder: emerging epidemiological associations and shared pathophysiology

B Bortolato, M Berk, M Maes, R McIntyre, A Carvalho

(2016), Vol. 16, pp. 119-136, Current molecular medicine, The Netherlands, Amsterdam, C1

journal

Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 study

S-W Kim, M Jhon, J-M Kim, S Smesny, S Rice, M Berk, C Klier, P McGorry, M Schfer, G Amminger

(2016), Vol. 11, pp. 1-12, PLoS one, San Francisco, Calif., C1

journal

Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis

J Rosenblat, R Kakar, M Berk, L Kessing, M Vinberg, B Baune, R Mansur, E Brietzke, B Goldstein, R McIntyre

(2016), Vol. 18, pp. 89-101, Bipolar disorders, London, Eng., C1

journal

Mental health for all Australians

M Berk

(2016), Vol. 50, pp. 301-302, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Leptin in bipolar disorder: a systematic review and meta-analysis

B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Khler, J Steiner, M da Graa Cantarelli, P Nardin, C Gonalves, M Berk

(2016), Vol. 35, pp. 1-7, European psychiatry, Amsterdam, The Netherlands, C1

journal

A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis

J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk

(2016), Vol. 65, pp. 185-194, Neuroscience & biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Associations between DNA damage, DNA base excision repair gene variability and Alzheimer's disease risk

D Kwiatkowski, P Czarny, M Toma, N Jurkowska, A Sliwinska, J Drzewoski, A Bachurska, J Szemraj, M Maes, M Berk, K-P Su, P Galecki, T Sliwinski

(2016), Vol. 41, pp. 152-171, Dementia and geriatric cognitive disorders, Basel, Switzerland, C1

journal

Areas of controversy in neuroprogression in bipolar disorder.

I Passos, B Mwangi, E Vieta, M Berk, F Kapczinski

(2016), Vol. 134, pp. 91-103, Acta psychiatrica scandinavica, London, Eng., C1

journal

Adjunctive nutraceuticals for depression: a systematic review and meta-analyses

J Sarris, J Murphy, D Mischoulon, G Papakostas, M Fava, M Berk, C Ng

(2016), Vol. 173, pp. 575-587, American journal of psychiatry, Arlington, Va., C1

journal

Antioxidant treatments for schizophrenia

P Magalhes, O Dean, A Andreazza, M Berk, F Kapczinski

(2016), Vol. 2016, pp. 1-93, Cochrane database of systematic reviews, London, Eng., C1

journal

N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis

B Fernandes, O Dean, S Dodd, G Malhi, M Berk

(2016), Vol. 77, pp. 457-466, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Integrating early intervention for borderline personality disorder and mood disorders

A Chanen, M Berk, K Thompson

(2016), Vol. 24, pp. 330-341, Harvard review of psychiatry, Philadelphia, Pa., C1

journal

Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials

E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk

(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Mental health system development in Asia: does Australia have a role?

K Arandjelovic, H Eyre, M Forbes, R Bauer, S Aggarwal, A Singh, B Baune, I Everall, M Berk, C Ng

(2016), Vol. 50, pp. 834-841, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

Bias in emerging biomarkers for bipolar disorder

A Carvalho, C Khler, B Fernandes, J Quevedo, K Miskowiak, A Brunoni, R Machado-Vieira, M Maes, E Vieta, M Berk

(2016), Vol. 46, pp. 2287-2297, Psychological Medicine, C1

journal

Is there a nexus between mental and bone health?

L Williams, J Pasco, J Hodge, M Berk

(2016), Vol. 50, pp. 829-830, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Gold, P Da Silva Magalhaes, D Henry, E Frank, M Otto, M Berk, D Dougherty, A Nierenberg, D Miklowitz

(2016), Vol. 203, pp. 152-157, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye

(2016), Vol. 6, pp. 1-7, Translational psychiatry, London, Eng., C1

journal

Unified selective sorting approach to analyse multi-electrode extracellular data

R Veerabhadrappa, C Lim, T Nguyen, M Berk, S Tye, P Monaghan, S Nahavandi, A Bhatti

(2016), Vol. 6, pp. 1-16, Scientific reports, London, Eng., C1

journal

The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmunue disease.

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, K Walder, M Maes

(2016), pp. 1-20, Molecular neurobiology, Berlin, Germany, C1

journal

Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder

F Kay-Lambkin, L Thornton, J Lappin, T Hanstock, L Sylvia, F Jacka, A Baker, M Berk, P Mitchell, R Callister, N Rogers, S Webster, S Dennis, C Oldmeadow, A MacKinnon, C Doran, A Turner, S Hunt

(2016), Vol. 5, pp. 1-7, Systematic reviews, London, Eng., C1

journal

Internet use by patients with bipolar disorder: results from an international multisite survey

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Hernandez, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, P Piotrowski, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, M Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, P Whybrow, M Bauer

(2016), Vol. 242, pp. 388-394, Psychiatry research, Amsterdam, The Netherlands, C1

journal

Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications

G Scaini, G Rezin, A Carvalho, E Streck, M Berk, J Quevedo

(2016), Vol. 68, pp. 694-713, Neuroscience & biobehavioral reviews, London, Eng., C1

journal

Predicting risk of suicide attempt using history of physical illnesses from electronic medical records

C Karmakar, W Luo, T Tran, M Berk, S Venkatesh

(2016), Vol. 3, pp. 1-10, JMIR mental health, Toronto, Ont., C1

journal

Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression

A Peters, L Shesler, L Sylvia, P Da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 50, pp. 667-677, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial

J Kulkarni, E Gavrilidis, S Gwini, R Worsley, J Grigg, A Warren, C Gurvich, H Gilbert, M Berk, S Davis

(2016), Vol. 73, pp. 947-954, JAMA psychiatry, Chicago, Ill., C1

journal

ASPREE-D: Aspirin for the prevention of depression in the elderly

M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, A Murray, B Kirpach, R Grimm, J McNeil

(2016), Vol. 28, pp. 1741-1748, International psychogeriatrics, Cambridge, Eng., C1

journal

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott

(2016), Vol. 17, pp. 1-11, Trials, London, Eng., C1

journal

Online information seeking by patients with bipolar disorder: results from an international multisite survey

J Conell, R Bauer, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Paredes Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, C Lam, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, P Piotrowski, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, I Zorrilla, P Whybrow, M Bauer

(2016), Vol. 4, pp. 1-14, International journal of bipolar disorders, London, Eng., C1

journal

The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia

A Rajasekaran, V Shivakumar, S Kalmady, J Narayanaswamy, M Subbana, D Venugopal, A Amaresha, G Venkatasubramanian, M Berk, M Debnath

(2016), Vol. 77, pp. 1166-1171, Human immunology, Amsterdam, The Netherlands, C1

journal

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle

(2016), Vol. 16, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

An ISBD perspective on the sociocultural challenges of managing bipolar disorder: a content analysis

C Oedegaard, L Berk, M Berk, E Youngstrom, S Dilsaver, R Belmaker, K Oedegaard, O Fasmer, I Engebretsen

(2016), Vol. 50, pp. 1096-1103, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease

F Barb-Tuana, M Parisi, B Panizzutti, G Fries, L Grun, F Guma, F Kapczinski, M Berk, C Gama, A Rosa

(2016), Vol. 38, pp. 281-286, Revista brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Immuno-psychiatry: an agenda for clinical practice and innovative research

M Leboyer, M Berk, R Yolken, R Tamouza, D Kupfer, L Groc

(2016), Vol. 14, pp. 1-8, BMC medicine, London, Eng., C1

journal

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C-A Gonalves, F Jacka, C Khler, C Karmakar, A Carvalho, M Berk

(2016), Vol. 3, pp. 1147-1156, Lancet psychiatry, Amsterdam, The Netherlands, C1

journal

Single-nucleotide polymorphisms of genes involved in repair of oxidative DNA damage and the risk of recurrent depressive disorder

P Czarny, D Kwiatkowski, M Toma, P Ga?ecki, A Orzechowska, K Bobi?ska, A Bielecka-Kowalska, J Szemraj, M Berk, G Anderson, T ?liwi?ski

(2016), Vol. 22, pp. 4455-4474, Medical science monitor, Smithtown, N.Y., C1-1

journal

Guidelines for developing and reporting machine learning predictive models in biomedical research : a multidisciplinary view

W Luo, Q Phung, T Tran, S Gupta, S Rana, C Karmakar, A Shilton, J Yearwood, N Dimitrova, T Ho, S Venkatesh, M Berk

(2016), Vol. 18, pp. 1-10, Journal of medical internet research, Toronto, Ont., C1

journal

Into the bowels of depression: unravelling medical symptoms associated with depression by applying machine-learning techniques to a community based population sample

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, pp. 1-19, PLoS one, San Francisco, Calif., C1

journal

The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in alzheimer's disease

C Khler, M Maes, A Slyepchenko, M Berk, M Solmi, K Lanctt, A Carvalho

(2016), Vol. 22, pp. 6152-6166, Current pharmaceutical design, Bussum, Netherlands, C1

journal

Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes

A Slyepchenko, M Maes, R Machado-Vieira, G Anderson, M Solmi, Y Sanz, M Berk, C Khler, A Carvalho

(2016), Vol. 22, pp. 6087-6106, Current pharmaceutical design, Bussum, The Netherlands, C1

journal

Gut permeability and microbiota in Parkinson's disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways

G Anderson, M Seo, M Berk, A Carvalho, M Maes

(2016), Vol. 22, pp. 6142-6151, Current pharmaceutical design, Bussum, The Netherlands, C1

journal

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, M Maes

(2016), Vol. 22, pp. 6058-6075, Current pharmaceutical design, Beijing, China, C1

journal

Electrical resistance increases at the tissue-electrode interface as an early response to nucleus accumbens deep brain stimulation

R Kale, A Kouzani, J Berk, K Walder, M Berk, S Tye

(2016), pp. 1814-1817, EMBC 2016 : Proceedings of the 38th Annual International Conference of the Engineering in Medicine and Biology Society, Orlando, Florida, E1

conference
2015

Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age

J Kulkarni, E Gavrilidis, Wang, W, R Worsley, P Fitzgerald, C Gurvich, T Van Rheenen, M Berk, H Burger

(2015), Vol. 20, pp. 695-702, Molecular psychiatry, Basingstoke, Eng., C1

journal

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean

(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

journal

Personality disorders and physical comorbidities in adults from the United States: data from the National Epidemiologic Survey on Alcohol and Related Conditions

S Quirk, R El-Gabalawy, S Brennan, J Bolton, J Sareen, M Berk, A Chanen, J Pasco, L Williams

(2015), Vol. 50, pp. 807-820, Social Psychiatry and Psychiatric Epidemiology, C1

journal

A randomized head to head trial of MoodSwings.net.au: an internet based self-help program for bipolar disorder

S Lauder, A Chester, D Castle, S Dodd, E Gliddon, L Berk, J Chamberlain, B Klein, M Gilbert, D Austin, M Berk

(2015), Vol. 171, pp. 13-21, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, M Berk, M Molendijk, A Gonzalez-Pinto, C Turck, P Nardin, C Gonalves

(2015), Vol. 20, pp. 1108-1119, Molecular Psychiatry, London, Eng., C1

journal

The association between attributions of responsibility for motor vehicle accidents and patient satisfaction: a study within a no-fault injury compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2015), Vol. 29, pp. 500-508, Clinical rehabilitation, London, Eng., C1

journal

The relationships between insomnia, sleep apnoea and depression: findings from the American national health and nutrition examination survey, 2005-2008

A Hayley, L Williams, K Venugopal, G Kennedy, M Berk, J Pasco

(2015), Vol. 49, pp. 156-170, Australian & New Zealand journal of psychiatry, London, England, C1

journal

Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass

J Davis, M Maes, A Andreazza, J McGrath, S Tye, M Berk

(2015), Vol. 20, pp. 152-153, Molecular Psychiatry, C1

journal

Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder

S Nunes, L Piccoli de Melo, M Pizzo de Castro, D Barbosa, H Vargas, M Berk, M Maes

(2015), Vol. 172, pp. 55-62, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey

S Mancuso, V Morgan, P Mitchell, M Berk, A Young, D Castle

(2015), Vol. 172, pp. 30-37, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The gut microbiome and diet in psychiatry: focus on depression

S Dash, G Clarke, M Berk, F Jacka

(2015), Vol. 28, pp. 1-6, Current opinion in psychiatry, Philadelphia, Pa., C1

journal

Restless leg syndrome associated with atypical antipsychotics : current status, pathophysiology, and clinical implications

S Aggarwal, S Dodd, M Berk

(2015), Vol. 10, pp. 98-105, Current drug safety, San Francisco, Calif., C1-1

journal

Excessive daytime sleepiness and metabolic syndrome: a cross-sectional study

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2015), Vol. 64, pp. 244-252, Metabolism, Maryland Heights, MO, C1

journal

STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders.

M Pizzo de Castro, S Vargas Nunes, R Guembarovski, C Ariza, J Oda, H Vargas, L Piccoli de Melo, M Watanabe, M Berk, M Maes

(2015), Vol. 172, pp. 347-354, Journal of Affective Disorders, Amsterdam , Netherlands, C1

journal

Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications.

A Rajasekaran, G Venkatasubramanian, M Berk, M Debnath

(2015), Vol. 48, pp. 10-21, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Influence of birth cohort on age of onset cluster analysis in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isomets, F Kapczinski, S Kliwicki, B Knig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Hatim Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 30, pp. 99-105, European psychiatry, Amsterdam, Netherlands, C1

journal

Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years

S Aggarwal, M Berk

(2015), Vol. 13, pp. 3-12, Asian journal of psychiatry, Amsterdam, The Netherlands, C1

journal

Fetal programming of schizophrenia: select mechanisms

M Debnath, G Venkatasubramanian, M Berk

(2015), Vol. 49, pp. 90-104, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

G Amminger, A Mechelli, S Rice, S Kim, C Klier, R McNamara, M Berk, P McGorry, M Schfer

(2015), Vol. 5, pp. e495-e495, Translational Psychiatry, United States, C1

journal

The association between use of antidepressants and bone quality using quantitative heel ultrasound

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 49, pp. 437-443, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal

RF rectifiers for EM power harvesting in a deep brain stimulating device

M Hosain, A Kouzani, S Tye, A Kaynak, M Berk

(2015), Vol. 38, pp. 157-172, Australasian physical and engineering sciences in medicine, Berlin, Germany, C1

journal

Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis

M Berk, J Tiller, J Zhao, L Yatham, G Malhi, E Weiller

(2015), Vol. 76, pp. 728-734, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control.

A O'Neil, F Jacka, S Quirk, F Cocker, C Taylor, B Oldenburg, M Berk

(2015), Vol. 15, pp. 15-15, BMC Psychiatry, England, C1

journal

The impact of maternal smoking during pregnancy on depressive and anxiety behaviors in children: the Norwegian Mother and Child Cohort Study.

S Moylan, K Gustavson, S verland, E Karevold, F Jacka, J Pasco, M Berk

(2015), Vol. 13, pp. 24-24, BMC Medicine, England, C1

journal

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

S Kim, B Jeong, J Kim, I Shin, M Hwang, G Paul Amminger, B Nelson, M Berk, P McGorry, J Yoon

(2015), Vol. 226, pp. 368-375, Psychiatry research, Shannon, Ireland, C1

journal

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

E Prado, M Maes, L Piccoli, M Baracat, D Barbosa, O Franco, S Dodd, M Berk, S Vargas Nunes

(2015), Redox report, Edinburgh, Scotland, C1

journal

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

G Morris, M Berk, K Walder, M Maes

(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1

journal

Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectiveness

G Murray, N Leitan, M Berk, N Thomas, E Michalak, L Berk, S Johnson, S Jones, T Perich, N Allen, M Kyrios

(2015), Vol. 178, pp. 46-51, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

An adjunctive antidepressant nutraceutical combination in treating major depression: study protocol and clinical considerations

J Sarris, C Stough, C Bousman, J Murphy, K Savage, D Smith, R Menon, S Chamoli, G Oliver, M Berk, G Byrne, C Ng, D Mischoulon

(2015), Vol. 2, pp. 49-56, Advances in integrative medicine, Amsterdam, The Netherlands, C1-1

journal

A brief review of exercise, bipolar disorder, and mechanistic pathways.

D Thomson, A Turner, S Lauder, M Gigler, L Berk, A Singh, J Pasco, M Berk, L Sylvia

(2015), Vol. 6, pp. 147-147, Frontiers in Psychology, Switzerland, C1

journal

Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy

E Callaly, K Walder, G Morris, M Maes, M Debnath, M Berk

(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1

journal

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

G Morris, M Berk

(2015), Vol. 13, pp. 1-25, BMC medicine, London, Eng., C1

journal

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder

C Bortolasci, H Vargas, S Vargas Nunes, L de Melo, M de Castro, E Moreira, S Dodd, D Barbosa, M Berk, M Maes

(2015), Vol. 179, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Influence of light exposure during early life on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, B Baune, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Wo Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, J Gottlieb, H Harima, S Hassel, C Henry, A Iacovides, E Isomets, F Kapczinski, S Kliwicki, B Knig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, Miranda-Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 64, pp. 1-8, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal

Instruments that prospectively predict bipolar disorder - a systematic review.

A Ratheesh, M Berk, C Davey, P McGorry, S Cotton

(2015), Vol. 179, pp. 65-73, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Gerwyn Morris, Michael Berk, Ken Walder, Michael Maes

(2015), Vol. 13, pp. 28-, BMC Med, England, C1

journal

Psychiatric disorders, psychotropic medication use and falls among women: an observational study

L Williams, J Pasco, A Stuart, F Jacka, S Brennan, A Dobbins, R Honkanen, H Koivumaa-Honkanen, P Rauma, M Berk

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

Oxidant/antioxidant imbalance is an inherent feature of depression

M Talarowska, J Szemraj, M Berk, M Maes, P Ga?ecki

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

journal

Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies

A Ghanizadeh, A Singh, M Berk, M Torabi-Nami

(2015), Vol. 19, pp. 1-13, Expert opinion on therapeutic targets, Oxford, Eng., C1

journal

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness

R Daglas, M Ycel, S Cotton, K Allott, S Hetrick, M Berk

(2015), Vol. 3, pp. 1-18, International Journal of Bipolar Disorders, Heidelberg, Germany, C1

journal

Tobacco use in bipolar disorder.

D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean

(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

journal

N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review

G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris

(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

M Maes, G Nowak, J Caso, J Leza, C Song, M Kubera, H Klein, P Galecki, C Noto, E Glaab, R Balling, M Berk

(2015), Molecular Neurobiology, C1

journal

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study

A Singh, C Bousman, C Ng, K Byron, M Berk

(2015), Vol. 13, pp. 53-61, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye

(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

N Hyde, S Dodd, K Venugopal, Purdie, M Berk, A O'Neil

(2015), Vol. 10, pp. 125-131, Current drug safety, San Francisco, Calif., C1

journal

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

B Panizzutti, C Gubert, A Schuh, P Ferrari, G Bristot, G Fries, R Massuda, J Walz, N Rocha, M Berk, A Teixeira, C Gama

(2015), Vol. 182, pp. 64-69, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages

A Ratheesh, S Cotton, J Betts, A Chanen, B Nelson, C Davey, P McGorry, M Berk, A Bechdolf

(2015), Vol. 183, pp. 45-48, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 15, pp. 177-185, Journal of Musculoskeletal and Neuronal Interactions, Greece, C1

journal

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

P Ga?ecki, M Talarowska, G Anderson, M Berk, M Maes

(2015), Vol. 21, pp. 1535-1547, Medical Science Monitor: international medical journal for clinical and experimental research, Warsaw, Poland, C1

journal

The putative role of viruses, bacteria, and chronic fungal biotoxin exposure in the genesis of intractable fatigue accompanied by cognitive and physical disability

G Morris, M Berk, K Walder, M Maes

(2015), Vol. In press, pp. 1-22, Molecular neurobiology, Clifton, N.J., C1

journal

Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample

A Hayley, L Williams, G Kennedy, K Holloway, M Berk, S Brennan-Olsen, J Pasco

(2015), Vol. 15, pp. 74-74, BMC geriatrics, London, Eng., C1

journal

Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials

S Dodd, A Schacht, K Kelin, H Dueas, V Reed, L Williams, F Quirk, G Malhi, M Berk

(2015), Vol. 76, pp. 702-711, Journal of clinical psychology, Weinheim, Germany, C1

journal

Evolution of optogenetic microdevices

R Kale, A Kouzani, K Walder, M Berk, S Tye

(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1

journal

Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder

S Kim, S Dodd, L Berk, J Kulkarni, A de Castella, P Fitzgerald, J Kim, J Yoon, M Berk

(2015), Vol. 12, pp. 349-355, Psychiatry Investigation, Seoul, Korea (South), C1

journal

Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis

A Carvalho, C Khler, R McIntyre, C Knchel, A Brunoni, M Thase, J Quevedo, B Fernandes, M Berk

(2015), Vol. 62, pp. 18-26, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1

journal

Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function?

J Pasco, L Williams, F Jacka, N Stupka, S Brennan-Olsen, K Holloway, M Berk

(2015), Vol. 13, pp. 351-357, Current Osteoporosis Reports, New York, N.Y., C1

journal

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

S Smesny, B Milleit, M Schaefer, U Hipler, C Milleit, C Wiegand, J Hesse, C Klier, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Paul Amminger

(2015), Vol. 101, pp. 15-21, Prostaglandins leukot essent fatty acids, Amsterdam, The Netherlands, C1

journal

Radio frequency energy harvesting from a feeding source in a passive deep brain stimulation device for murine preclinical research

M Hosain, A Kouzani, S Tye, M Samad, R Kale, K Bennet, F Manciu, M Berk

(2015), Vol. 37, pp. 1020-1026, Medical engineering and physics, Amsterdam, The Netherlands, C1

journal

Antimanic-like activity of candesartan in mice: possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms

J de Souza Gomes, G de Souza, M Berk, L Cavalcante, F de Sousa, J Budni, D de Lucena, J Quevedo, A Carvalho, D Macdo

(2015), Vol. 25, pp. 2086-2097, European neuropsychopharmacology, Amsterdam, The Netherlands, C1

journal

Citalopram and sertraline exposure compromises embryonic bone development

D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert

(2015), Vol. In press, pp. 1-9, Molecular psychiatry, Hampshire, Eng., C1

journal

N-Acetyl Cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study

J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng

(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1

journal

Symptoms of depression and difficulty initiating sleep from early adolescence to early adulthood: a longitudinal study

A Hayley, J Skogen, B Sivertsen, B Wold, M Berk, J Pasco, S verland

(2015), Vol. 38, pp. 1599-1606, Sleep, Darien, Ill., C1

journal

Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial

P Conus, M Berk, S Cotton, L Kader, C Macneil, M Hasty, K Hallam, M Lambert, B Murphy, P McGorry

(2015), Vol. 30, pp. 975-982, European psychiatry, Amsterdam, The Netherlands, C1-1

journal

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study

E Gliddon, S Lauder, L Berk, V Cosgrove, D Grimm, S Dodd, T Suppes, M Berk

(2015), Vol. 15, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials

M Berk, R Otmar, O Dean, L Berk, E Michalak

(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1

chapter

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

B Fernandes, M Molendijk, C Kohler,, J Soares, C Leite, R Machado-Vieria, T Ribeiro, J Silva, P Sales, J Quevedo, V Oertel-Knochel, E Vieta, A Gonzalez-Pinto, M Berk, A Carvalho

(2015), Vol. 13, pp. 1-22, BMC Medicine, London, Eng., C1

journal

The use of statins for the treatment of depression in patients with acute coronary syndrome

S Kim, K Bae, J Kim, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon

(2015), Vol. 5, pp. 1-7, Translational psychiatry, London, Eng., C1-1

journal

Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation

R Kale, A Kouzani, M Berk, K Walder, J Berk, S Tye

(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1

journal
2014

Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns

T Nordfjrn, O Bjerkeset, G Bratberg, S Moylan, M Berk, R Grwe

(2014), Vol. 68, pp. 107-116, Nordic Journal of Psychiatry, C1

journal

Omega-3 fatty acid supplementation changes intracellular phospholipase A 2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

S Smesny, B Milleit, U Hipler, C Milleit, M Schfer, C Klier, M Holub, I Holzer, G Berger, M Otto, I Nenadic, M Berk, P Mcgorry, H Sauer, G Amminger

(2014), Vol. 19, pp. 317-324, Molecular Psychiatry, C1

journal

Investigating the predictive validity of an emergency department mental health triage tool

N Sands, S Elsom, M Berk, J Hosking, R Prematunga, M Gerdtz

(2014), Vol. 16, pp. 11-18, Nursing and Health Sciences, C1

journal

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome

G Anderson, M Berk, M Maes

(2014), Vol. 129, pp. 83-97, Acta Psychiatrica Scandinavica, C1

journal

Antidepressant pharmacogenetics

A Singh, C Bousman, C Ng, M Berk

(2014), Vol. 27, pp. 43-51, Current Opinion in Psychiatry, C1

journal

Atopic disorders and depression: Findings from a large, population-based study

L Sanna, A Stuart, J Pasco, F Jacka, M Berk, M Maes, A O'Neil, P Girardi, L Williams

(2014), Vol. 155, pp. 261-265, Journal of Affective Disorders, C1

journal

The association between poor dental health and depression: Findings from a large-scale, population-based study (the NHANES study)

A O'Neil, M Berk, K Venugopal, S Kim, L Williams, F Jacka

(2014), Vol. 36, pp. 266-270, General Hospital Psychiatry, C1

journal

Depression following fracture in women: A study of age-matched cohorts

L Williams, M Berk, M Henry, A Stuart, S Brennan, F Jacka, J Pasco

(2014), Vol. 4, BMJ Open, C1

journal

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: Therapeutic implications

G Anderson, M Berk, O Dean, S Moylan, M Maes

(2014), Vol. 28, pp. 1-10, CNS Drugs, C1

journal

Stress, inflammation, and cellular vulnerability during early stages of affective disorders: Biomarker strategies and opportunities for prevention and intervention

A Walker, Y Kim, J Blair Price, R Kale, J McGillivray, M Berk, S Tye

(2014), Vol. 5, Frontiers in Psychiatry, C1-1

journal

Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders

H Vargas, S Nunes, D Barbosa, M Vargas, A Cestari, S Dodd, K Venugopal, M Maes, M Berk

(2014), Vol. 102, pp. 65-71, Life Sciences, C1

journal

Prevalence of excessive daytime sleepiness in a sample of the Australian adult population

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 15, pp. 348-354, Sleep Medicine, C1

journal

Risk stratification using data from electronic medical records better predicts suicide risks than clinician assessments

T Tran, W Luo, D Phung, R Harvey, M Berk, R Kennedy, S Venkatesh

(2014), Vol. 14, pp. 1-9, BMC psychiatry, London, Eng., C1

journal

Systematic review of N-acetylcysteine in the treatment of addictions

E Asevedo, A Mendes, M Berk, E Brietzke

(2014), Vol. 36, pp. 168-175, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

M Maes, G Anderson, M Kubera, M Berk

(2014), Vol. 18, pp. 495-512, Expert opinion on therapeutic targets, London, England, C1

journal

The efficacy of adjunctive N-Acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial

M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi

(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

C Bortolasci, H Odebrecht Vargas, A Souza-Nogueira, D Barbosa, E Moreira, S Obedrecht Vargas Nunes, M Berk, S Dodd, M Maes

(2014), Vol. 159, pp. 23-30, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania

J Kulkarni, M Berk, W Wang, L Mu, E Scarr, T Van Rheenen, R Worsely, C Gurvich, E Gavrilidis, A de Castella, P Fitzgerald, S David

(2014), Vol. 43, pp. 52-61, Psychoneuroendocrinology, Oxford, England, C1

journal

Neuroprogression in schizophrenia : pathways underpinning clinical staging and therapeutic corollaries

J Davis, S Moylan, B Harvey, M Maes, M Berk

(2014), Vol. 48, pp. 512-529, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Oxidative & nitrosative stress in depression: why so much stress?

S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes

(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Predominant polarity as a course specifier for bipolar disorder: a systematic review

A Carvalho, R McIntyre, D Dimelis, X Gonda, M Berk, P Nunes-Neto, D Cha, T Hyphantis, J Angst, K Fountoulakis

(2014), Vol. 163, pp. 56-64, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study

M Bauer, T Glenn, M Alda, O Andreasssen, E Angelopoulos, R Ardua, C Baethge, R Bauer, F Belliver, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagionlini, M Frye, K Fountoulaski, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsa, F Kapczinski, S Kliwicki, B Konig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2014), Vol. 167, pp. 104-111, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Urdahl, P Magalhaes, M Otto, E Frank, D Miklowitz, M Berk, G Kinryn, A Nierenberg

(2014), Vol. 171, pp. 178-186, American journal of psychiatry, Arlington, VA, C1

journal

Suicidal ideation and physical illness: Does the link lie with depression?

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, L Williams

(2014), Vol. 152-154, pp. 422-426, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)

G Morris, M Berk, P Galecki, M Maes

(2014), Vol. 49, pp. 741-756, Molecular Neurobiology, C1

journal

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder

S Kim, L Berk, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, G Amminger, M Berk

(2014), Vol. 166, pp. 243-248, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

journal

Lifestyle medicine for depression

J Sarris, A O'Neil, C Coulson, I Schweitzer, M Berk

(2014), Vol. 14, BMC Psychiatry, C1

journal

Comparison of self-report and structured clinical interview in the identification of depression

A Stuart, J Pasco, F Jacka, S Brennan, M Berk, L Williams

(2014), Vol. 55, pp. 866-869, Comphrensive psychiatry, Amsterdam, The Netherlands, C1

journal

Attributions of responsibility and recovery within a no-fault insurance compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2014), Vol. 59, pp. 247-255, Rehabilitation psychology, Washington DC, C1

journal

Predicting bipolar disorder on the basis of phenomenology: Implications for prevention and early intervention

G Malhi, D Bargh, C Coulston, P Das, M Berk

(2014), Vol. 16, pp. 455-470, Bipolar Disorders, C1

journal

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk

(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

journal

Assessing regional cerebral blood flow in depression using 320-slice computed tomography

Y Wang, H Zhang, S Tang, X Liu, A O'Neil, A Turner, F Chai, F Chen, M Berk

(2014), Vol. 9, pp. 1-10, PLoS One, San Francisco, Cal., C1

journal

Adipokines as emerging depression biomarkers: a systematic review and meta-analysis

A Carvalho, D Rocha, R McIntyre, L Mesquita, C Khler, T Hyphantis, P Sales, R Machado-Vieira, M Berk

(2014), Vol. 59, pp. 28-37, Journal of psychiatric research, Oxford, England, C1

journal

Relationship between diet and mental health in children and adolescents: a systematic review

A O'Neil, S Quirk, S Housden, S Brennan, L Williams, J Pasco, M Berk, F Jacka

(2014), Vol. 104, pp. e31-e42, American journal of public health, Washington, DC, C1

journal

Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.

C Bortolasci, M Maes, H Vargas, A Souza-Nogueira, E Moreira, S Nunes, M Berk, S Dodd, D Barbosa

(2014), Vol. 581, pp. 46-51, Neuroscience letters, Shannon, Ireland, C1

journal

The impact of insight in a first-episode mania with psychosis population on outcome at 18 months

L Smith, C Shelton, M Berk, M Hasty, S Cotton, L Henry, R Daglas, E Gentle, P McGorry, C Macneil, P Conus

(2014), Vol. 167, pp. 74-79, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis

S Kim, M Schfer, C Klier, M Berk, S Rice, K Allott, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger

(2014), Vol. 158, pp. 39-44, Schizophrenia Research, Amsterdam, The Netherlands, C1

journal

Application of the gradient boosted method in randomised clinical trials: participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo

S Dodd, M Berk, K Kelin, Q Zhang, E Eriksson, W Deberdt, J Craig Nelson

(2014), Vol. 168, pp. 284-293, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey

M Berk, L Williams, A Andreazza, J Pasco, S Dodd, F Jacka, S Moylan, E Reiner, P Magalhaes

(2014), Vol. 4, pp. 1-9, BMJ Open, London, England, C1

journal

Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.

A Ghanizadeh, Z Rezaee, S Dehbozorgi, M Berk, S Akhondzadeh

(2014), Vol. 219, pp. 431-435, Psychiatry Research, Ireland, C1

journal

Data Integration Protocol In Ten-steps (DIPIT) : a new standard for medical researchers

J Dipnall, M Berk, F Jacka, L Williams, S Dodd, J Pasco

(2014), Vol. 69, pp. 237-246, Methods, Amsterdam, The Netherlands, C1

journal

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study

M Pizzo de Castro, M Maes, R Guembarovski, C Ariza, E Reiche, H Vargas, M Vargas, L de Melo, S Dodd, M Berk, M Watanabe, S Nunes

(2014), Vol. 15, pp. 1-9, BMC Genetics, London, England, C1

journal

Quality of life in bipolar and schizoaffective disorder - a naturalistic approach.

M Martin-Subero, L Berk, S Dodd, V Kamalesh, M Maes, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2014), Vol. 55, pp. 1540-1545, Comprehensive Psychiatry, Malden, Mass., C1

journal

Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

M Debnath, M Berk

(2014), Vol. 40, pp. 1412-1421, Schizophrenia Bulletin, Oxford , England, C1

journal

Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence

S Odebrecht Vargas Nunes, M Pizzo de Castro, M Ehara Watanabe, R Losi Guembarovski, H Odebrecht Vargas, E Reiche, H Kaminami Morimoto, S Dodd, M Berk

(2014), Vol. 24, pp. 87-93, Psychiatric genetics, Philadelphia, PA, C1

journal

Stage managing bipolar disorder.

M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, A Bechdolf, S Moylan, G Malhi

(2014), Vol. 16, pp. 471-477, Bipolar Disorders, Malden, Mass., C1

journal

Age of onset, course of illness, and response to psychotherapy for bipolar depression

A Peters, L Sylvia, P Magalhaes, D Miklowitz, E Frank, M Otto, M Berk, A Nierenberg, T Deckersbach

(2014), Vol. 16, pp. 44-44, ISBD 2014 : Proceedings of the 16th Annual Conference of the International Society for Bipolar Disorders, Seoul, South Korea, E1-1

conference

The integrative management of treatment-resistant depression: a comprehensive review and perspectives.

A Carvalho, M Berk, T Hyphantis, R McIntyre

(2014), Vol. 83, pp. 70-88, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial

A Ghanizadeh, A Sahraeizadeh, M Berk

(2014), Vol. 45, pp. 185-192, Child Psychiatry & Human Development, New York, NY, C1

journal

The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study

A Bechdolf, A Bechdolf, A Rateesh, A Rateesh, S Cotton, S Cotton, B Nelson, B Nelson, A Chanen, A Chanen, J Betts, J Betts, T Bingmann, T Bingmann, A Yung, A Yung, M Berk, M Berk, P McGorry, P McGorry

(2014), Vol. 16, pp. 493-504, Bipolar Disorders: an international journal of psychiatry and neurosciences, London, Eng., C1

journal

Atypical antipsychotic agents; peas in a pod or chalk and cheese?

A Singh, A Nierenberg, L Yatham, M Berk

(2014), Vol. 12, pp. 1-4, BMC Medicine, London, England, C1

journal

Staging systems in bipolar disorder: An International Society for Bipolar Disorders Task Force Report

F Kapczinski, P Magalhes, V Balanz-Martinez, V Dias, S Frangou, C Gama, A Gonzalez-Pinto, I Grande, K Ha, M Kauer-Sant'Anna, M Kunz, R Kupka, M Leboyer, C Lopez-Jaramillo, R Post, J Rybakowski, J Scott, S Strejilevitch, M Tohen, G Vazquez, L Yatham, E Vieta, M Berk

(2014), Vol. 130, pp. 354-363, Acta Psychiatrica Scandinavica, Malden, United States, C1

journal

The Glutathione System: a new drug target in neuroimmune disorders

G Morris, G Morris, G Anderson, G Anderson, O Dean, O Dean, M Berk, M Berk, P Galecki, P Galecki, M Martin-Subero, M Martin-Subero, M Maes, M Maes

(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1

journal

Excessive daytime sleepiness and body composition: a population-based study of adults

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, CA, C1

journal

Association between attributions of responsibility for motor vehicle crashes, depressive symptoms, and return to work

J Thompson, M O'Donnell, L Stafford, T Nordfjaern, M Berk

(2014), Vol. 59, pp. 376-385, Rehabilitation Psychology, Washington, D.C., United States, C1

journal

Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)

S Sarr, M Madre, P Fernndez-Corcuera, M Valent, J Goikolea, E Pomarol-Clotet, M Berk, B Amann

(2014), Vol. 172, pp. 110-115, Journal of Affective Disorders, Amsterdam , Netherlands, C1

journal

Age at onset, course of illness and response to psychotherapy in bipolar disorder: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

A Peters, L Sylvia, P Da Silva Magalhes, D Miklowitz, E Frank, M Otto, N Hansen, D Dougherty, M Berk, A Nierenberg, T Deckersbach

(2014), Vol. 44, pp. 3455-3467, Psychological medicine, Cambridge, Eng., C1

journal

Affective and content analysis of online depression communities

T Nguyen, D Phung, B Dao, S Venkatesh, M Berk

(2014), Vol. 5, pp. 217-226, IEEE Transactions on Affective Computing, Piscataway, N.J, C1

journal

Association between alcohol consumption and self-reported depression among elderly Australian men

C Coulson, L Williams, M Berk, D Lubman, S Quirk, J Pasco

(2014), Vol. 2, pp. 3-8, Geriatric Mental Health Care, Amsterdam, The Netherlands, C1

journal

Biomarkers and clinical staging in psychiatry

P McGorry, M Keshavan, S Goldstone, P Amminger, K Allott, M Berk, S Lavoie, C Pantelis, A Yung, S Wood, I Hickie

(2014), Vol. 13, pp. 211-223, World psychiatry, Oxford, England, C1

journal

High-impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2014), Vol. 48, pp. 124-124, RANZCP 2014 : Evolving landscapes in mental health: interface & interaction : Proceedings of Congress 2014, Perth, W.A., E1-1

conference

Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

C Bortolasci, H Vargas, A Souza-Nogueira, E Gastaldello Moreira, S Vargas Nunes, M Berk, S Dodd, D Barbosa, M Maes

(2014), Vol. 19, pp. 232-241, Redox report, Leeds, England, C1

journal

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry

(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1

journal

The impact of past direct-personal traumatic events on 12-month outcome in first episode psychotic mania: trauma and early psychotic mania

R Daglas, P Conus, S Cotton, C Macneil, M Hasty, L Kader, M Berk, K Hallam

(2014), Vol. 48, pp. 1017-1024, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder : a review

N Leitan, E Michalak, L Berk, M Berk, G Murray

(2014), pp. 1-13, Bipolar Disorders, Malden, United States, C1

journal

Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder : an empirical cross-sectional study

Aydemir, Z ubukuo?lu, S Erdin, C Ta?, E Onur, M Berk

(2014), Vol. 36, pp. 293-297, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

journal

Statin use and risk of depression: a Swedish national cohort study

C Redlich, M Berk, L Williams, J Sundquist, K Sundquist, X Li

(2014), Vol. 14, pp. 1-9, BMC Psychiatry, London, Eng., C1

journal

The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression.

Y Wang, H Zhang, F Chai, X Liu, M Berk

(2014), Vol. 14, pp. 1-7, BMC Psychiatry, London, England, C1

journal

Cognitive dysfunction in depression - pathophysiology and novel targets

A Carvalho, K Miskowiak, T Hyphantis, C Kohler, G Alves, B Bortolato, P Sales, R Machado-Vieira, M Berk, R McIntyre

(2014), Vol. 13, pp. 1-17, CNS & Neurological Disorders - Drug Targets, Bussum, Netherlands, C1

journal

Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.

S Vargas Nunes, M Pizzo de Castro, E Moreira, R Guembarovski, D Barbosa, H Vargas, L Piccoli de Melo, C Bortolasci, M Watanabe, S Dodd, M Berk, M Maes

(2014), Vol. 585C, pp. 132-137, Neuroscience letters, Shannon, Ireland, C1

journal

Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome

M Maes, J Leunis, M Geffard, M Berk

(2014), Vol. 35, pp. 445-453, Neuroendocrinology Letters, Sweden, C1

journal

Relationship between membrane fatty acids and cognitive function in individuals at ultra-high risk for psychosis

S Kim, M Schfer, C Klier, M Berk, S Rice, K Allot, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger

(2014), Vol. 8, pp. 166-166, IEPA 2014 : To the new horizon : Proceedings of the 9th International Conference on Early Psychosis, Tokyo, Japan, E1-1

conference

The association between dietary patterns, diabetes and depression.

J Dipnall, J Pasco, D Meyer, M Berk, L Williams, S Dodd, F Jacka

(2014), Vol. 174, pp. 215-224, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

journal

Treatment implications of predominant polarity and the polarity index: a comprehensive review.

A Carvalho, J Quevedo, R McIntyre, M Soeiro-de-Souza, K Fountoulakis, M Berk, T Hyphantis, E Vieta

(2014), Vol. 18, International Journal of Neuropsychopharmacology, England, C1

journal

e-Mental health for mood and anxiety disorders in general practice

J Orman, B O'Dea, F Shand, M Berk, J Proudfoot, H Christensen

(2014), Vol. 43, pp. 832-837, Australian family physician, Melbourne, Vic., C1

journal

Construct validity of the Experiences of Therapy Questionnaire (ETQ)

G Parker, A Paterson, K Fletcher, G McClure, M Berk

(2014), Vol. 14, pp. 1-6, BMC psychiatry, London, England, C1-1

journal

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial.

O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk

(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

journal

Development of a compact rectenna for wireless powering of a head-mountable deep brain stimulation device

M Hosain, A Kouzani, S Tye, O Abulseoud, A Amiet, A Galehdar, A Kaynak, M Berk

(2014), Vol. 2, pp. 1-13, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1

journal

The Association Between Use of Antidepressants and Bone Quality Using Quantitative Ultrasound.

Paivi Rauma, Julie Pasco, Michael Berk, Amanda Stuart, Risto Honkanen, Heli Koivumaa-Honkanen, Jason Hodge, Lana Williams

(2014), Vol. 29, pp. S462-S462, JOURNAL OF BONE AND MINERAL RESEARCH, Houston, TX, C1-1

journal
2013

The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications

S Moylan, M Maes, N Wray, M Berk

(2013), Vol. 18, pp. 595-606, Molecular Psychiatry, C1

journal

Development of an online intervention for bipolar disorder. www.moodswings.net.au

S Lauder, A Chester, D Castle, S Dodd, L Berk, B Klein, D Austin, M Gilbert, J Chamberlain, G Murray, C White, L Piterman, M Berk

(2013), Vol. 18, pp. 155-165, Psychology, health and medicine, Oxon, England, C1

journal

The sick role, illness cognitions and outcomes in bipolar disorder

M Berk, L Berk, S Dodd, P Fitzgerald, A De Castella, S Filia, K Filia, A Brnabic, K Kelin, W Montgomery, J Kulkarni, L Stafford

(2013), Vol. 146, pp. 146-149, Journal of Affective Disorders, C1

journal

Clinical characteristics and smoking cessation: An analysis of sex and depressive disorders differences

S Nunes, M Pizzo De Castro, H Odebrecht Vargas, M Mendona Vargas, R Bueno Rezende MacHado, I Batista Fonseca, S Dodd, M Berk

(2013), Vol. 12, pp. 158-165, Addictive Disorders and their Treatment, C1

journal

Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women

F Jacka, J Pasco, L Williams, B Meyer, R Digger, M Berk

(2013), Vol. 109, pp. 2059-2066, British Journal of Nutrition, C1

journal

Depression, diet and exercise

F Jacka, M Berk

(2013), Vol. 199, pp. S21-S23, The Medical journal of Australia, C1

journal

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach

A Ghanizadeh, M Berk, H Farrashbandi, A Alavi shoushtari, K Villagonzalo

(2013), Vol. 13, pp. 515-519, Mitochondrion, C1

journal

Diet quality and mental health problems in adolescents from East London: A prospective study

F Jacka, C Rothon, S Taylor, M Berk, S Stansfeld

(2013), Vol. 48, pp. 1297-1306, Social Psychiatry and Psychiatric Epidemiology, C1

journal

The nocebo effect: A clinicians guide

J Data-Franco, M Berk

(2013), Vol. 47, pp. 617-623, Australian and New Zealand Journal of Psychiatry, C1

journal

Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: A systematic review of randomized controlled clinical trials

A Ghanizadeh, M Berk

(2013), Vol. 67, pp. 122-124, European Journal of Clinical Nutrition, C1

journal

Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders

L Williams, J Pasco, F Jacka, J Hodge, M Kotowicz, M Berk

(2013), Vol. 146, pp. 395-400, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal

Putative neuroprotective agents in neuropsychiatric disorders

S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk

(2013), Vol. 42, pp. 135-145, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1

journal

Neurocognitive functioning in the prodrome of mania - An exploratory study

A Ratheesh, A Lin, B Nelson, S Wood, W Brewer, J Betts, M Berk, P McGorry, A Yung, A Bechdolf

(2013), Vol. 147, pp. 441-445, Journal of Affective Disorders, C1

journal

Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function

J Hodge, Y Wang, M Berk, F Collier, T Fernandes, M Constable, J Pasco, S Dodd, G Nicholson, R Kennedy, L Williams

(2013), Vol. 74, pp. 32-39, Biological psychiatry, Amsterdam, The Netherlands, C1

journal

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

G Anderson, M Maes, M Berk

(2013), Vol. 42, pp. 101-114, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1

journal

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

M Mller, J Du Preez, F Viljoen, M Berk, R Emsley, B Harvey

(2013), Vol. 30, pp. 156-167, Brain, Behavior, and Immunity, C1

journal

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013

L Yatham, S Kennedy, S Parikh, A Schaffer, S Beaulieu, M Alda, C O'Donovan, G Macqueen, R Mcintyre, V Sharma, A Ravindran, L Young, R Milev, D Bond, B Frey, B Goldstein, B Lafer, B Birmaher, K Ha, W Nolen, M Berk

(2013), Vol. 15, pp. 1-44, Bipolar Disorders, C1

journal

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression

M Maes, M Kubera, I Mihaylova, M Geffard, P Galecki, J Leunis, M Berk

(2013), Vol. 149, pp. 23-29, Journal of Affective Disorders, C1

journal

Development of a measure quantifying adverse psychotherapeutic ingredients: The experiences of therapy questionnaire (ETQ)

G Parker, K Fletcher, M Berk, A Paterson

(2013), Vol. 206, pp. 293-301, Psychiatry Research, C1-1

journal

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye

(2013), Vol. 242, pp. 76-83, Behavioural Brain Research, C1

journal

Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: A systematic review of non-controlled and controlled trials

A Ghanizadeh, R Freeman, M Berk

(2013), Vol. 8, pp. 2-8, Reviews on Recent Clinical Trials, C1

journal

The promise of N-acetylcysteine in neuropsychiatry

M Berk, G Malhi, L Gray, O Dean

(2013), Vol. 34, pp. 167-177, Trends in Pharmacological Sciences, C1

journal

Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo

P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi

(2013), Vol. 47, pp. 347-354, Australian and New Zealand Journal of Psychiatry, C1

journal

Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young

(2013), Vol. 47, pp. 321-332, Australian and New Zealand Journal of Psychiatry, C1-1

journal

Lifestyle management of unipolar depression

M Berk, J Sarris, C Coulson, F Jacka

(2013), Vol. 127, pp. 38-54, Acta Psychiatrica Scandinavica, C1-1

journal

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes

M Maes, M Kubera, J Leunis, M Berk, M Geffard, E Bosmans

(2013), Vol. 127, pp. 344-354, Acta Psychiatrica Scandinavica, C1

journal

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

P Da Silva Magalhes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2013), Vol. 47, pp. 564-568, Australian and New Zealand Journal of Psychiatry, C1

journal

Differences between first episode schizophrenia and schizoaffective disorder

S Cotton, M Lambert, B Schimmelmann, A Mackinnon, J Gleeson, M Berk, L Hides, A Chanen, J Scott, D Schttle, P McGorry, P Conus

(2013), Vol. 147, pp. 169-174, Schizophrenia Research, C1

journal

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta Psychiatrica Scandinavica, C1

journal

The relationship between excessive daytime sleepiness and depressive and anxiety disorders in women

A Hayley, L Williams, M Berk, G Kennedy, F Jacka, J Pasco

(2013), Vol. 47, pp. 772-778, Australian and New Zealand Journal of Psychiatry, C1

journal

Physical comorbidities in men with mood and anxiety disorders: A population-based study

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, S Brennan, L Williams

(2013), Vol. 11, BMC Medicine, C1

journal

Extreme attributions predict the course of bipolar depression : results from the STEP-BD randomized controlled trial of psychosocial treatment

J Strange, L Sylvia, P Vieira da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 74, pp. 249-255, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

Gender differences in first episode psychotic mania

S Cotton, M Lambert, M Berk, B Schimmelmann, F Butselaar, P McGorry, P Conus

(2013), Vol. 13, BMC Psychiatry, C1

journal

Aspirin: A review of its neurobiological properties and therapeutic potential for mental illness

M Berk, M Berk, O Dean, O Dean, H Drexhage, H Drexhage, J McNeil, J McNeil, S Moylan, S Moylan, A O'Neil, A O'Neil, C Davey, C Davey, L Sanna, L Sanna, M Maes, M Maes

(2013), Vol. 11, pp. 1-17, BMC Medicine, C1

journal

How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: A critical review of biological pathways

S Moylan, F Jacka, J Pasco, M Berk

(2013), Vol. 3, pp. 302-326, Brain and Behavior, C1

journal

The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction

Y Wang, X Liu, D Zhang, J Chen, S Liu, M Berk

(2013), Vol. 11, BMC Medicine, C1

journal

The Impact of Smoking in Adolescence on Early Adult Anxiety Symptoms and the Relationship between Infant Vulnerability Factors for Anxiety and Early Adult Anxiety Symptoms: The TOPP Study

S Moylan, K Gustavson, E Karevold, S verland, F Jacka, J Pasco, M Berk

(2013), Vol. 8, PLoS ONE, C1

journal

Psychomotor depressive symptoms may differentially respond to venlafaxine

A Singh, C Bousman, C Ng, K Byron, M Berk

(2013), Vol. 28, pp. 121-126, International clinical psychopharmacology, Philadelphia, Pa., C1

journal

Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

S Moylan, H Eyre, M Maes, B Baune, F Jacka, M Berk

(2013), Vol. 37, pp. 573-584, Neuroscience and Biobehavioral Reviews, C1

journal

Oxidative stress and inflammatory markers are associated with depression and nicotine dependence

H Vargas, S Nunes, M de Castro, M Vargas, D Barbosa, C Bortolasci, K Venugopal, S Dodd, M Berk

(2013), Vol. 544, pp. 136-140, Neuroscience Letters, C1

journal

A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): Study protocol

A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka

(2013), Vol. 13, BMC Psychiatry, C1

journal

Obesity and the relationship with positive and negative affect

J Pasco, L Williams, F Jacka, S Brennan, M Berk

(2013), Vol. 47, pp. 477-482, Australian and New Zealand Journal of Psychiatry, C1

journal

Prevention of common mental disorders: What can we learn from those who have gone before and where do we go next?

F Jacka, N Reavley, A Jorm, J Toumbourou, A Lewis, M Berk

(2013), Vol. 47, pp. 920-929, Australian and New Zealand Journal of Psychiatry, C1

journal

The association between diet quality, dietary patterns and depression in adults: a systematic review

S Quirk, L Williams, A O'Neil, J Pasco, F Jacka, S Housden, M Berk, S Brennan

(2013), Vol. 13, pp. 1-22, BMC psychiatry, London, England, C1

journal

The chemistry and biological activities of N-acetylcysteine

Y Samuni, S Goldstein, O Dean, M Berk

(2013), Vol. 1830, pp. 4117-4129, Biochimica et Biophysica Acta - General Subjects, C1

journal

Socioeconomic status and quality of life in population-based Australian men: Data from the Geelong Osteoporosis Study

S Brennan, S Brennan, L Williams, L Williams, M Berk, M Berk, J Pasco, J Pasco

(2013), Vol. 37, pp. 226-232, Australian and New Zealand Journal of Public Health, C1-1

journal

Alcohol consumption and body composition in a population-based sample of elderly Australian men

C Coulson, L Williams, S Brennan, M Berk, M Kotowicz, D Lubman, J Pasco

(2013), Vol. 25, pp. 183-192, Aging Clinical and Experimental Research, C1

journal

Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

H Vargas, S Nunes, M De Castro, C Bortolasci, D Barbosa, H Morimoto, K Venugopal, S Doddd, M Maes, M Berk

(2013), Vol. 150, pp. 923-930, Journal of Affective Disorders, C1

journal

Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder

S Dodd, M Berk, K Kelin, M Mancini, A Schacht

(2013), Vol. 150, pp. 344-349, Journal of Affective Disorders, C1

journal

Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: A population-based study in women

L Sanna, A Stuart, M Berk, J Pasco, P Girardi, L Williams

(2013), Vol. 13, BMC Psychiatry, C1

journal

Design and analysis of an antenna for wireless energy harvesting in a head-mountable DBS device

M Hosain, A Kouzani, S Tye, O Abulseoud, M Berk

(2013), pp. 3078-3081, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, E1-1

conference

Online social capital : mood, topical and psycholinguistic analysis

T Nguyen, B Dao, D Phung, S Venkatesh, M Berk

(2013), pp. 449-456, ICWSM 2013 : Proceedings of the 7th AAAI International Conference on Weblogs and Social Media, Cambridge, Massachusetts, E1

conference

A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior

G Morris, G Anderson, P Galecki, M Berk, M Maes

(2013), Vol. 11, pp. 1-19, BMC Medicine, C1-1

journal

DSM-5: A collection of psychiatrist views on the changes, controversies, and future directions

C Nemeroff, D Weinberger, M Rutter, H MacMillan, R Bryant, S Wessely, D Stein, C Pariante, F Seemller, M Berk, G Malhi, M Preisig, M Brne, P Lysaker

(2013), Vol. 11, BMC Medicine, C1

journal

N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats

M Mller, J Du Preez, F Viljoen, M Berk, B Harvey

(2013), Vol. 28, pp. 687-696, Metabolic Brain Disease, C1

journal

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia

Ahmad Ghanizadeh, Michael Berk

(2013), Vol. 3, pp. 11-11, Medical Gas Research, C1

journal

Clock face drawing test performance in children with ADHD

A Ghanizadeh, S Safavi, M Berk

(2013), Vol. 4, pp. 50-56, Basic and Clinical Neuroscience, C1

journal

Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study

T Nordfjrn, O Bjerkeset, S Moylan, M Berk, R Grwe

(2013), Vol. 38, pp. 2575-2580, Addictive Behaviors, C1

journal

Altered cardiac autonomic nervous function in depression

Y Wang, X Zhao, A O'Neil, A Turner, X Liu, M Berk

(2013), Vol. 13, BMC Psychiatry, C1

journal

Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients

Adrienne O?Neil, Michael Berk, Justin Davis, Lesley Stafford

(2013), Vol. 05, pp. 6-14, Health, C1

journal

DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

R McIntyre, M Tohen, M Berk, J Zhao, E Weiller

(2013), Vol. 150, pp. 378-383, Journal of Affective Disorders, C1

journal

The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence

S Nunes, H Vargas, E Prado, D Barbosa, L de Melo, S Moylan, S Dodd, M Berk

(2013), Vol. 37, pp. 1336-1345, Neuroscience and Biobehavioral Reviews, C1

journal

A Low Power Micro Deep Brain Stimulation Device for Murine Preclinical Research

A Kouzani, O Abulseoud, S Tye, M Hosain, M Berk

(2013), Vol. 1, pp. 1500109-1500109, IEEE Journal of Translational Engineering in Health and Medicine, C1

journal

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, D Bond, R Baldessarini, W Nolen, H Grunze, R Licht, R Post, M Berk, G Goodwin, G Sachs, L Tondo, R Findling, E Youngstrom, M Tohen, J Undurraga, A Gonzlez-Pinto, J Goldberg, A Yildiz, L Altshuler, J Calabrese, P Mitchell, M Thase, A Koukopoulos, F Colom, M Frye, G Malhi, K Fountoulakis, G Vzquez, R Perlis, T Ketter, F Cassidy, H Akiskal, J Azorin, M Valent, D Mazzei, B Lafer, T Kato, L Mazzarini, A Martnez-Aran, G Parker, D Souery, A zerdem, S McElroy, P Girardi, M Bauer, L Yatham, C Zarate, A Nierenberg, B Birmaher, S Kanba, R El-Mallakh, A Serretti, Z Rihmer, A Young, G Kotzalidis, G Macqueen, C Bowden, S Ghaemi, C Lopez-Jaramillo, J Rybakowski, K Ha, G Perugi, S Kasper, J Amsterdam, R Hirschfeld, F Kapczinski, E Vieta

(2013), Vol. 170, pp. 1249-1262, American Journal of Psychiatry, C1

journal

Maternal and early postnatal nutrition and mental health of offspring by age 5 years: A prospective cohort study

F Jacka, E Ystrom, A Brantsaeter, E Karevold, C Roth, M Haugen, H Meltzer, S Schjolberg, M Berk

(2013), Vol. 52, pp. 1038-1047, Journal of the American Academy of Child and Adolescent Psychiatry, C1

journal

Hyponatraemia: An audit of aged psychiatry patients taking SSRIs and SNRIs

F Giorlando, J Teister, S Dodd, M Udina, M Berk

(2013), Vol. 8, pp. 175-180, Current Drug Safety, C1

journal

Emerging pharmacotherapy for cancer patients with cognitive dysfunction

J Davis, F Ahlberg, M Berk, D Ashley, M Khasraw

(2013), Vol. 13, BMC Neurology, C1

journal

N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial

A Ghanizadeh, N Derakhshan, M Berk

(2013), Vol. 12, pp. 223-228, Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, C1

journal

So depression is an inflammatory disease, but where does the inflammation come from?

M Berk, M Berk, L Williams, L Williams, F Jacka, F Jacka, A O'Neil, A O'Neil, J Pasco, J Pasco, S Moylan, S Moylan, N Allen, N Allen, A Stuart, A Stuart, A Hayley, A Hayley, M Byne, M Byne, M Maes, M Maes

(2013), Vol. 11, pp. 1-16, BMC medicine, London, UK, C1-1

journal

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

M Bauer, A Pfennig, E Severus, P Whybrow, J Angst, H Mller, M Adli, O Benkert, T Bschor, A Tadi?, E Holsboer-Trachsler, I Anderson, D Baldwin, J Cookson, H Grunze, C Katona, E Paykel, A Tylee, J Ayuso-Gutierrez, E Vieta, P Bech, R Licht, H Lublin, P Vestergaard, M Berk, G Burrows, P Mitchell, I Schweitzer, I Bitter, G Cassano, M Cetkovich-Bakmas, D Da Costa, M Gheorghe, G Heinze, T Higuchi, R Hirschfeld, M Keller, D Kupfer, A Rush, J Untzer, C Hschl, R Kang, M Lee, S Lim, J Paik, Y Park, S Kasper, S Kirli, A Yazici, E Kostukova, P Kulhara, B Leonard, O Lingjaerde, C Liu, J Mendlewicz, S Puzynski, J Rybakowski, K Yamada

(2013), Vol. 14, pp. 334-385, World Journal of Biological Psychiatry, C1-1

journal

Potential mechanisms of action of lithium in bipolar disorder : current understanding

G Malhi, M Tanious, P Das, C Coulston, M Berk

(2013), Vol. 27, pp. 135-153, CNS drugs, Auckland, New Zealand, C1-1

journal

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder

L Berk, M Berk, S Dodd, C Kelly, S Cvetkovski, A Jorm

(2013), Vol. 11, pp. 1-13, BMC medicine, London, Eng., C1-1

journal

To a broader concept of remission: rating the health-related quality of life in bipolar disorder

M Subero, L Berk, S Dodd, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2013), Vol. 150, pp. 673-676, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 47, pp. 1191-1195, Australian & New Zealand journal of psychiatry, London, Eng., C1-1

journal

Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants

J Nelson, Q Zhang, K Kelin, E Eriksson, W Deberdt, M Berk

(2013), Vol. 29, pp. 827-833, Current medical research and opinion, London, Eng., C1-1

journal

Increased IL-6 trans-signaling in depression: Focus on the tryptophan catabolite pathway, melatonin and neuroprogression

G Anderson, M Kubera, W Duda, W Lasoz, M Berk, M Maes

(2013), Vol. 65, pp. 1647-1654, Pharmacological Reports, C1-1

journal

Difficult-to-treat depression

D Castle, L Piterman, M Berk

(2013), Vol. 199, pp. S4-S5, The medical journal of australia, Australia, C1-1

journal

Tobacco smoking predicts depression and poorer quality of life in heart disease

L Stafford, M Berk, H Jackson

(2013), Vol. 13, pp. 1-10, BMC cardiovascular disorders, London, Eng., C1-1

journal

Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder

J Stange, L Sylvia, P Magalhes, E Frank, M Otto, D Miklowitz, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 47, pp. 1329-1336, Journal of psychiatric research, Amsterdam, The Netherlands, C1-1

journal

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

G Morris, G Anderson, M Berk, M Maes

(2013), Vol. 48, pp. 883-903, Molecular neurobiology, New York, N.Y., C1-1

journal

Safe and effective use of lithium

G Malhi, M Tanious, D Bargh, P Das, M Berk

(2013), Vol. 36, pp. 18-21, Australian prescriber, Surry Hills, N.S.W., C1-1

journal

An integrated framework for suicide risk prediction

T Tran, Q Phung, W Luo, R Harvey, M Berk, S Venkatesh

(2013), pp. 1410-1418, KDD'13: Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining, Chicago, Ill., E1-1

conference

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies

A Young, J Calabrese, U Gustafsson, M Berk, S McElroy, M Thase, T Suppes, W Earley

(2013), Vol. 1, pp. 1-12, International journal of bipolar disorders, London, Eng., C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Mller, S Kasper, M Berk

(2013), Vol. 14, pp. 154-219, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2012

Psychometric properties of a scale to measure investment in the sick role: The Illness Cognitions Scale

M Berk, L Berk, S Dodd, F Jacka, P Fitzgerald, A De Castella, S Filia, K Filia, J Kulkarni, H Jackson, L Stafford

(2012), Vol. 18, pp. 360-364, Journal of Evaluation in Clinical Practice, C1-1

journal

Dietary selenium intake and major depressive disorder: a nested case-control study

J Pasco, F Jacka, L Williams, M Evans-Cleverdon, S Brennan, M Kotowicz, G Nicholson, M Ball, M Berk

(2012), Vol. 20, pp. 119-123, Complementary therapies in medicine, Kidlington, England, C1

journal

Pure and comorbid depression : a comparison of symptom profile and impairment in 64.000 adults. The HUNT Study.

O Bjerkeset, L Williams, U Romild, M Berk

(2012), British journal of psychiatry, London, England, C1

journal

Nutrient intakes and the common mental disorders in women

F Jacka, M Maes, J Pasco, L Williams, M Berk

(2012), Vol. 141, pp. 79-85, Journal of Affective Disorders, C1

journal

A comparison of inflammatory markers in depressed and nondepressed smokers

S Nunes, H Vargas, J Brum, E Prado, M Vargas, M de Castro, S Dodd, M Berk

(2012), Vol. 14, pp. 540-546, Nicotine and Tobacco Research, C1-1

journal

Co-morbid cardiovascular disease and depression: Sequence of disease onset is linked to mental but not physical self-rated health. Results: From a cross-sectional, population-based study

A O'Neil, E Williams, C Stevenson, B Oldenburg, M Berk, K Sanderson

(2012), Vol. 47, pp. 1145-1151, Social Psychiatry and Psychiatric Epidemiology, C1

journal

The role of alprazolam for the treatment of panic disorder in Australia

S Moylan, F Giorlando, T Nordfjrn, M Berk

(2012), Vol. 46, pp. 212-224, Australian and New Zealand Journal of Psychiatry, C1

journal

Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut

M Maes, M Kubera, J Leunis, M Berk

(2012), Vol. 141, pp. 55-62, Journal of Affective Disorders, C1

journal

Complementary medicine, self-help, and lifestyle interventions for Obsessive Compulsive Disorder (OCD) and the OCD spectrum: A systematic review

J Sarris, D Camfield, M Berk

(2012), Vol. 138, pp. 213-221, Journal of Affective Disorders, C1

journal

Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder

A Bechdolf, A Ratheesh, S Wood, T Tecic, P Conus, B Nelson, S Cotton, A Chanen, G Amminger, S Ruhrmann, F Schultze-Lutter, J Klosterktter, P Polij, A Yung, M Berk, P McGorry

(2012), Vol. 18, pp. 358-375, Current Pharmaceutical Design, C1-1

journal

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

G Malhi, D Bargh, R Mcintyre, M Gitlin, M Frye, M Bauer, M Berk

(2012), Vol. 14, pp. 1-21, Bipolar Disorders, C1

journal

Impact of sunlight on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, R Ardau, F Bellivier, M Berk, T Bjella, L Bossini, M Del Zompo, S Dodd, A Fagiolini, M Frye, A Gonzalez-Pinto, C Henry, F Kapczinski, S Kliwicki, B Knig, M Kunz, B Lafer, C Lopez-Jaramillo, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, G Morken, R Munoz, F Nery, C O'Donovan, A Pfennig, D Quiroz, N Rasgon, A Reif, J Rybakowski, K Sagduyu, C Simhandl, C Torrent, E Vieta, M Zetin, P Whybrow

(2012), Vol. 14, pp. 654-663, Bipolar Disorders, C1

journal

Deep brain stimulation for treatment-resistant depression : efficacy, safety and mechanisms of action

R Anderson, M Frye, O Abulseound, K Lee, J McGillivray, M Berk, S Tye

(2012), Vol. 36, pp. 1920-1933, Neuroscience and biobehavioral reviews, Oxford, England, C1

journal

Pain and the relationship with mood and anxiety disorders and psychological symptoms

L Williams, J Pasco, F Jacka, S Dodd, M Berk

(2012), Vol. 72, pp. 452-456, Journal of Psychosomatic Research, C1

journal

Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome

G Anderson, M Maes, M Berk

(2012), Vol. 78, pp. 752-756, Medical Hypotheses, C1

journal

The use of hormonal contraceptive agents and mood disorders in women

G Svendal, M Berk, J Pasco, F Jacka, A Lund, L Williams

(2012), Vol. 140, pp. 92-96, Journal of Affective Disorders, C1

journal

Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization

G Anderson, M Maes, M Berk

(2012), Vol. 88, pp. 27-48, Advances in Protein Chemistry and Structural Biology, C1

journal

Palliative models of care for later stages of mental disorder: Maximizing recovery, maintaining hope, and building morale

M Berk, L Berk, M Udina, S Moylan, L Stafford, K Hallam, S Goldstone, P McGorry

(2012), Vol. 46, pp. 92-99, Australian and New Zealand Journal of Psychiatry, C1

journal

Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study

C Macneil, M Hasty, S Cotton, M Berk, K Hallam, L Kader, P Mcgorry, P Conus

(2012), Vol. 6, pp. 380-388, Early Intervention in Psychiatry, C1-1

journal

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

P Magalhes, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 37, pp. 132-135, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1

journal

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

P Magalhes, F Kapczinski, A Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk

(2012), Vol. 125, pp. 303-308, Acta Psychiatrica Scandinavica, C1

journal

Minocycline: Therapeutic potential in psychiatry

O Dean, J Data-Franco, F Giorlando, M Berk

(2012), Vol. 26, pp. 391-401, CNS Drugs, C1

journal

Amygdala and insula volumes prior to illness onset in bipolar disorder: A magnetic resonance imaging study

A Bechdolf, S Wood, B Nelson, D Velakoulis, M Ycel, T Takahashi, A Yung, M Berk, M Wong, C Pantelis, P McGorry

(2012), Vol. 201, pp. 34-39, Psychiatry Research - Neuroimaging, C1-1

journal

Depressive symptoms in first episode schizophrenia spectrum disorder

S Cotton, M Lambert, B Schimmelmann, A Mackinnon, J Gleeson, M Berk, L Hides, A Chanen, P McGorry, P Conus

(2012), Vol. 134, pp. 20-26, Schizophrenia Research, C1

journal

New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors

M Maes, Z Fi?ar, M Medina, G Scapagnini, G Nowak, M Berk

(2012), Vol. 20, pp. 127-150, Inflammopharmacology, C1-1

journal

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

M Maes, M Berk, L Goehler, C Song, G Anderson, P Ga?ecki, B Leonard

(2012), Vol. 10, BMC Medicine, C1-1

journal

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi

(2012), Vol. 10, BMC Medicine, C1

journal

Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

M Maes, K Ringel, M Kubera, M Berk, J Rybakowski

(2012), Vol. 136, pp. 386-392, Journal of Affective Disorders, C1

journal

Cigarette smoking, nicotine dependence and anxiety disorders: A systematic review of population-based, epidemiological studies

S Moylan, F Jacka, J Pasco, M Berk

(2012), Vol. 10, BMC Medicine, C1

journal

Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: A review of current evidence

J Sarris, S Moylan, D Camfield, M Pase, D Mischoulon, M Berk, F Jacka, I Schweitzer

(2012), Vol. 2012, Evidence-based Complementary and Alternative Medicine, C1

journal

Using lithium as a neuroprotective agent in patients with cancer

M Khasraw, D Ashley, G Wheeler, M Berk

(2012), Vol. 10, BMC Medicine, C1

journal

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

A Singh, C Bousman, C Ng, K Byron, M Berk

(2012), Vol. 2, Translational Psychiatry, C1

journal

Moving towards a population health approach to the primary prevention of common mental disorders

F Jacka, A Mykletun, M Berk

(2012), Vol. 10, BMC Medicine, C1

journal

Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study with focus on gender differences

G Svendal, O Fasmer, A Engeland, M Berk, A Lund

(2012), Vol. 10, BMC Medicine, C1

journal

State-related alterations of gene expression in bipolar disorder: A systematic review

K Munkholm, M Vinberg, M Berk, L Kessing

(2012), Vol. 14, pp. 684-696, Bipolar Disorders, C1

journal

The science and practice of lithium therapy

G Malhi, M Tanious, P Das, M Berk

(2012), Vol. 46, pp. 192-211, Australian and New Zealand Journal of Psychiatry, C1

journal

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: Implications for clinical practice

J Kulkarni, S Filia, L Berk, K Filia, S Dodd, A de Castella, A Brnabic, A Lowry, K Kelin, W Montgomery, P Fitzgerald, M Berk

(2012), Vol. 12, BMC Psychiatry, C1

journal

Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for bipolar disorder (STEP-BD)

P Magalhes, S Dodd, A Nierenberg, M Berk

(2012), Vol. 46, pp. 1058-1067, Australian and New Zealand Journal of Psychiatry, C1

journal

Mania: Diagnosis and treatment recommendations

G Malhi, M Tanious, M Berk

(2012), Vol. 14, pp. 676-686, Current Psychiatry Reports, C1

journal

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 66, pp. 514-517, Psychiatry and Clinical Neurosciences, C1

journal

The impact of statins on psychological wellbeing: 12A systematic review and meta-analysis

A O'Neil, L Sanna, C Redlich, K Sanderson, F Jacka, L Williams, J Pasco, M Berk

(2012), Vol. 10, BMC Medicine, C1

journal

Pathways to new drug discovery in neuropsychiatry

M Berk

(2012), Vol. 10, BMC Medicine, C1

journal

Glutamatergic antidepressants

H Kalra, O Dean, S Dodd, M Berk

(2012), pp. 95-107, Antidepressants and Major Depressive Disorder, B1-1

chapter
2011

Habitual physical activity and the risk for depressive and anxiety disorders among older men and women

J Pasco, L Williams, F Jacka, M Henry, C Coulson, S Brennan, E Leslie, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 292-298, International Psychogeriatrics, C1

journal

Lower levels of physical activity in childhood associated with adult depression

F Jacka, J Pasco, L Williams, E Leslie, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 14, pp. 222-226, Journal of Science and Medicine in Sport, C1

journal

Diet quality in bipolar disorder in a population-based sample of women

F Jacka, J Pasco, A Mykletun, L Williams, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 129, pp. 332-337, Journal of Affective Disorders, C1-1

journal

Annual high-dose vitamin D3 and mental well-being: Randomised controlled trial

K Sanders, A Stuart, E Williamson, F Jacka, S Dodd, G Nicholson, M Berk

(2011), Vol. 198, pp. 357-364, British Journal of Psychiatry, C1-1

journal

Qualitative methods in early-phase drug trials : data and methods from a trial of N-acetylcysteine in schizophrenia

M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush

(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1

journal

N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action

O Dean, F Giorlando, M Berk

(2011), Vol. 36, pp. 78-86, Journal of Psychiatry and Neuroscience, C1-1

journal

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder

O Dean, M Van Den Buuse, M Berk, D Copolov, C Mavros, A Bush

(2011), Vol. 499, pp. 149-153, Neuroscience Letters, C1-1

journal

Antioxidant treatments for schizophrenia

P Magalhaes, A Andreazza, M Berk, F Kapczinski, O Dean

(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1

journal

N-acetyl cysteine add-on treatment for bipolar II disorder: A subgroup analysis of a randomized placebo-controlled trial

P Magalhes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 129, pp. 317-320, Journal of Affective Disorders, C1-1

journal

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder

P Magalhes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 23, pp. 87-88, Acta Neuropsychiatrica, C1-1

journal

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, G Malhi, L Berk, P Conus, P McGorry

(2011), Vol. 13, pp. 87-98, Bipolar Disorders, C1

journal

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Ycel, C Gama, S Dodd, B Dean, P Magalhes, P Amminger, P McGorry, G Malhi

(2011), Vol. 35, pp. 804-817, Neuroscience and Biobehavioral Reviews, C1-1

journal

The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2011), Vol. 52, pp. 562-566, Comprehensive Psychiatry, C1-1

journal

Bipolar disorder and adiposity: A study using whole body dual energy X-ray absorptiometry scans

L Williams, J Pasco, F Jacka, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 219-223, Acta Neuropsychiatrica, C1

journal

Paracetamol (acetaminophen) use, fracture and bone mineral density

L Williams, J Pasco, M Henry, K Sanders, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 48, pp. 1277-1281, Bone, C1

journal

The association between depressive and anxiety symptoms and bone mineral density in the general population: The HUNT Study

L Williams, O Bjerkeset, A Langhammer, M Berk, J Pasco, M Henry, B Schei, S Forsmo

(2011), Vol. 131, pp. 164-171, Journal of Affective Disorders, C1

journal

Area-based socioeconomic status and mood disorders: Cross-sectional evidence from a cohort of randomly selected adult women

L Williams, S Brennan, M Henry, M Berk, F Jacka, G Nicholson, M Kotowicz, J Pasco

(2011), Vol. 69, pp. 173-178, Maturitas, C1

journal

Glutamate cysteine ligase (GCL) and self reported depression: An association study from the HUNT

M Berk, S Johansson, N Wray, L Williams, C Olsson, J Haavik, O Bjerkeset

(2011), Vol. 131, pp. 207-213, Journal of Affective Disorders, C1

journal

Modeling gene-environment interaction in longitudinal data: Risk for neuroticism due to interaction between maternal care and the Dopamine 4 Receptor gene (DRD4)

P Badcock, E Moore, E Williamson, M Berk, L Williams, O Bjerkeset, H Nordahl, G Patton, C Olsson

(2011), Vol. 63, pp. 18-25, Australian Journal of Psychology, C1-1

journal

A prospective study of diet quality and mental health in adolescents

F Jacka, F Jacka, P Kremer, P Kremer, M Berk, M Berk, A de Silva-Sanigorski, A de Silva-Sanigorski, M Moodie, M Moodie, E Leslie, E Leslie, J Pasco, J Pasco, B Swinburn, B Swinburn

(2011), Vol. 6, pp. 1-7, PLos one, San Francisco, Calif., C1

journal

Don't worry, be active: Positive affect and habitual physical activity

J Pasco, F Jacka, L Williams, S Brennan, E Leslie, M Berk

(2011), Vol. 45, pp. 1047-1052, Australian and New Zealand Journal of Psychiatry, C1

journal

The association between habitual diet quality and the common mental disorders in community-dwelling adults: The hordaland health study

F Jacka, A Mykletun, M Berk, I Bjelland, G Tell

(2011), Vol. 73, pp. 483-490, Psychosomatic Medicine, C1-1

journal

Nutraceuticals in the treatment of Obsessive Compulsive Disorder (OCD): A review of mechanistic and clinical evidence

D Camfield, J Sarris, M Berk

(2011), Vol. 35, pp. 887-895, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1

journal

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi

(2011), Vol. 135, pp. 389-394, Journal of Affective Disorders, C1

journal

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk

(2011), Vol. 45, pp. 712-725, Australian and New Zealand Journal of Psychiatry, C1

journal

Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium

Y Wang, Z Xiao, X Liu, M Berk

(2011), Vol. 26, pp. 95-101, Human Psychopharmacology, C1

journal

Development of guidelines for caregivers of people with bipolar disorder: A Delphi expert consensus study

L Berk, A Jorm, C Kelly, S Dodd, M Berk

(2011), Vol. 13, pp. 556-570, Bipolar Disorders, C1

journal

Meta-analytic review of neurocognition in bipolar II disorder

E Bora, M Ycel, C Pantelis, M Berk

(2011), Vol. 123, pp. 165-174, Acta Psychiatrica Scandinavica, C1

journal

Who's left? Symptoms of schizophrenia that predict clinical trial dropout

J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov

(2011), Vol. 26, pp. 609-613, Human Psychopharmacology, C1-1

journal

N-acetylcysteine for major depressive episodes in bipolar disorder

P Magalhes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, C1

journal

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder

S Moylan, J Staples, S Ward, J Rogerson, D Stein, M Berk

(2011), Vol. 31, pp. 647-652, Journal of Clinical Psychopharmacology, C1

journal

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression : proof of concept for the inflammatory and oxidative hypotheses of depression?

L Stafford, M Berk

(2011), Vol. 72, pp. 1229-1235, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Psychological needs of adolescents in the early phase of bipolar disorder: Implications for early intervention

C Macneil, M Hasty, M Berk, L Henry, M Evans, C Redlich, R Daglas, P Mcgorry, P Conus

(2011), Vol. 5, pp. 100-107, Early Intervention in Psychiatry, C1-1

journal

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

M Maes, P Ruckoanich, Y Chang, N Mahanonda, M Berk

(2011), Vol. 35, pp. 769-783, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1-1

journal

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

M Maes, P Galecki, Y Chang, M Berk

(2011), Vol. 35, pp. 676-692, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1-1

journal

An examination of risk factors for readmission to acute adult mental health services within 28 days of discharge in the Australian setting

T Callaly, T Trauer, M Hyland, T Coombs, M Berk

(2011), Vol. 19, pp. 221-225, Australasian Psychiatry, C1-1

journal
2010

Association of western and traditional diets with depression and anxiety in women

F Jacka, J Pasco, A Mykletun, L Williams, A Hodge, S O'Reilly, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 167, pp. 305-311, American Journal of Psychiatry, C1-1

journal

Associations between diet quality and depressed mood in adolescents: Results from the Australian Healthy Neighbourhoods Study

F Jacka, P Kremer, E Leslie, M Berk, G Patton, J Toumbourou, J Williams

(2010), Vol. 44, pp. 435-442, Australian and New Zealand Journal of Psychiatry, C1

journal

Mental health services for young people - The challenge of integrating services

T Callaly, K Von Treuer, S Dodd, M Berk

(2010), Vol. 22, pp. 158-160, Acta Neuropsychiatrica, C1

journal

Readmission to an acute psychiatric unit within 28 days of discharge: Identifying those at risk

T Callaly, M Hyland, T Trauer, S Dodd, M Berk

(2010), Vol. 34, pp. 282-285, Australian Health Review, C1

journal

A naturalistic study of treatment outcomes with aripiprazole in young people with first episode psychosis

S Dodd, T Callaly, A Thampi, S McConnell, P Hantz, D Goodman, K Kohlmann, P Vieira da Silva Magalhaes, M Berk

(2010), Vol. 8, pp. 105-110, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

journal

Obesity is associated with previous suicide attempts in bipolar disorder

F Gomes, M Kauer-Sant'Anna, P Magalhes, F Jacka, S Dodd, C Gama, A Cunha, M Berk, F Kapczinski

(2010), Vol. 22, pp. 63-67, Acta Neuropsychiatrica, C1-1

journal

Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women

A Mykletun, F Jacka, L Williams, J Pasco, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 10, BMC Gastroenterology, C1-1

journal

Clinical implications of the cytokine hypothesis of depression: The association between use of statins and aspirin and the risk of major depression

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 79, pp. 323-325, Psychotherapy and Psychosomatics, C1-1

journal

Association of high-sensitivity C-reactive protein with de novo major depression

J Pasco, G Nicholson, L Williams, F Jacka, M Henry, M Kotowicz, H Schneider, B Leonard, M Berk

(2010), Vol. 197, pp. 372-377, British Journal of Psychiatry, C1-1

journal

The prevalence of mood and anxiety disorders in Australian women

L Williams, F Jacka, J Pasco, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 18, pp. 250-255, Australasian Psychiatry, C1-1

journal

Termination of therapy: What can clinicians do to maximise gains?

C MacNeil, M Hasty, P Conus, M Berk

(2010), Vol. 22, pp. 43-45, Acta Neuropsychiatrica, C1-1

journal

Enhancing medication adherence in patients with bipolar disorder

L Berk, K Hallam, F Colom, E Vieta, M Hasty, C Macneil, M Berk

(2010), Vol. 25, pp. 1-16, Human Psychopharmacology, C1-1

journal

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

K Choy, O Dean, M Berk, A Bush, M van den Buuse

(2010), Vol. 649, pp. 224-228, European Journal of Pharmacology, C1-1

journal

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2010), Vol. 97, pp. 293-300, Pharmacology Biochemistry and Behavior, C1-1

journal

Oxidative pathways as a drug target for the treatment of autism

K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk

(2010), Vol. 14, pp. 1301-1310, Expert Opinion on Therapeutic Targets, C1-1

journal

Restless leg syndrome associated with olanzapine: A case series

S Aggarwal, S Dodd, M Berk

(2010), Vol. 5, pp. 129-131, Current Drug Safety, C1-1

journal

From neuroprogression to neuroprotection: Implications for clinical care

M Berk, P Conus, F Kapczinski, A Andreazza, M Ycel, S Wood, C Pantelis, G Malhi, S Dodd, A Bechdolf, G Amminger, I Hickie, P McGorry

(2010), Vol. 193, Medical Journal of Australia, C1-1

journal

The validity and internal structure of the Bipolar Depression Rating Scale: Data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi

(2010), Vol. 22, pp. 237-242, Acta Neuropsychiatrica, C1-1

journal

Evidence and implications for early intervention in bipolar disorder

M Berk, K Hallam, G Malhi, L Henry, M Hasty, C MacNeil, M Yucel, C Pantelis, B Murphy, E Vieta, S Dodd, P McGorry

(2010), Vol. 19, pp. 113-126, Journal of Mental Health, C1-1

journal

Do we need to flick the switch? the need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder

M Berk, F Ng, S Dodd, J Goldberg, G Malhi

(2010), Vol. 64, pp. 367-371, Psychiatry and Clinical Neurosciences, C1-1

journal

A qualitative evaluation of a regional Early Psychosis Service 3 years after its commencement

T Callaly, C Ackerly, M Hyland, S Dodd, M O'Shea, M Berk

(2010), Vol. 34, pp. 382-385, Australian Health Review, C1-1

journal

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

S Dodd, A Brnabic, L Berk, P Fitzgerald, A De Castella, S Filia, K Filia, K Kelin, M Smith, W Montgomery, J Kulkarni, M Berk

(2010), Vol. 51, pp. 504-509, Comprehensive Psychiatry, C1-1

journal

A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder

S Dodd, J Kulkarni, L Berk, F Ng, P Fitzgerald, A de Castella, S Filia, K Filia, W Montgomery, K Kelin, M Smith, A Brnabic, M Berk

(2010), Vol. 124, pp. 22-28, Journal of Affective Disorders, C1-1

journal

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

J Kulkarni, C Gurvich, S Lee, H Gilbert, E Gavrilidis, A de Castella, M Berk, S Dodd, P Fitzgerald, S Davis

(2010), Vol. 35, pp. 1142-1147, Psychoneuroendocrinology, C1-1

journal

The role of psychotherapy in bipolar disorder

S Lauder, M Berk, D Castle, S Dodd, L Berk

(2010), Vol. 193, Medical Journal of Australia, C1-1

journal

The utility of the mood disorders questionnaire as a screening tool in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2010), Vol. 14, pp. 150-153, International Journal of Psychiatry in Clinical Practice, C1-1

journal

Patterns of alcohol use and associated physical and lifestyle characteristics according to new Australian guidelines

C Coulson, L Williams, M Henry, M Berk, D Lubman, S Brennan, G Nicholson, M Kotowicz, S Korn, J Pasco

(2010), Vol. 44, pp. 946-951, Australian and New Zealand Journal of Psychiatry, C1-1

journal

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

A Bechdolf, B Nelson, S Cotton, A Chanen, A Thompson, J Kettle, P Conus, G Amminger, A Yung, M Berk, P McGorry

(2010), Vol. 127, pp. 316-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Group-based psychosocial intervention for bipolar disorder : randomised controlled trial

D Castle, C White, J Chamberlain, M Berk, L Berk, S Lauder, G Murray, I Schweitzer, L Piterman, M Gilbert

(2010), Vol. 196, pp. 383-388, British journal of psychiatry, London, Eng., C1-1

journal

Characterisation of the prodrome to a first episode of psychotic mania : results of a retrospective study

P Conus, J Ward, N Lucas, S Cotton, A Yung, M Berk, P McGorry

(2010), Vol. 124, pp. 341-345, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

The impact of smoking on clinical outcomes after first episode psychosis: longer-term outcome findings from the EPPIC 800 follow-up study

M Berk, L Henry, K Elkins, S Harrigan, M Harris, H Herrman, H Jackson, P McGorry

(2010), Vol. 6, pp. 212-234, Journal of dual diagnosis, Philadelphia, Pa., C1-1

journal

Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania

P Conus, S Cotton, B Schimmelmann, M Berk, R Daglas, P McGorry, M Lambert

(2010), Vol. 12, pp. 244-252, Bipolar disorders, Hoboken, N.J., C1-1

journal

Pre-morbid and outcome correlates of first episode mania with psychosis: is a distinction between schizoaffective and bipolar I disorder valid in the early phase of psychotic disorders?

P Conus, A Abdel-Baki, S Harrigan, M Lambert, P McGorry, M Berk

(2010), Vol. 126, pp. 88-95, Journal of affective disorders, Amsterdam, Netherlands, C1-1

journal

Assessing oxidative pathway genes as risk factors for bipolar disorder

J Fullerton, Y Tiwari, G Agahi, A Heath, M Berk, P Mitchell, P Schofield

(2010), Vol. 12, pp. 550-556, Bipolar disorders, Hoboken, N.J., C1-1

journal

Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study

K Kelin, M Berk, M Spann, D Sagman, J Raskin, D Walker, D Perahia

(2010), Vol. 64, pp. 719-726, International journal of clinical practice, Chichester, Eng., C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Mller, S Kasper, M Berk, WFSBP Task Force On Treatment Guidelines For Bipol

(2010), Vol. 11, pp. 81-109, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2009

Description and qualitative evaluation of Jigsaw, an integrated young persons' mental health program

T Callaly, S Dodd, C Ackerly, P Hantz, M O'Shea, M Berk

(2009), Vol. 17, pp. 480-483, Australasian Psychiatry, C1-1

journal

Suicidality - The challenge for public mental health services

T Callaly, M Berk, S Dodd

(2009), Vol. 21, pp. 41-43, Acta Neuropsychiatrica, C1-1

journal

Vitamin D: Is it relevant to psychiatry?

M Berk, S Dodd, L Williams, F Jacka, J Pasco

(2009), Vol. 21, pp. 205-206, Acta Neuropsychiatrica, C1-1

journal

Reliability of the Mood Disorder Questionnaire: Comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample

S Dodd, L Williams, F Jacka, J Pasco, O Bjerkeset, M Berk

(2009), Vol. 43, pp. 526-530, Australian and New Zealand Journal of Psychiatry, C1-1

journal

Association between magnesium intake and depression and anxiety in community-dwelling adults: The Hordaland health study

F Jacka, S Overland, R Stewart, G Tell, I Bjelland, A Mykletun

(2009), Vol. 43, pp. 45-52, Australian and New Zealand Journal of Psychiatry, C1-1

journal

Lifetime psychiatric disorders and body composition: A population-based study

L Williams, J Pasco, M Henry, F Jacka, S Dodd, G Nicholson, M Kotowicz, M Berk

(2009), Vol. 118, pp. 173-179, Journal of Affective Disorders, C1-1

journal

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi

(2009), Vol. 14, pp. 357-360, CNS Spectrums, C1-1

journal

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2009), Vol. 198, pp. 258-262, Behavioural Brain Research, C1-1

journal

Role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice

O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk

(2009), Vol. 16, pp. 2965-2976, Current Medicinal Chemistry, C1-1

journal

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: A double-blind, randomised placebo-controlled clinical trial

M Berk, C Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, H Malloy, C Rowland, A Monkhouse, A Monkhouse, F Bole, S Sathiyamoorthy, D Piskulic, S Dodd

(2009), Vol. 24, pp. 233-238, Human Psychopharmacology, C1-1

journal

Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives

M Berk, G Malhi, K Hallam, C Gama, S Dodd, A Andreazza, B Frey, F Kapczinski

(2009), Vol. 114, pp. 1-13, Journal of Affective Disorders, C1-1

journal

Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial

M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk

(2009), Vol. 21, pp. 239-245, Acta Neuropsychiatrica, C1-1

journal

The impact of age at onset of bipolar I disorder on functioning and clinical presentation

F Biffin, S Tahtalian, K Filia, P Fitzgerald, A De Castella, S Filia, M Berk, S Dodd, P Callaly, L Berk, K Kelin, M Smith, W Montgomery, J Kulkarni

(2009), Vol. 21, pp. 191-196, Acta Neuropsychiatrica, C1-1

journal

Client-reported reasons for non-engagement in drug and alcohol treatment

C Coulson, F Ng, M Geertsema, S Dodd, M Berk

(2009), Vol. 28, pp. 372-378, Drug and Alcohol Review, C1-1

journal

'Mind and body' : a lifestyle programme for people on antipsychotic medication

A Jones, A Benson, S Griffiths, M Berk, S Dodd

(2009), Vol. 15, pp. 276-280, Journal of evaluation of clinical practice, Oxford, England, C1-1

journal

Improvement of negative and positive symptoms in treatment-refractory schizophrenia : a double-blind, randomized, placebo-controlled trial with memantine as add-On therapy to clozapine

D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama

(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.

G Malhi, D Adams, C Cahill, S Dodd, M Berk

(2009), Vol. 69, pp. 2063-2101, Drugs, C1-1

journal

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes?

L Stafford, M Berk, H Jackson

(2009), Vol. 66, pp. 211-220, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1

journal

Medial temporal lobe glutathione concentration in first episode psychosis : a 1H-MRS investigation

S Wood, G Berger, R Wellard, T Proffitt, M McConchie, M Berk, P McGorry, C Pantelis

(2009), Vol. 33, pp. 354-357, Neurobiology of disease, Amsterdam, The Netherlands, C1-1

journal

Is lithium in a class of its own? A brief profile of its clinical use

G Malhi, D Adams, M Berk

(2009), Vol. 43, pp. 1096-1104, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Medicating mood with maintenance in mind : bipolar depression pharmacotherapy

G Malhi, D Adams, M Berk

(2009), Vol. 11, pp. 55-76, Bipolar disorders, London, Eng., C1-1

journal

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

M Tohen, E Frank, C Bowden, F Colom, S Ghaemi, L Yatham, G Malhi, J Calabrese, W Nolen, E Vieta, F Kapczinski, G Goodwin, T Suppes, G Sachs, K Chengappa, H Grunze, P Mitchell, S Kanba, M Berk

(2009), Vol. 11, pp. 453-473, Bipolar disorders, London, Eng., C1-1

journal

Clinical practice recommendations for bipolar disorder

G Malhi, D Adams, L Lampe, M Paton, N O'Connor, L Newton, G Walter, A Taylor, R Porter, R Mulder, M Berk

(2009), Vol. 119, pp. 27-46, Acta psychiatrica Scandinavica, London, Eng., C1-1

journal

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

F Kapczinski, V Dias, M Kauer-Sant'Anna, E Brietzke, G Vazquez, E Vieta, M Berk

(2009), Vol. 33, pp. 1366-1371, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1-1

journal

Neuroprogression: pathways to progressive brain changes in bipolar disorder

M Berk

(2009), Vol. 12, pp. 441-445, International journal of neuropsychopharmacology, Cambridge, Eng., C1-1

journal

Clinical implications of a staging model for bipolar disorders

F Kapczinski, V Dias, M Kauer-Sant'Anna, B Frey, R Grassi-Oliveira, F Colom, M Berk

(2009), Vol. 9, pp. 957-966, Expert review of neurotherapeutics, London, Eng., C1-1

journal

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

P McGorry, B Nelson, G Amminger, A Bechdolf, S Francey, G Berger, A Riecher-Rssler, J Klosterktter, S Ruhrmann, F Schultze-Lutter, M Nordentoft, I Hickie, P McGuire, M Berk, E Chen, M Keshavan, A Yung

(2009), Vol. 70, pp. 1206-1212, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Cognitive-personality style as vulnerability to depression in patients with coronary artery disease: roles of sociotropy and autonomy

L Stafford, H Jackson, M Berk

(2009), Vol. 71, pp. 63-69, Psychosomatic medicine, Philadelphia, Pa., C1-1

journal

Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series

M Juruena, C Gama, M Berk, P Belmonte-de-Abreu

(2009), Vol. 23, pp. 985-987, Journal of psychopharmacology, Thousand Oaks, Calif., C1-1

journal

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

F Ng, O Mammen, I Wilting, G Sachs, I Ferrier, F Cassidy, S Beaulieu, L Yatham, M Berk

(2009), Vol. 11, pp. 559-595, Bipolar disorders, London, Eng., C1-1

journal

The elephant on the couch: side-effects of psychotherapy

M Berk, G Parker

(2009), Vol. 43, pp. 787-794, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

journal

Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder

S Boer, M Berk, B Dean

(2009), Vol. 466, pp. 27-29, Neuroscience letters, Shannon, Ireland, C1-1

journal

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis

F Benazzi, M Berk, M Frye, W Wang, A Barraco, M Tohen

(2009), Vol. 70, pp. 1424-1431, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

L Yatham, S Kennedy, A Schaffer, S Parikh, S Beaulieu, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, A Young, M Alda, R Milev, E Vieta, J Calabrese, M Berk, K Ha, F Kapczinski

(2009), Vol. 11, pp. 225-255, Bipolar disorders, London, Eng., E1-1

conference

Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression

K Hallam, D Smith, M Berk

(2009), Vol. 112, pp. 212-218, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients

E Vieta, M Berk, W Wang, F Colom, M Tohen, R Baldessarini

(2009), Vol. 119, pp. 22-27, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

A critical update on psychological interventions for bipolar disorders

E Vieta, I Pacchiarotti, M Valent, M Berk, J Scott, F Colom

(2009), Vol. 11, pp. 494-502, Current psychiatry reports, [Philadelphia, Pa.], C1-1

journal

Family intervention for suicide prevention: a specialized emergency department intervention for suicidal youths

J Asarnow, M Berk, L Baraff

(2009), Vol. 40, pp. 118-125, Professional psychology: research and practice, [Washington, D.C.], C1-1

journal

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, Chichester, Eng., C1-1

journal

Bipolar disorder in young people: a psychological intervention manual

C Macneil, M Hasty, P Conus, M Berk, J Scott

(2009), A1-1

book

Medication adherence

Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott

(2009), pp. 55-64, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1

chapter

Cognitive behavioral therapy interventions

Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott

(2009), pp. 65-97, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1

chapter

Assessment and engagement

Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott

(2009), pp. 21-35, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1

chapter

Social rhythm regulation

Craig Macneil, Melissa Hasty, Philippe Conus, Michael Berk, Jan Scott

(2009), pp. 98-104, Bipolar disorder in young people: a psychological intervention manual, Cambridge, Eng., B1-1

chapter

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

Heinz Grunze, Eduard Vieta, Guy Goodwin, Charles Bowden, Rasmus Licht, Hans-Jurgen Moller, Siegfried Kasper, H Akiskal, J Ayuso-Gutierrez, M Bauer, P Bech, Michael Berk, I Bitter, G Burrows, J Calabrese, G Cassano, M Cetkovich-Bakmas, J Cookson, I Ferrier, W Gattaz, F Goodwin, G Heinze, T Higuchi, R Hirschfeld, C Hoeschl, E Holsboer-Trachsler, K Redfield Jamison, C Katona, M Keller, E Kostukova, H Kruger, P Kulhara, Y Lecruibier, V Larach

(2009), Vol. 10, pp. 85-116, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2008

A descriptive interview with 64 patients discharged from an acute-psychiatric-inpatient service

T Callaly, S Dodd, D Goodman, Y Asgari, M Berk

(2008), Vol. 14, pp. 990-995, Journal of Evaluation in Clinical Practice, C1-1

journal

Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample

M Berk, F Jacka, L Williams, F Ng, S Dodd, J Pasco

(2008), Vol. 42, pp. 874-878, Australian and New Zealand Journal of Psychiatry, C1-1

journal

Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet

L Guimares, F Jacka, C Gama, M Berk, C Leito-Azevedo, M Belmonte de Abreu, M Lobato, A Andreazza, K Ceresr, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 32, pp. 1595-1598, Progress in Neuro-Psychopharmacology and Biological Psychiatry, C1-1

journal

Brain-derived neurotrophic factor: A modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments

F Jacka, C Gama, M Berk

(2008), Vol. 20, pp. 223-225, Acta Neuropsychiatrica, C1-1

journal

Leptin in depressed women: Cross-sectional and longitudinal data from an epidemiologic study

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 107, pp. 221-225, Journal of Affective Disorders, C1-1

journal

Tobacco smoking as a risk factor for major depressive disorder: Population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British Journal of Psychiatry, C1-1

journal

Depression and bone metabolism: A review

L Williams, J Pasco, F Jacka, M Henry, S Dodd, M Berk

(2008), Vol. 78, pp. 16-25, Psychotherapy and Psychosomatics, C1-1

journal

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

L Williams, M Henry, M Berk, S Dodd, F Jacka, M Kotowicz, G Nicholson, J Pasco

(2008), Vol. 23, pp. 84-87, International Clinical Psychopharmacology, C1-1

journal

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder-A Double-Blind Randomized Placebo-Controlled Trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush

(2008), Vol. 64, pp. 468-475, Biological Psychiatry, C1-1

journal

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia-A Double-Blind, Randomized, Placebo-Controlled Trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological Psychiatry, C1-1

journal

Glutathione: a novel treatment target in psychiatry

M Berk, F Ng, O Dean, S Dodd, A Bush

(2008), Vol. 29, pp. 346-351, Trends in Pharmacological Sciences, C1-1

journal

Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications

F Ng, M Berk, O Dean, A Bush

(2008), Vol. 11, pp. 851-876, International Journal of Neuropsychopharmacology, C1-1

journal

N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility

S Dodd, O Dean, D Copolov, G Malhi, M Berk

(2008), Vol. 8, pp. 1955-1962, Expert Opinion on Biological Therapy, C1-1

journal

Small shifts in diurnal rhythms are associated with an increase in suicide: The effect of daylight saving

M Berk, S Dodd, K Hallam, L Berk, J Gleeson, M Henry

(2008), Vol. 6, pp. 22-25, Sleep and Biological Rhythms, C1-1

journal

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

M Berk, F Ng, S Dodd, T Callaly, S Campbell, M Bernardo, T Trauer

(2008), Vol. 14, pp. 979-983, Journal of Evaluation in Clinical Practice, C1-1

journal

Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania

M Berk, F Ng, W Wang, M Tohen, D Lubman, E Vieta, S Dodd

(2008), Vol. 110, pp. 126-134, Journal of Affective Disorders, C1-1

journal

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

S Dodd, M Berk

(2008), Vol. 8, pp. 1299-1306, Expert review of neurotherapeutics, London, England, C1-1

journal

Duloxetine for major depression

S Dodd, M Berk

(2008), Vol. 9, pp. 65-66, Medicine today, Neutral Bay, N.S.W., C1-1

journal

The Bipolar Comprehensive Outcomes Study (BCOS): Baseline findings of an Australian cohort study

J Kulkarni, M Berk, P Fitzgerald, A de Castella, W Montgomery, K Kelin, A Brnabic, R Granger, S Dodd

(2008), Vol. 107, pp. 135-144, Journal of Affective Disorders, C1-1

journal

Depressive disorders and bone mineral density in a community based sample of premenopausal women

L Williams, J Pasco, F Jacka, S Dodd, G Nicholson, M Berk

(2008), Vol. 107, pp. S96-S97, JOURNAL OF AFFECTIVE DISORDERS, C1-1

journal

Illness beliefs about heart disease and adherence to secondary prevention regimens

L Stafford, H Jackson, M Berk

(2008), Vol. 70, pp. 942-948, Psychosomatic Medicine, Philadelphia, Pa., C1-1

journal

Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?

E Bora, M Yucel, A Fornito, M Berk, C Pantelis

(2008), Vol. 118, pp. 172-187, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal

Decreased serum neurotrophin 3 in chronically medicated schizophrenic males

H Vargas, C Gama, A Andreazza, D Medeiros, L Stertz, G Fries, J Palha, K Cereser, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 440, pp. 197-201, Neuroscience Letters, Shannon, Clare Ireland, C1-1

journal

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1

journal

The empirical redefinition of the psychometric criteria for remission in bipolar disorder

M Berk, F Ng, W Wang, J Calabrese, P Mitchell, G Malhi, M Tohen

(2008), Vol. 106, pp. 153-158, Journal of Affective Disorders, Amsterdam, The Netherlands, C1-1

journal

Pure and mixed manic subtypes: A review of diagnostic classification and validation

F Cassidy, L Yatham, M Berk, P Grof

(2008), Vol. 10, pp. 131-143, Bipolar Disorders, C1-1

journal

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression

G Malhi, F Ng, M Berk

(2008), Vol. 42, pp. 346-349, Australian & New Zealand Journal of Psychiatry, London, Eng., C1-1

journal

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

M Kunz, C Gama, A Andreazza, M Salvador, K Ceresr, F Gomes, P Belmonte-de-Abreu, M Berk, F Kapczinski

(2008), Vol. 32, pp. 1677-1681, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Philadelphia, Pa., C1-1

journal

Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

C Gama, M Berk, A Andreazza, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 30, pp. 337-340, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

journal

Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum

B Harvey, C Joubert, J du Preez, M Berk

(2008), Vol. 33, pp. 508-517, Neurochemical Research, New York, N.Y., C1-1

journal

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

S Lavoie, M Murray, P Deppen, M Knyazeva, M Berk, O Boulat, P Bovet, A Bush, P Conus, D Copolov, E Fornari, R Meuli, A Solida, P Vianin, M Cunod, T Buclin, K Do

(2008), Vol. 33, pp. 2187-2199, Neuropsychopharmacology, London, Eng., C1-1

journal

Tobacco smoking as a risk factor for major depressive disorder: population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British Journal of Psychiatry, London, Eng., C1-1

journal

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males

C Gama, M Salvador, A Andreazza, M Lobato, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 433, pp. 270-273, Neuroscience Letters, Shannon, Clare Ireland, C1-1

journal

The proximal prodrome to first episode mania--a new target for early intervention

P Conus, J Ward, K Hallam, N Lucas, C Macneil, P McGorry, M Berk

(2008), Vol. 10, pp. 555-565, Bipolar Disorders, Hoboken, N.J., C1-1

journal

A functional MRI study of Theory of Mind in euthymic bipolar disorder patients

G Malhi, J Lagopoulos, P Das, K Moss, M Berk, C Coulston

(2008), Vol. 10, pp. 943-956, Bipolar Disorders, Hoboken, N.J., C1-1

journal

The importance of the treatment alliance in bipolar disorder

L Berk, C Macneil, D Castle, M Berk

(2008), pp. 167-182, Psychotherapies for the psychoses: theoretical, cultural and clinical integration, Abingdon, Eng., B1-1

chapter
2007

Effects of a walking program in the psyhiatric in-patient treatment setting: A cohort study

F Ng, S Dodd, F Jacka, E Leslie, M Berk

(2007), Vol. 18, pp. 39-42, Health Promotion Journal of Australia, C1

journal

The Bipolar Depression Rating Scale (BDRS): Its development, validation and utility

M Berk, G Malhi, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen, P Mitchell

(2007), Vol. 9, pp. 571-579, Bipolar Disorders, C1-1

journal

Vitamin D deficiency may play a role in depression

M Berk, K Sanders, J Pasco, F Jacka, L Williams, A Hayles, S Dodd

(2007), Vol. 69, pp. 1316-1319, Medical Hypotheses, C1-1

journal

Depression and bone mineral density in a community sample of men : Geelong Osteoporosis Study

F Jacka, J Pasco, M Henry, S Korn, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 4, pp. 292-297, Journal of men's health & gender, Amsterdam, The Netherlands, C1-1

journal

Self-reported depression and cardiovascular risk factors in a community sample of women

F Jacka, J Pasco, S McConnell, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 48, pp. 54-59, Psychosomatics, C1-1

journal

Food for thought

F Jacka, M Berk

(2007), Vol. 19, pp. 321-323, Acta Neuropsychiatrica, C1-1

journal

Setting the stage: From prodrome to treatment resistance in bipolar disorder

M Berk, P Conus, N Lucas, K Hallam, G Malhi, S Dodd, L Yatham, A Yung, P McGorry

(2007), Vol. 9, pp. 671-678, Bipolar Disorders, C1-1

journal

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

M Berk, S Dodd, P Callaly, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, S Tahtalian, F Biffin, K Kelin, M Smith, W Montgomery, J Kulkarni

(2007), Vol. 103, pp. 181-186, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder

M Berk, S Dodd, M Kauer-Sant'Anna, G Malhi, M Bourin, F Kapczinski, T Norman

(2007), Vol. 116, pp. 41-49, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal

Monitoring the safe use of clozapine: A consensus view from Victoria, Australia

M Berk, J Fitzsimons, T Lambert, C Pantelis, J Kulkarni, D Castle, E Ryan, S Jespersen, P McGorry, G Berger, B Kuluris, T Callaly, S Dodd

(2007), Vol. 21, pp. 117-127, CNS Drugs, C1-1

journal

A survey of combination antidepressant use in Australia

D Horgan, S Dodd, M Berk

(2007), Vol. 15, pp. 26-29, Australasian Psychiatry, C1-1

journal

Atypical antipsychotics for bipolar disorder : overblown or blown over?

F Ng, S Dodd, M Berk

(2007), Vol. 5, pp. 53-64, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1-1

journal

The effects of physical activity in the acute treatment of bipolar disorder: A pilot study

F Ng, S Dodd, M Berk

(2007), Vol. 101, pp. 259-262, Journal of Affective Disorders, C1-1

journal

The benefits of physical activity in the management of bipolar disorder

F Ng, S Dodd, M Berk

(2007), Vol. 9, pp. 83-83, BIPOLAR DISORDERS, Pittsburgh, PA, C1-1

journal

The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure

F Ng, T Trauer, S Dodd, T Callaly, S Campbell, M Berk

(2007), Vol. 19, pp. 304-310, Acta Neuropsychiatrica, C1-1

journal

Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.

L Stafford, M Berk, H Jackson

(2007), Vol. 29, pp. 417-424, General Hospital Psychiatry, United States, C1-1

journal

The role of lamotrigine in the management of bipolar disorder.

F Ng, K Hallam, N Lucas, M Berk

(2007), Vol. 3, pp. 463-474, Neuropsychiatric Disease and Treatment, New Zealand, C1-1

journal

CNS 14-3-3zeta: changes with sex but not psychiatric diagnoses or psychotropic drug treatment.

B Dean, S Boer, A Mackinnon, M Berk

(2007), Vol. 93, pp. 51-57, Schizophrenia Research, Netherlands, C1-1

journal

Pilot of group intervention for bipolar disorder

D Castle, M Berk, L Berk, S Lauder, J Chamberlain, M Gilbert

(2007), Vol. 11, pp. 279-284, International Journal of Psychiatry in Clinical Practice, Abingdon, Eng., C1-1

journal

Should we be targeting exercise as a routine mental health intervention?

M Berk

(2007), Vol. 19, pp. 217-218, Acta Neuropsychiatrica, C1-1

journal

The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

M Berk, K Hallam, P McGorry

(2007), Vol. 100, pp. 279-281, Journal of Affective Disorders, Netherlands, C1-1

journal

Neuroprotection in emerging psychotic disorders

G Berger, M Dell'Olio, P Amminger, B Cornblatt, L Phillips, A Yung, Y Yan, M Berk, P McGorry

(2007), Vol. 1, pp. 114-127, Early Intervention in Psychiatry, Richmond, Vic., C1-1

journal

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.

C Gama, A Andreazza, M Kunz, M Berk, P Belmonte-de-Abreu, F Kapczinski

(2007), Vol. 420, pp. 45-48, Neuroscience Letters, Ireland, C1-1

journal

Does dopamine dysfunction drive depression?

G Malhi, M Berk

(2007), Beyond DSM, Beyond Neurotransmitters : 2006 Conference on Melancholia, Copenhagen, Denmark, E1-1

conference

Net-effect? Online psychological interventions

S Lauder, A Chester, M Berk

(2007), Vol. 19, pp. 386-388, Acta Neuropsychiatrica, C1-1

journal

DNA damage in rats after treatment with methylphenidate.

A Andreazza, B Frey, S Valvassori, C Zanotto, K Gomes, C Comim, C Cassini, L Stertz, L Ribeiro, J Quevedo, F Kapczinski, M Berk, C Gonalves

(2007), Vol. 31, pp. 1282-1288, Progress in Neuro-Psychopharmacology & Biological Psychiatry, England, C1-1

journal

Does dopamine dysfunction drive depression?

G Malhi, M Berk

(2007), Vol. 115, pp. 116-124, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

journal
2006

Depression and pain: An overview

L Williams, F Jacka, J Pasco, S Dodd, M Berk

(2006), Vol. 18, pp. 79-87, Acta Neuropsychiatrica, C1-1

journal

Pharmacological treatment of anxiety and depression in pregnancy and lactation

S Dodd, J Opie, M Berk

(2006), pp. 163-184, Mood and anxiety disorders in women, Cambridge, England, B1-1

chapter

Diagnosing bipolar disorder: How can we do it better?

M Berk, L Berk, K Moss, S Dood, G Malhi

(2006), Vol. 184, pp. 459-462, Medical Journal of Australia, C1-1

journal

Do ambient electromagnetic fields affect behaviour? A demonstration of the relationship between geomagnetic storm activity and suicide

M Berk, S Dodd, M Henry

(2006), Vol. 27, pp. 151-155, Bioelectromagnetics, C1-1

journal

It's the economy : the effect of macroeconomic variables of the rate of suicide

M Berk, S Dodd, M Henry

(2006), Vol. 36, pp. 181-189, Psychological medicine, Cambridge, England, C1-1

journal

Health-related quality of life and functioning in bipolar disorder: The impact of pharmacotherapy

M Berk, K Hallam, N Lucas, L Kader, C MacNeil, M Hasty, S Dodd, G Malhi, P Conus

(2006), Vol. 6, pp. 509-523, Expert Review of Pharmacoeconomics and Outcomes Research, C1-1

journal

The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium.

S Dodd, M Berk

(2006), Vol. 1, pp. 25-33, Current drug safety, C1-1

journal

Combination pharmacotherapy in unipolar depression

F Ng, S Dodd, M Berk

(2006), Vol. 6, pp. 1049-1060, Expert review of neurotherapeutics, London, England, C1-1

journal

Seasonal influences on first-episode admission in affective and non-affective psychosis

K Hallam, M Berk, L Kader, P Conus, N Lucas, M Hasty, C Macneil, P McGorry

(2006), Vol. 18, pp. 154-161, Acta neuropsychiatrica, Cambridge, Eng., C1-1

journal

Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?

P Conus, M Berk, P McGorry

(2006), Vol. 40, pp. 199-207, Australian and New Zealand Journal of Psychiatry, Australia, C1-1

journal

Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample

P Conus, S Cotton, A Abdel-Baki, M Lambert, M Berk, P McGorry

(2006), Vol. 8, pp. 221-231, Bipolar disorders, Chichester, Eng., C1-1

journal

The orygen first episode mania study. A randomised trial of olanzapine compared to chlorpromazine

M Berk

(2006), Vol. 9, pp. S44-S44, International Journal of Neuropsychopharmacology, Chicago, IL, E1-1

conference
2005

Depression and bone mineral density in a community sample of perimenopausal women: Geelong osteoporosis study

F Jacka, J Pasco, M Henry, M Kotowicz, S Dodd, G Nicholson, M Berk

(2005), Vol. 12, pp. 88-91, Menopause, C1-1

journal

The relationship between depression and cardiovascular disease

S McConnell, F Jacka, L Williams, S Dodd, M Berk

(2005), Vol. 9, pp. 157-167, International Journal of Psychiatry in Clinical Practice, C1-1

journal

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

M Berk, S Dodd

(2005), Vol. 65, pp. 39-43, Medical Hypotheses, C1-1

journal

Bipolar II disorder: A review

M Berk, S Dodd

(2005), Vol. 7, pp. 11-21, Bipolar Disorders, C1-1

journal

Efficacy of atypical antipsychotics in bipolar disorder

M Berk, S Dodd

(2005), Vol. 65, pp. 257-269, Drugs, C1-1

journal

The management of bipolar disorder in primary care: A review of existing and emerging therapies

M Berk, S Dodd, L Berk

(2005), Vol. 59, pp. 229-239, Psychiatry and Clinical Neurosciences, C1-1

journal

Diagnosis and management of patients with bipolar disorder in primary care

M Berk, S Dodd, L Berk, J Opie

(2005), Vol. 55, pp. 662-664, British journal of general practice, London, Eng., C1-1

journal

'Bipolar missed states': The diagnosis and clinical salience of bipolar mixed states

M Berk, S Dodd, G Malhi

(2005), Vol. 39, pp. 215-221, Australian and New Zealand Journal of Psychiatry, C1-1

journal

To combine or not to combine? A literature review of antidepressant combination therapy

S Dodd, D Horgan, G Malhi, M Berk

(2005), Vol. 89, pp. 1-11, Journal of Affective Disorders, C1-1

journal

Clinical Characteristics and Management of Bipolar Disorder in Women across the Life Span

Seetal Dodd, Spiri Katsenos, John Tiller, Michael Berk

(2005), Vol. 1, pp. 421-428, Women's Health, C1-1

journal

A review of clozapine safety

J Fitzsimons, M Berk, T Lambert, M Bourin, S Dodd

(2005), Vol. 4, pp. 731-744, Expert Opinion on Drug Safety, C1-1

journal

Atypical mood stabilizers: A 'typical' role for atypical antipsychotics

G Malhi, M Berk, M Bourin, B Ivanovski, S Dodd, J Lagopoulos, P Mitchell

(2005), Vol. 111, pp. 29-38, Acta Psychiatrica Scandinavica, Supplement, C1-1

journal

Australasian commentary on CANMAT guidelines for treatment of bipolar disorder

M Berk, I Shah, C Andrade, P Joyce, L Tiebang, K-S Ha

(2005), Vol. 7, pp. 83-86, Bipolar disorders, Copenhagen, Denmark, C1-1

journal

Executive functioning and theory of mind in euthymic bipolar disorder

A Olley, G Malhi, J Bachelor, C Cahill, P Mitchell, M Berk

(2005), Vol. 7, pp. 43-52, Bipolar disorders, Copenhagen, Denmark, C1-1

journal
2004

Scale matters: The need for a Bipolar Depression Rating Scale (BDRS)

M Berk, G Malhi, P Mitchell, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen

(2004), Vol. 110, pp. 39-45, Acta Psychiatrica Scandinavica, Supplement, C1-1

journal

Dietary omega-3 fatty acids and depression in a community sample

F Jacka, J Pasco, M Hensry, M Kotowicz, G Nicholson, M Berk

(2004), Vol. 7, pp. 101-106, Nutritional Neuroscience, C1-1

journal

The pharmacology of bipolar disorder during pregnancy and breastfeeding

S Dodd, M Berk

(2004), Vol. 3, pp. 221-229, Expert opinion on drug safety, London, England, C1-1

journal

Predictors of antidepressant response: A selective review

S Dodd, M Berk

(2004), Vol. 8, pp. 91-100, International Journal of Psychiatry in Clinical Practice, C1-1

journal

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use

S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud

(2004), Vol. 19, pp. 161-164, International Clinical Psychopharmacology, C1-1

journal

An audit of clinical outcomes and client and referrer satisfaction with a Mood and Anxiety Disorders Unit

R Lewis, E Musella, M Berk, S Dodd, H McKenzie, M Hyland

(2004), Vol. 10, pp. 549-552, Journal of Evaluation in Clinical Practice, C1-1

journal

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

H Grunze, S Kasper, G Goodwin, C Bowden, H-J Mller, M Berk, WFSBP Task Force on Treatment Guidelines for Bipol

(2004), Vol. 5, pp. 120-135, World journal of biological psychiatry, Abingdon, Eng., C1-1

journal
2003

Recent development in the treatment of bipolar disorders

M Berk, S Dodd

(2003), Vol. 12, pp. 1621-1632, Expert Opinion on Investigational Drugs, C1-1

journal

The evolution of clinical audit as a tool for quality improvement.

M Berk, T Callaly, M Hyland

(2003), Vol. 9, pp. 251-257, Journal of Evaluation in Clinical Practice, England, C1-1

journal

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.

D Wynchank, M Berk

(2003), Vol. 18, pp. 271-275, Human Psychopharmacology, England, C1-1

journal

Effects of electroconvulsive therapy on regional cerebral blood flow measured by ??m technetium HMPAO SPECT

M Vangu, J Esser, I Boyd, M Berk

(2003), Vol. 27, pp. 15-19, Progess in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1

journal
2002

Serological observations in patients suffering from acute manic episodes

A Wadee, R Kuschke, L Wood, M Berk, L Ichim, M Maes

(2002), Vol. 17, pp. 175-179, Human psychopharmacology, Chichester, Eng., C1-1

journal

Barriers to treatment among members of a mental health advocacy group in South Africa

S Seedat, D Stein, M Berk, Z Wilson

(2002), Vol. 37, pp. 483-487, Social psychiatry and psychiatric epidemiology, Berlin, Germany, C1-1

journal

Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat

M Yang, N Stull, M Berk, E Snyder, L Iacovitti

(2002), Vol. 177, pp. 50-60, EXPERIMENTAL NEUROLOGY, C1-1

journal
2001

Emerging options in the treatment of bipolar disorders

M Berk, J Segal, L Janet, M Vorster

(2001), Vol. 61, pp. 1407-1414, Drugs, Berlin, Germany, C1-1

journal

Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study.

G Schutz, M Berk

(2001), Vol. 16, pp. 275-278, International Clinical Psychopharmacology, England, C1-1

journal

Platelet glutamate receptor supersensitivity in major depressive disorder.

M Berk, H Plein, D Ferreira

(2001), Vol. 24, pp. 129-132, Clinical Neuropharmacology, United States, C1-1

journal

The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.

W Verbeeck, M Berk, J Paiker, B Jersky

(2001), Vol. 11, pp. 215-220, European Neuropsychopharmacology, Netherlands, C1-1

journal

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

M Berk, C Ichim, S Brook

(2001), Vol. 16, pp. 87-92, International Clinical Psychopharmacology, England, C1-1

journal

The platelet as a peripheral marker in psychiatric illness

H Plein, M Berk

(2001), Vol. 16, pp. 229-236, Human Psychopharmacology - Clinical and Experimental, C1-1

journal

Personality factors, stress and immunity

A Wadee, R Kuschke, S Kometz, M Berk

(2001), Vol. 17, pp. 25-40, Stress and health, Chichester, Eng., C1-1

journal
2000

Platelet supersensitivity to thrombin stimulation in depression: a possible mechanism for the association with cardiovascular mortality.

M Berk, H Plein

(2000), Vol. 23, pp. 182-185, Clinical Neuropharmacology, UNITED STATES, C1-1

journal

Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan

M Berk, D Stein, A Potgieter, C Maud, C Els, M Janet, E Viljoen

(2000), Vol. 15, pp. 291-295, International clinical psychopharmacology, Philadelphia, Pa., C1-1

journal

Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial.

L Ichim, M Berk, S Brook

(2000), Vol. 12, pp. 5-10, Annals of Clinical Psychiatry, United States, C1-1

journal

The specificity of platelet glutamate receptor supersensitivity in psychotic disorders.

M Berk, H Plein, B Belsham

(2000), Vol. 66, pp. 2427-2432, Life Sciences, England, C1-1

journal

Augmented platelet calcium uptake in response to serotonin stimulation in patients with major depression measured using Mn2+ influx and 45Ca2+ uptake.

H Plein, M Berk, S Eppel, N Butkow

(2000), Vol. 66, pp. 425-431, Life Sciences, ENGLAND, C1-1

journal

Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status.

H Plein, M Berk

(2000), Vol. 15, pp. 93-98, International Clinical Psychopharmacology, England, C1-1

journal

Pharmacotherapy of mania: a review

J Segal, S Walton, H Clark, M Berk

(2000), Vol. 4, pp. 171-193, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1

journal

Risperidone compared to haloperidol in cannabis-induced psychotic disorder: a double blind randomized controlled trial

M Berk, S Brook, F Nur

(2000), Vol. 4, pp. 139-142, International journal of psychiatry in clinical practice, Abingdon, Eng., C1-1

journal
1999

Relationship between serotonin and the temperament and character inventory

A Peirson, J Heuchert, L Thomala, M Berk, H Plein, C Cloninger

(1999), Vol. 89, pp. 29-37, Psychiatry Research, Shannon, Clare Ireland, C1-1

journal

A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial

M Berk, S Brook, A Trandafir

(1999), Vol. 14, pp. 177-180, International clinical psychopharmacology, London, Eng., C1-1

journal

Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia.

M Berk, H Plein, T Csizmadia

(1999), Vol. 14, pp. 119-122, International Clinical Psychopharmacology, ENGLAND, C1-1

journal

The platelet intracellular calcium response to serotonin and thrombin in patients with panic disorder.

H Plein, M Berk

(1999), Vol. 9, pp. 107-110, European Neuropsychopharmacology, NETHERLANDS, C1-1

journal

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa

D Stein, M Berk, C Els, R Emsley, L Gittelson, D Wilson, R Oakes, B Hunter

(1999), Vol. 89, pp. 402-406, South African Medical Journal, Claremont, South Africa, C1-1

journal
1998

Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial.

D Wynchank, M Berk

(1998), Vol. 8, pp. 21-23, Depression and Anxiety, UNITED STATES, C1-1

journal

The platelet intracellular calcium response to serotonin in subsyndromal depression

M Berk, V Mitchell, H Plein

(1998), Vol. 13, pp. 107-110, International clinical psychopharmacology, London, Eng., C1-1

journal

Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone.

S Saffer, M Berk

(1998), Vol. 14, pp. 89-93, The Journal of Electroconvulsive Therapy, UNITED STATES, C1-1

journal

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.

J Segal, M Berk, S Brook

(1998), Vol. 21, pp. 176-180, Clinical Neuropharmacology, United States, C1-1

journal

Selective serotonin reuptake inhibitor-induced disturbances of haemostasis - Mechanisms and therapeutic implications

M Berk, B Jacobson

(1998), Vol. 10, pp. 441-446, CNS Drugs, C1-1

journal
1997

A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.

D Mattson, M Berk, M Lucas

(1997), Vol. 158, pp. 487-494, The Journal of Genetic Psychology: Research and Theory on Human Development, United States, C1-1

journal

Acute phase proteins in major depression

M Berk, A Wadee, R Kuschke, A O'Neill-Kerr

(1997), Vol. 43, pp. 529-534, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1

journal

The augmented platelet intracellular calcium response to serotonin in anorexia nervosa but not bulimia may be due to subsyndromal depression

M Berk, K Kessa, C Szabo, N Butkow

(1997), Vol. 22, pp. 57-63, International journal of eating disorders, Chichester, Eng., C1-1

journal

An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder

M Berk, A du Plessis, M Birkett, D Richardt, Lilly Duloxetine Depression Study Group

(1997), Vol. 12, pp. 137-140, International Clinical Psychopharmacology, Philadelphia, Pa., C1-1

journal

A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania

H Clark, M Berk, S Brook

(1997), Vol. 12, pp. 325-328, Human psychopharmacology, Chichester, Eng., C1-1

journal
1996

Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls.

M Berk, N Kirchmann, N Butkow

(1996), Vol. 19, pp. 48-51, Clinical Neuropharmacology, United States, C1-1

journal
1995

The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients

M Berk, W Bodemer, T Van Oudenhove, N Butkow

(1995), Vol. 10, pp. 189-193, Human psychopharmacology: clinical and experimental, Chichester, Eng., C1-1

journal
1990

SPONTANEOUS-ABORTIONS IN REPEAT DIABETIC PREGNANCIES - A RELATIONSHIP WITH GLYCEMIC CONTROL

M MIODOVNIK, F MIMOUNI, T SIDDIQI, J KHOURY, M BERK

(1990), Vol. 75, pp. 75-78, OBSTETRICS AND GYNECOLOGY, C1-1

journal

ALTERATIONS IN CIRCULATING HUMAN CHORIONIC-GONADOTROPIN FREE ALPHA-SUBUNIT IN INSULIN-DEPENDENT DIABETIC PREGNANCY - CORRELATION WITH MATERNAL CHARACTERISTICS

F CAMUSBABLON, R COHEN, M BERK, G PERISUTTI, K HUNTER, L FROHMAN

(1990), Vol. 71, pp. 46-52, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, C1-1

journal
1989

ALLOXAN-INDUCED DIABETES-MELLITUS IN THE PREGNANT EWE - METABOLIC AND CARDIOVASCULAR EFFECTS ON THE MOTHER AND HER FETUS

M MIODOVNIK, F MIMOUNI, M BERK, K CLARK

(1989), Vol. 160, pp. 1239-1244, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, C1-1

journal

MACROSOMIA IN INFANTS OF INSULIN-DEPENDENT DIABETIC MOTHERS

M BERK, F MIMOUNI, M MIODOVNIK, V HERTZBERG, J VALUCK

(1989), Vol. 83, pp. 1029-1034, PEDIATRICS, C1-1

journal
1988

MAJOR MALFORMATIONS IN INFANTS OF IDDM WOMEN - VASCULOPATHY AND EARLY 1ST-TRIMESTER POOR GLYCEMIC CONTROL

M MIODOVNIK, F MIMOUNI, P DIGNAN, M BERK, J BALLARD, T SIDDIQI, J KHOURY, R TSANG

(1988), Vol. 11, pp. 713-718, DIABETES CARE, C1-1

journal

HIGH SPONTANEOUS PREMATURE LABOR RATE IN INSULIN-DEPENDENT DIABETIC PREGNANT-WOMEN - AN ASSOCIATION WITH POOR GLYCEMIC CONTROL AND UROGENITAL INFECTION

F MIMOUNI, M MIODOVNIK, T SIDDIQI, M BERK, C WITTEKIND, R TSANG

(1988), Vol. 72, pp. 175-180, OBSTETRICS AND GYNECOLOGY, C1-1

journal

IMPACT OF PREGNANCY ON COMPLICATIONS OF INSULIN-DEPENDENT DIABETES-MELLITUS

M BERK, M MIODOVNIK, F MIMOUNI

(1988), Vol. 5, pp. 359-367, AMERICAN JOURNAL OF PERINATOLOGY, C1-1

journal
1987

DIFFERENTIAL-EFFECTS OF INSULIN-INDUCED AND PROINSULIN-INDUCED HYPOGLYCEMIA ON PITUITARY-HORMONE AND CATECHOLAMINE SECRETION

T WILLIAMS, M BERELOWITZ, M BERK, L FROHMAN

(1987), Vol. 10, pp. 278-285, DIABETES CARE, C1-1

journal
1984

BETA-2-ADRENERGIC AND ALPHA-2-ADRENERGIC RECEPTORS AND RECEPTOR COUPLING TO ADENYLATE-CYCLASE IN HUMAN MONONUCLEAR LEUKOCYTES AND PLATELETS IN RELATION TO PHYSIOLOGICAL VARIATIONS OF SEX STEROIDS

S ROSEN, M BERK, D POPP, P SERUSCLAT, E SMITH, S SHAH, A GINSBERG, W CLUTTER, P CRYER

(1984), Vol. 58, pp. 1068-1076, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, C1-1

journal
undefined

Adjunctive antioxidants for bipolar disorder

Pedro Magalhes, Olivia Dean, Ana Andreazza, Michael Berk, Flvio Kapczinski

(), Cochrane Database of Systematic Reviews, C1-1

journal

Funded Projects at Deakin

Australian Competitive Grants

Providing evidence for the primary prevention of the high-prevalence mental disorders in men: the role of diet in the aetiology of depression, anxiety, and psychological distress

Prof Felice Jacka, Prof Michael Berk, Prof Julie Pasco, A/Prof Lana Williams

NHMRC Project Grant

  • 2014: $13,687
  • 2013: $142,302
  • 2012: $144,871

Diet as a therapeutic target in depression: A randomised controlled trial

Prof Felice Jacka, Prof Michael Berk, Prof David Castle, Dr Laima Brazionis, A/Prof Catherine Itsiopoulos, Dr Adrienne O'Neil

NHMRC Project Grant

  • 2015: $9,996
  • 2014: $114,611
  • 2013: $227,006
  • 2012: $65,002

Inflammatory cytokines as risk factors for the development of both depression and osteoporosis in men

Prof Michael Berk, Prof Julie Pasco, A/Prof Lana Williams, Prof Felice Jacka, Dr Margaret Henry

NHMRC Project Grant

  • 2014: $92,771
  • 2013: $129,413
  • 2012: $158,906

The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial

Prof Michael Berk, A/Prof Olivia Dean, A/Prof Susan Cotton, Dr Seetal Dodd, Prof Gin Malhi, A/Prof Chee Ng

NHMRC Project Grant

  • 2015: $69,545
  • 2014: $169,437
  • 2013: $74,883
  • 2012: $197,858

Developing evidence for the primary prevention of depressive disorders: The role of diet and physical activity

Prof Michael Berk, Prof Julie Pasco, A/Prof Evie Leslie, Prof Colin Bell, Prof Felice Jacka

NHMRC Project Grant

  • 2012: $196,827
  • 2011: $71,971

The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression

Prof Michael Berk, Prof Gin Malhi, Dr Seetal Dodd, A/Prof Olivia Dean

NHMRC Project Grant

  • 2012: $32,725
  • 2011: $48,924

Proof of principle of the inflammatory and oxidative theory of depression: A treatment study

Prof Michael Berk, Dr Andrew Chanen, Ms Susan Harrigan, Mr Christopher Davey, Dr Sarah Hetrick, A/Prof Olivia Dean, Dr Seetal Dodd

NHMRC Project Grant

  • 2018: $20,933
  • 2017: $102,975
  • 2016: $152,181
  • 2015: $110,745
  • 2014: $111,704
  • 2013: $105,227
  • 2012: $26,547

Novel therapies, risk pathways and prevention of mood disorders - Senior Principal Research Fellow (SPRF)

Prof Michael Berk

NHMRC - Research Fellowship

  • 2018: $177,653
  • 2017: $175,200
  • 2016: $172,781
  • 2015: $170,395
  • 2014: $167,382

Diet and nutritional status of people with major depression

Prof Felice Jacka, Dr Ewa Szymlek-Gay, Prof Michael Berk

MLA Grant - Research - Meat & Livestock Australia Limited

  • 2015: $84,485
  • 2013: $84,300

Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder

Prof Ken Walder, Prof Michael Berk, Prof Marion Leboyer, Prof Brian Dean

NHMRC Project Grant

  • 2017: $157,493
  • 2016: $207,762
  • 2015: $117,544

The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial.

A/Prof Olivia Dean, Prof Michael Berk, A/Prof Chee Ng, Dr Seetal Dodd, Prof Malcolm Hopwood, Dr Alyna Turner, Prof Felice Jacka

NHMRC Project Grant

  • 2019: $231,082
  • 2018: $342,644
  • 2017: $209,758

ARC Research Hub for Digital Enhanced Living

Prof Kon Mouzakis, Prof Svetha Venkatesh, Prof Anthony Maeder, Prof Alison Hutchinson, Prof Michael Berk, Prof Ralph Maddison, Prof Abbas Kouzani, Prof Rajesh Vasa, Prof Helen Christensen, Prof Patricia Williams, Prof John Yearwood, Prof Susan Gordon, Prof David Powers, Prof Nilmini Wickramasinghe, A/Prof Niranjan Bidargaddi, A/Prof Santu Rana, A/Prof Truyen Tran, A/Prof Sunil Gupta, Dr Wei Luo, A/Prof Mohamed Abdelrazek, Dr Felix Tan, Prof Henning Langberg, A/Prof Lars Kayser, Prof Finn Kensing, Prof Freimut Bodendorf, Prof James Warren, Dr Roopak Sinha, Prof A Smeaton, Mr Fonda Voukelatos, Mr Jeffrey Fiebig, Mr John Fouyaxis, Dr Kit Huckvale, Prof John Grundy, Dr Leonard Hoon, David Varley, Nicole Cockayne, Dr Tanya Petrovich, Mr Voytek Szapirko, Dr Hermant Ghayvat, Dr Anju Kissoon Curumsing, Matthew Macfarlane, Dr Scott Barnett, Dr Tom McClean, Prof Deborah Parker

ARC Industrial Transformation Research Hubs

  • 2019: $349,946
  • 2018: $449,083
  • 2017: $601,698

Novel therapies for psychiatric disorders

Prof Michael Berk

NHMRC - Research Fellowship

  • 2019: $165,292

CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders

Prof Michael Berk, Prof John McGrath, Prof Patrick McGorry, Prof John McNeil, Prof Gin Malhi, Prof Felice Jacka, A/Prof Susan Cotton, Prof Ken Walder, A/Prof Olivia Dean, A/Prof Lana Williams

NHMRC - Centres of Research Excellence

  • 2019: $467,816

The Candesartan Adjunctive bipolar DEpression Trial - CADET

Prof Michael Berk, Prof Gin Malhi, A/Prof Chee Ng, Prof Malcolm Hopwood, Ms Brisa Simoes Fernandes, Dr Stella Gwini, Dr John Amerena, Dr Mary Lou Chatterton, Prof Trisha Suppes, A/Prof Lana Williams

MRFF Clinical Trials Activity: Rare Cancers, Rare Diseases and Unmet Need Grant

  • 2019: $2,103,202

Other Public Sector Funding

MoodSwings: an online intervention for bipolar affective disorder

Prof Michael Berk, Ms Sue Lauder, Prof David Castle, Ms Monica Gilbert, Prof L Pitterman, A/Prof B Klein, Prof David Austin, Dr G Murray, A/Prof A Chester, Dr Seetal Dodd, Ms C Holdsworth, Dr J Chamberlain, Ms L Berk

  • 2011: $14,831

Using Lithium as a neuroprotectant in patients undergoing prophylactic cranial irradiation for small cell lung cancer - A feasibility study.

Prof David Ashley, Dr Greg Wheeler, Dr Mustafa Khasraw, Prof Michael Berk, A/Prof Robert Ramsay

  • 2012: $80,000

NHMRC Equipment Grant 2011 - Barwon Psychiatric Research Centre

Prof Michael Berk

  • 2011: $10,000

Personality disorders in the community

Prof Michael Berk, Ms Shae Quirk

  • 2015: $14,549
  • 2014: $27,642

Eppendorf Refrigerated Centrifuge 5702R

Prof Michael Berk

  • 2014: $8,100

Refrigerated Centrifuge and Vortex

Prof Michael Berk, A/Prof Olivia Dean

  • 2015: $8,187

NHMRC Equipment Grant 2016

Prof Michael Berk, Prof Ken Walder

  • 2016: $17,691

Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder

Prof Michael Berk, Mrs Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon

  • 2018: $99,872

Industry and Other Funding

Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial

Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Katherine Gray, Prof Bruce Tonge

  • 2013: $143,821
  • 2012: $119,640

Assessing an Online Psychotherapy Program for Bipolar Disorder

Prof Michael Berk, Dr Emma Gliddon

  • 2017: $3,500
  • 2016: $8,500
  • 2015: $17,000
  • 2014: $17,000
  • 2013: $17,000

The efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for the treatment of Schizophrenia: A double-blind, randomized, placebo controlled trial.

Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Alyna Turner, A/Prof Susan Cotton, Prof John McGrath, Dr Frances Dark

  • 2019: $32,055
  • 2018: $167,831
  • 2017: $363,170
  • 2016: $239,559

ARC Research Hub for Digital Enhanced Living

Prof Kon Mouzakis, Prof Svetha Venkatesh, Prof Anthony Maeder, Prof Alison Hutchinson, Prof Michael Berk, Prof Ralph Maddison, Prof Abbas Kouzani, Prof Rajesh Vasa, Prof Helen Christensen, Prof Patricia Williams, Prof John Yearwood, Prof Susan Gordon, Prof David Powers, Prof Nilmini Wickramasinghe, A/Prof Niranjan Bidargaddi, A/Prof Santu Rana, A/Prof Truyen Tran, A/Prof Sunil Gupta, Dr Wei Luo, A/Prof Mohamed Abdelrazek, Dr Felix Tan, Prof Henning Langberg, A/Prof Lars Kayser, Prof Finn Kensing, Prof Freimut Bodendorf, Prof James Warren, Dr Roopak Sinha, Prof A Smeaton, Mr Fonda Voukelatos, Mr Jeffrey Fiebig, Mr John Fouyaxis, Dr Kit Huckvale, Prof John Grundy, Dr Leonard Hoon, David Varley, Nicole Cockayne, Dr Tanya Petrovich, Mr Voytek Szapirko, Dr Hermant Ghayvat, Dr Anju Kissoon Curumsing, Matthew Macfarlane, Dr Scott Barnett, Dr Tom McClean, Prof Deborah Parker

  • 2019: $353,745

1/2 A Randomized Trial of Internet-Based Interventions for Bipolar Disorder

Prof Trisha Suppes, Prof Michael Berk

  • 2017: $81,508
  • 2016: $56,252

Development of MyMAPS, a novel integrative intervention for bipolar disorder

Prof Michael Berk, Mrs Lesley Berk, Ms Frances Quirk, Prof David Castle, Dr Steve Moylan, Mrs Janine Haigh, Prof Sheri Johnson, Dr Tim Denton, A/Prof Thilo Deckersbach

  • 2017: $9,090

The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial

A/Prof Olivia Dean, Prof Michael Berk, Miss Melanie Ashton

  • 2019: $12,750
  • 2018: $17,000
  • 2017: $13,136
  • 2016: $3,863

Can we reduce tobacco smoking using N-acetylcysteine as a cessation treatment?

Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean

  • 2018: $25,000
  • 2017: $25,000

MACH-3 Exploratory Depression Diagnostic Performance: An Abbreviated Investigational Device Exemption Study

Prof Michael Berk

  • 2017: $170,500

Development of MyMAPS, an innovative blended face-to-face and mobile application psychosocial intervention for bipolar disorder

Prof Michael Berk, Mrs Lesley Berk, Prof David Castle, Prof Malcolm Hopwood, Dr Mohammadreza Mohebbi, Prof Greg Murray, Prof John Grundy, Dr Mary Lou Chatterton, Dr Sue Lauder, Dr Emma Gliddon

  • 2018: $100,000

Beyond Blue Mentally Healthy learning Communities.

Dr Erin Hoare, Prof Felice Jacka, Prof Michael Berk

  • 2019: $25,000

Other Funding Sources

Deakin as a participant member of Mental Health CRC

Prof Michael Berk

  • 2018: $28,204
  • 2017: $98,592

Neon Open System Electroporator

Prof Ken Walder, Prof Michael Berk

  • 2019: $11,347

Supervisions

Principal Supervisor
2016

Emma Gliddon

Thesis entitled: Discussion Forum Engagement in an Online Intervention for Bipolar Disorder

Doctor of Philosophy (Medicine), School of Medicine

2015

Steven Edward John Moylan

Thesis entitled: Cigarette Smoking and Increased Anxiety Symptoms and Disorders

Doctor of Philosophy (Medicine), School of Medicine

2014

Jason Hugh Thompson

Thesis entitled: Attributions of responsibility for motor vehicle accidents and post-injury outcomes

Doctor of Philosophy (Medicine), School of Medicine

Associate Supervisor
2019

Melanie Ashton

Thesis entitled: Exploring factors that contribute to treatment response in bipolar depression

Doctor of Philosophy (Medicine), School of Medicine

2018

Srisaiyini Kidnapillai

Thesis entitled: Molecular Mechanisms of Action of Drugs Used to Treat Bipolar Disorder

Doctor of Philosophy (Medicine), School of Medicine

2017

Joanna Frith Dipnall

Thesis entitled: The Development of a Risk Index for Depression (RID)

Doctor of Philosophy (Medicine), School of Medicine

2016

Rajas Kale

Thesis entitled: Developing Neurostimulation Techniques to Investigate Antidepressant and Mood Modulating Behaviors

Doctor of Philosophy (Engineering), School of Engineering

Kevin Elliott Bennet

Thesis entitled: Diamond-Based Electrode for Chronic Sensing in Deep Brain Stimulation

Doctor of Philosophy (Engineering), School of Engineering

2015

Shae Quirk

Thesis entitled: Personality Disorders in the community

Doctor of Philosophy (Medicine), School of Medicine